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ABSTRACT 
SYNTHES I S  AND B I OLOG I CAL EVALUATI ON OF SPARSOMYC I N  ANALOGUES 
Scherer Preston Sanders Duke , Ph . D .  
Medical  Co l lege o f  V i r g i n i a  -- V i r g i n i a  Commonwe a l t h  Un iver­
s it y , 1981 
Maj or D i rector : Dr . M .  R .  Boo t s  
I n  1962 , Owen , D i etz , a n d  Camiener repor t ed the  i s o l a-
t ion of  a new an t i tumor ant ibiot i c  f rom the  cul ture f i lt ra t e  
o f  Streptomyces sparsogenes . The st ructure of t h e  crys t a l-
l in e  ant i b i ot i c , named sparsomyc i n , rema ined e lusive  unt i l  
1970 ,  when W i ley and MacKe llar reported resu l t s  o f  spect ro-
scopic and degradat ion  s t udies  wh ich  e luc i dated t he s t ructure . 
I n  add i t ion to the  mo lecu lar  st ructure , invest i gators have 
examined t he mechan ism of  act i on, t ox i c i t y , and related  
analogues , s t r i v ing  t o  e s t ab l ish  sparsomy c in or a synthet i c  
anal ogue ' s  usefulness  a s  an e f f ect ive chemotherapeut i c  agent . 
The i n i t i a l  pharmaco log i ca l  evaluat i on o f  sparsomy c i n  
revealed i t  pos sessed act i v i t y  aga inst  K B  human e p i dermo i d  
carc inoma ce l ls ,  a variety  of  gram-nega t i ve a n d  gram-pos i-
t ive bacter i a , and fung i . Th i s  broad spect rum of  act i v i t y  
prompted a c loser exam i n at ion of  t he b iochem i c a l  mechan i sms . 
These studies  reve a l e d  sparsomy c i n  interf ered with  prot e i n  
syn t hes i s  by i n h ib i t i n g  pept i de bond f o rmat ion near t h e  
xvi  
enzyme pept idyl  t ransferase . 
Ottenhe ijm , L i skamp , and T i j h u i s  reported the  f i rst 
total  synthes i s  o f  sparsomy c i n  in  1979 , wh ich  prov i ded ac­
cess t o  greater quan t i t ies  o f  the  mat e r i a l  for  invest i ga­
t ion al use . Sparsomy c i n  was s e l ected for use by  cancer 
pat i e n t s  in phase I c l in i c a l  t r ia l s , but was found to 
cause ocu lar  tox i c i t y  wh ich  h indered its  development  as an 
an t it umor agen t . I n  an e f fort to reduce or erad i cate  t h e  
t ox i c  e f f e c t s  wh i le ma i n t a in ing  the  an t i tumor act i v i t y , 
analogues o f  sparsomy c i n  were prepared . 
Us i n g  t he sparsomyc in  anal ogues wh ich  were synthes i zed , 
studies  were performed t o  determine the  e f f ect  a l terat ion 
o f  key s t ructural parameters  had on t he e f f i cacy o f  the  
compounds . Previous inves t i gators examined  analogues wh ich  
i ncorporat ed  mod i f i cat ions of  the  urac i l  r ing , t h e  un ique 
mono-oxo d i t h ioac e t a l  mO iety , and the st ereochem i c a l  con­
f igurat ion o f  the chiral cen ters . V i nce and Lee reported 
t he re was an apparent requi rement  for the Q- con f i gurat ion 
at t he asymme t r i c  carbon atom . Over a l l , however , t he sma l l  
n umbe r  o f  sparsomy c i n  analogues prepared and evaluat ed 
l imi ted t he de f i n i t ive s t a t emen t s  concern ing t he funct i on a l  
groups requ ired  f o r  an t i tumor act i v i t y . I n  order t o  expand 
and c l ar i f y  the  s t ructure-act i v i t y  relat ionsh ips , t h ree  
s e r i e s  o f  new sparsomy c i n  an a logues were prepared for t h i s  
proj ect . The compoun ds o f  Ser i e s  I a n d  I I , d i s t i ngu i shed 
by  t he i n c lus ion or exc l u s i on of a hydroxyme t h y l  funct ion al 
group , were des i gned to e l uc i date  the  e f fect  on act i v i t y  
xv i i  
o f  rep l a c i n g  t h e  mono- oxodi t h ioace t a l  s i de chain  o f  
sparsomy c i n  w i t h  4- sub s t i tuted benzy l groups . The Ser i e s  
I I I  an alogues, which  exc luded t he hydroxyme t h y l  funct ional  
group , f eatured a 4 - subst i tuted benzyl  ami de group i n  p l ace 
of the mono-oxod i t h ioace t a l  mo i e t y  o f  sparsomyc in , and were 
des i gned to i nvest i gate the  pot en t i a l  i n t e ract ion o f  an 
amide oxygen in  con t rast to the  sul fox i de oxygen of sparso­
myc i n . 
The t arget compounds synthes ized for  t h i s  proj ect were 
expe r i men t a l ly exam i ned to quan t i t at e  t h e i r  e f f e c t s  on 
ce l l  growth ,  [ 75S e ] - se lenometh ion i n e  incorporat ion as an 
i n d i rect measurement of prot e i n  synthes i s , and 5_12 5 I _ iodo_ 
2-deoxyur i dine  i n corporat ion as an i n d i rect measurement of  
DNA synthe s i s  i n  bone marrow , P388 lymphocy t i c  l eukemi a ,  
and P815  mas tocytoma ce l l s . The resu l t s  for the  Ser i es I 
and I I  anal ogues i n d i cated t h e  removal o f  the  hydroxymet h y l  
f un c t ion a l  group as seen i n  sparsomyc i n  a f fected  act i v i t y  
t o  vary i n g  degrees depend i n g  upon t he assay and t h e  type 
of ce l l s  used . The resu l t s  for the  Ser ies  I I I  compoun ds 
suggested  the removal of t he hydroxyme t h y l  funct ional  group 
and subs t itut ion of the mono-oxod i t h ioacet a l  s i de cha i n  o f  
sparsomyc i n  w i t h  a subst i t uted benzy l ami de mOi e t y  was n o t  
bene f i c i a l  for act i v i t y . F i n al ly , exam i nat ion of  t h e  
co l lect ive d a t a  revealed  t h a t  t he bromobenzy l -sub s t ituted  
an a logues cons i s ten t ly imparted the  greatest  i n h ib i tory 
act iv i t y , wh i l e  the  methoxybenzy l-sub s t ituted  an alogues 
d i sp l ayed the least . The methylbenzy l and t h e  unsubst i tuted 
xv i i i  
benzyl compounds were i n t e rmediate  i n  i n h i b i tory poten cy . 
The act i v i t y  may correspond to the  l ipoph i l i c and e le c t ron i c  
characte r i s t i c s  of  t h e  subst i t uent s on the  benzyl mo i e t y  
o f  the  an a logues . I t  appears that the bromobenzy l- sub-
s t i t uent of hydrophob i c  and e l e c t ron withdraw i n g  character 
i s  opt ima l for  inh ib itory act i v i t y , and converse l y , the  
met hoxybenzy l sub s t ituent  of  hydroph i l ic and e le c t ron don a t ­
i n g  character i s  l e a s t  des irab l e . 
I .  INTRODUCT I ON 
The adven t of  an t ib iot ics , i n i t i at ed by the  d iscovery of  
pen i c i l l in ' s  ant imicrob i a l  act i v i ty , marked a great advance 
in chemotherapy . S ince  that t ime , the  developmen t  and ex­
pans ion of s creen i n g  techn iques for chemot herapeut i c  agent s  
h ave enabled i n ve s t i gators to i s o l at e  several t housand new 
an t ib iot i cs , but few o f  t hese have d i s p l ayed the  se lect i ve 
toxi c i t y  des ired for c l in i c a l  use ( 1 ) .  To assess t h e  poten-
t i al  therapeut i c  value , each sub s t ance iden t i f ied requ ired 
de t a i led characte r i zat ion , inc luding inves t i gat ion of  the 
mechan i sm o f  act ion . 
I n  1962 , Owen , D i et z ,  and Cami ener reported the iso la­
t ion of  a new an t i tumor an t ib iot ic  f rom the  cu lture f i l t rate 
of  Streptooyces sparsogenes var . sparsogenes ( 2 ) . Separa-
t ion and pur i f i cat ion  of  t h e  an t ib iot i c  were ach ieved by 
Argoude l i s  an d Herr u s i n g  part i t ion chromatography and coun ­
t ercurren t d i s t r ibu i t i on ( 3 ) .  The s t ructure o f  the  cry s t a l ­
l i ne ant ib iot i c , n amed sparsomy c i n  ( F i gure I , rema i ned 
e lus ive unt i l  1970 when Wi ley and MacKe l lar reported resu l t s  
o f  spect roscop i c  and degradat ion studies  wh i ch e l uc i dated 
the  s t ructure (4,5). I n  add i t i on t o  the  t rans o l e f i n i c  bond , 
t h e  mo lecule featured one c h i ra l  carbon atom wh ich had S-con­
f i gur at ion , and one c h i ra l  s u l fur atom with R-con f i gurat ion ( 6 ) . 
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The in i t i a l  ph armacolog i c a l  evaluat ion of  sparsomyc in 
revealed  it possessed act i v i t y  aga i n s t  KB human ep idermo i d  
ca�ci noma ce l l s  in  t i ssue cul ture , again s t  a var i e t y  o f  gram­
negat ive and gram-po s i t ive bact er i a , and aga inst  fungi ( 2 ,  
3 , 7 , 8 ) .  The b io l o g i c a l  act iv i t y  d i s p l ay ed by sparsomyc in 
s t imulated  the  invest igat ion o f  the  b iochem i c a l  mechan i sms 
respon s i b l e  for the  broad spect rum of a c t i v i ty . Exper imen t s  
performed t o  measure DNA , RNA , and prot e i n  syn th e s i s  in 
E sche r i ch ia co l i  �. col i )  ce l l s  indicated sparsomycin  acted 
pr imar i ly by  inh i b i t ing prot e in synthe s i s  and corresponding­
ly , was  mos t cytotox i c  t o  ce l ls dur i n g  the  S phase  of t h e  
cel l c y l e  ( 7 , 9- 1 1 ) . 
Many an t i b iot i c s , inc luding sparsomyc in , accomp l ish  
t he i r  inh ib i t ion o f  prote in syn t he s i s  by i n t erfer ing  w i t h  the  
funct ion o f  r ibosomes , the  macromo lecu l ar comp lexes on wh i ch 
decoding o f  the gene t i c  message occurs ( 12 ) .  Prokaryot i c  
3 
and eukaro t i c  r i bosomes can be  d i s t i ngu i shed v ia sed imen­
t at i on coe f f i c ie n t s  ( abbreviated S )  and are re ferred to as 70S 
and 80S r ibosomes , respect ive l y . By d i a l y s i s  with  buffers  
con t a i n i ng magnes i um ions , r ibosomes can be f ract ionated 
into  subun i t s  wit� lower sedimentat ion coe f f ic ien t s . Bac­
t e r i a l  r ibosomes d i s so c i at e  into 50S and 30S fragme n t s  and 
mammal i an r ibosomes c leave into 60S and 40S s ubun i t s  ( 12 ) .  
The r i bosomes are spec i f i c a l l y  des igned for pro t e in 
synt he s i s  and i t  i s  at t hese s i t es that t h e  L- amino ac ids 
are assemb l ed an d coup led to form t he polypept ide chains  
wh i ch compose prot e i n s . The process can be  d i v i ded into  
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four s t ages ( 13-22 ) ( F i gure I I ) .  The f i rs t  s tage , t h e  act iva­
t ion s t ep is the on ly  one wh i ch t akes p l ace ent ire l y  i n  the  
solub le  cytopl asm . I n  th is s t age , t h e  ami no acids are  enzymat i ­
cal ly  e s t er i f i ed t o  t h e i r  correspon d i n g  tran s fe r  RNA ( tRNA ) 
molecules by  ami noacy l - t RNA syn thet ases . The product s of  t hese 
reaction s , t he ami noacy l - t RNA mo l e cu l e s , are used i n  the  
next s t age . Pr ior to t h e  secon d s t age , however ,  t h e  genet i c  
code of  t h e  DNA molecule  carry ing  t h e  i n f ormat ion spec i fy ing  
t h e  sequence of  ami no ac ids required for synthes i s  of a par­
t i cu l ar prot e i n  is  t rans c r ibed onto a newly  synthes ized 
s i ng l e  s t rand of mes s en ge r  RNA ( mRNA ) by the  act ion of RNA 
polymeras e .  Dur i n g  t h e  secon d st age , the  i n i t i at ion step , 
t h i s  mRNA and t h e  i n i t i a l  ami noacy l - t RNA of  t h e  sequence 
b ind to the sma l l  subun i t  of the  r i bosome ( 40S ) .  The l arge 
r ibosoma l subun i t , 60S , then a t t aches to form a funct ion a l  
r ibosome , whi ch i s  re ady to t rans l a t e  t h e  t ran scribed in­
format ion of  t h e  mRNA into the  correspon d i n g  prot e i n  mo lecule . 
Spec i f i c i ty of  prot e i n  synt h e s i s  i s  incorporated i n to 
t h e  b in d i n g  of  the  mRNA and the  ami noac y l - t RNA by the  i n ­
teract ion of spec i f ic nucleot i de b a s e  t r i p l e t s  present on 
each . The t RNA mo i et y  of  t h e  ami noacy l-t RNA mol ecule con ­
t ains  a t ri p l et of n u c l eot ides , the  an t i codon , wh i ch pairs  
by  hydrogen bon d i n g  w i t h  a comp lement ary t r ip l et , the  codon , 
on t he mRNA mol e cu l e . A l t hough r ibosomes do not con t r ibute 
to the spec i f i c i t y  of  prot e in synthes i s , t h ey provi de t h e  
approp r iate  e n v i ronment  for the  codon -ant i codon i n teract ion 
anticodon 
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and subsequent  pept ide bon d format ion . The r i bosome con ­
t a ins  two s it e s  on wh i ch the tRNA molecu les may be located 
dur i n g  the t h i rd st age of  prote i n  synthe s i s , the e longat ion 
c y c l e . Dur i n g  t h i s  st age the pept ide bon d i s  formed and 
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t he pol ypept ide chain  i s  lengthened . Pep t i de bon d format ion 
begins  with  the n ascent pept i de bound to one of the two s it e s , 
the  pept i d y l  donor s i t e  or P s it e , and the  aminoac y l -t RNA 
bound to the other , the aminoacy l acceptor s i t e  or A s i te . 
The f irst react ion to occur i s  the t ransfer of  the nascent 
pept i de to the aminoacy l - t RNA . Th i s  react ion i s  catal yzed 
b y  the enzyme pept i d y l  t ran s f e rase , an i n t egral part of  the 
l arger r ibosomal subun i t , and the product i s  a pol ypept i de 
lengthened at i t s  carboxy terminus by one amino a c i d  res i ­
due . The t ranslocat ion process fo l lows , wh ich sh i f t s  the 
e longated pept i de st i l l  a t tached to t RNA f rom the  A s i t e  to 
the P s it e .  Meanwh i le , the deac y l ated t RNA , wh ich  had car­
r ied  the nascent pept i de , is ej ected f rom theP s i t e  and the 
r ibosome moves toward the 3 '  end of  the mRNA by sh i f t i n g  
over one codon un i t . Repet i t ion of the process resu l t s  in  
a po lypept i de chain  l en gthened by sequen t ia l  add i t ion of  new 
amino ac i ds from the ami noac y l- t RNA esters , each bound to 
the r ibosome in  response  to a spec i f i c  codon in  the mRNA 
mo lecu l e . A f t er the format ion of each new pept i de bond , the 
r ibosome moves a long the mRNA a l i gn ing  the  next codon in  
the correct or i en t at ion to  b in d  w i t h  t he next aminoacyl -
t RNA an t i codon . Th i s  cont inues un t i l  the f in a l  s t age of  
prot e i n  synthes i s , the terminat ion s t ep , in  wh i ch appropr i a t e  
codons in  the  mRNA s i gn a l  the  comp let ion of  t h e  po l ypept ide 
chain  and the  product is  r e l e ased f rom the r ibosome . 
The mechan i sm of  pept ide bond format ion on r ibosomes 
was c l ar i f ied  through research performed to e luc i date the  
mode o f  act ion o f  the  ant ib iot i c  puromyc i n  ( 12 , 13 , 2 3 ) . Puro-
myc in is a s t ructural an a logue of aminoacy l -adenosine  ( Figure 
I I I ) , the  3 '  t ermin a l  n uc leot ide of aminoac y l - t RNAs . I n  
con t rast  t o  the  norma l e s t e r  l inkage between t h e  2 ' - o r  3 ' -
hydroxy l group of  the  r i bose mOi e t y  and the  carbox y l  group 
of the  amino a c i d  of the  aminoacyl - tRNA , puromyc in con t a in s  
a n  amide l inkage between i t s  sugar compon ent a n d  t h e  carboxyl 
group of  t h e  4-methoxyphen y l a lan i n e  port ion of  the molecule . 
Despi t e  t h i s  var iat ion , puromyc in can b in d  to the  r ibosomal 
A s i t e  in  a manner  an a logous to the 3 '  termi nus of  aminoacy l -
t RNA and can form a pept ide l inkage w i t h  t he nascent pept ide 
chain . Puromyc i n  int errupts pept i de chain e longat ion , how-
ever , as i t  forms a covalent  pept idyl-puromycin  der ivat ive . 
The format ion of  pept idyl -puromyc in can be  measured direc t ly 
3 
by det e rm i n i n g  the  i n corporat ion of [ H ] -puromyc i n  into 
n ascent  polypept i de chains  ( 24 ) . Since  the pept idy l-puromy -
c i n  wh ich  forms does  not have the  prec ise  s t ructure for 
recogn i t ion by the t r an s locat ion apparatus to move it  to the  
P s i te , t h e  der ivat ive d i s soc iates  f rom the  r ibosome . The 
s imi l ar i t ies between the puromy c i n  react ion and the t rue 
pept ide bond form i n g  react ion have promoted the puromyc i n  
react ion as a u s e f u l  model for s t udying  t h e  mechan i sm of  
pept ide bond format ion as wel l  as  the  mode of  act ion of  other 
7 
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ant i b iot i c s . 
Puromyc i n  has p l ayed a key ro le in  det e rm i n i n g  the 
mechan i sm o f  act ion o f  the an t ib iot i c  sparsomyc in , one of 
the f ew age n t s  found to spec i f i c a l ly i n h ib i t  prot e i n  syn-
thes i s  in both 70S and 80S r ibosoma l centers ( 7 ) . I n  an 
a t t empt to i den t i fy the prec i s e  locat ion of  i n teract ion , the  
puromy c i n  react ion has been  used to accumu l at e  e v i dence 
wh i ch sugges t s  that sparsomy c i n  inh i b i t s  the pept ide bon d 
forming  step  o f  prot e i n  syn t hes i s  ( 2 5 ) . I n  the  puromy c i n  
react ion , the t r an s f e r  o f  the  nascent  pep t i de chain  from the  
P s it e  of  t h e  r ibosome to the  ami no group of  puromyc in 
resu l t s  in  t he re l e ase of  the nascent pept i de f rom the  r ibo-
some as pept i dy l -puromyc in . Th i s  react ion i s  read i ly  b locked 
by sparsomy c i n  ( 16 , 2 3 , 26-32 ) ( F i gure I V ) . 
Experimen t s  per formed to ver i f y i t s  i n h i b i tory e f fect  
h ave shown t hat sparsomy c i n  b locks the  puromyc in - induced 
release  o f  po ly lys ine f rom po l y l ysyl - t RNA bound to Escheri-
ch i a  col i r ibosomes ( 32 , 33 ) . The format ion of  pol y l y s y l -
puromyc in serves as a mode l for the  format ion of  a s in g l e  
pept ide bon d . Sparsomy c i n  does  not cause the  deacy l at ion of  
po ly l y s y l- t RNA nor does i t  prevent t he b inding  of  aminoacyl -
t RNA , but i t  does  act as a compet i t i ve inh i b i tor of  the pep-
t idyl  t rans f erase react ion w i t h  respect  to puromyc i n  ( 25 , 27 ,  
28 , 34 ) . To further clar i fy t he act ion of  sparsomyc in , i t s  
e f fect  on t h e  l imited  addi t ion of  l abeled  l y s y l- t RNA to 
po ly l y s y l -t RNA bound to r ibosomes was stud i ed . Th i s  reac-
t ion has been shown to i nvolve the add it ion of  one l y s y l  
9 
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res i due p e r  react i n g  pept i de chain  and i s  ext reme ly sen s i t ive 
to inh ib i t ion by sparsomyc in . I ncreas ing the  concent rat ion 
o f  l y s y l - t RNA , for wh i ch puromy c in serves as an analogue , 
does not overcome the i n h i b i t ion . Th i s  resu l t  i s  expected 
s in ce aminoacy l - t RNA depends pr imar i ly on  codon recogn i t ion 
and in teract ion w i t h  the  sma l ler  r ibosoma l subun i t  for i t s  
b in d i n g  t o  t h e  r ibosome , whereas puromyc i n  i n t eract ion oc­
curs at another locat ion in  t h e  A s i t e  o f  the  r ibosome , 
presumab l y  w i th the  pept idyl  t ransferase i t se l f . The dat a  
s howi n g  t h a t  sparsomy c i n  compet es  w i t h  t h e  puromyc i n  but 
n ot w i t h  ami noacy l - t RNA b in d i n g  suggest that sparsomyc in , 
l ike puromy c i n , act s at or c lose to the  s it e  where pep t i de 
bond format ion takes p l ace , the pept idyl  t ransferase ( 33 ) . 
Add i t i on a l  support for the  suppos i t ion that sparsomy c i n  
inh ib i t s  pept i de bond format ion h a s  been gen erated f rom ex­
per imen t s  wh ich  examined the  format ion of  a s i n g l e  pept ide 
bond i s o l at e d  from the  other s t eps o f  po lypept ide synthes i s . 
One o f  the react ion s  studied , the  " f ragment react ion " , 
ut i l i zed  a short f ragment of  t ran s fer RNA , t h e  3' t ermi n a l  
cyt i dy l i c-cyt i dy l i c-aden y l i c  ac i d  res i due ( C-C-A ) . I n  t h i s  
react ion , a n  N- sub s t i tuted aminoacyl or pept idyl  mo i e t y  
a t t ached to t h e  short f ragment  s im i lar to the  3 '  terminus 
o f  t RNA was t ransferred to puromy c i n  or another acceptor 
in  t h e  presence of  on l y  the larger r ibosoma l subun it  ( 50S ) 
( 33 , 35- 4 1 ) . I n  an exper iment invest i gat ing  the  " fragmen t  
reac t i on " , acet y l leuc in e  was t ransf erred f rom C-C-A t o  puro­
myc i n , form i n g  acet y l  leucine-puromyc in  and C-C-A ( 36 ) ( F i g-
ure V) . Th i s  " f ragmen t react ion"  has t h e  advan t age that 
i n t eract ions between subs t rates and r ibosomes are con f ined 
t o  the  imme d i ate v i c i n i t y  of  pept i dy l  t rans ferase . Sparso­
myc i n  i n h i b i t s  t h i s  " fragment  reac t ion " , prov i d i n g  further 
e v i dence t hat i t s  t arget for  inhib it i n g  prot e i n  synthes i s  
i s  t h e  pept i d y l  t rans ferase . 
Supp lemen t ary reports  ind icate that sparsomy c i n  int er­
acts w i t h  r ibosoma l pept idy l t rans f e rase to form an inert 
complex  between the 50S subun i t  and the C- C-A-pept idy l 
mo i et y , t hereby " freez in g "  the  pept i d y l -t RNA in the  P s i t e  
o n  t h e  r i bosome ( 30 , 3 3 , 40 , 42-44 ) . Low con centrat ions o f  
sparsomy c i n  st imu l ate t h e  b in d i n g  of  pept i dy l - t RNA t o  r ibo­
somes whereby it  cannot be rel eased by puromyc in . The 
" f reez i n g "  e f fect  of sparsomy c i n  e v i dent in the  " fragment 
react i on "  may i nvo lve the steps shown in F i gure VI ( 30 , 38 ) . 
I n  the  f irst  s t e p , a C-C-A-pept i d y l  group b inffito the  P s i t e  
o n  t h e  50S subun i t , in  t h e  v i c i n i t y  of  t h e  pep t idyl  t rans-
f erase catalyt i c  center . I n  the secon d s t ep , the bound 
f ragment e i t her reacts w i t h  puromyc in  or i n t eracts w i t h  
sparsomy c i n  to g ive t he non i n t erconvert ib le  product s ,  pep­
t idy l -puromy c i n  or the sparsomy c i n  complex , respect ive l y . 
12 
The format ion of  e i t h er product i rreve r s ib l y  b locks t he normal 
process o f  pept i de e l ongat ion . 
The preponderan ce o f  ev idence substan t iates  t h e  hypo­
t h e s i s  that sparsomy c i n  inter feres w i t h  prot e i n  synthe s i s 
b y  i nh ib i t i n g  pept i de bond format ion by  pept i dy l  t ransferase . 
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FIGURE1Zr. PROPOSED S C HEME OF S PARS OMYC IN 'S 
MECHAN ISM OF ACTION 
Pestka ( 2 8 , 24 )  h ave observed that i n h i b i t ion  by sparsomy c in 
of  the  react ion between r ibosome-bound aminoacyl - t RNA and 
puromy c in d i sp lays compet i t ive k i n et i c s . Th i s  sugges t s  
t hat sparsomy c i n  i n t erferes w i t h  t h e  pept i de bond form i n g  
step  e i ther  d i rec t l y  or by a n  a l l o s t e r i c  mechan i sm .  
I n  order t o  fac i l i t ate t h e  study o f  sparsomy c i n , i t s  
b i ochem i c a l  mode o f  act ion , pharmaco logy , an d tox i co logy , 
a synthet i c  rout e for  produc t i on of  the  drug was sough t . 
15  
Unt i l  1979 , sparsomy c i n  had to be  obtai ned by i so l at ion f rom 
bact e r i a  f o l l owed by pur i f icat ion . I n  t hat year , Ottenhe ij m ,  
L i skamp , and T i j h u i s  reported the f i rst t o t a l  syn the s i s  of  
the  enant iomer of  n a t ural l y  occurr ing sparsomy c i n  ( 4 5 ) . 
The sparsomy c i n  mo lecule  was d i v i ded i n t o  two inter­
med i at e  segme n t s  ( A  and B ) , wh ich  were coup led  i n  the  f i n a l  
s t e p  of  a convergent synthes i s  ( Fi gure V I I ) .  Two procedures 
were developed for the p reparat ion of  i n t e rmed iate  A ,  the S ­
urac i l y l acry l i c  a c i d  � ,  w i t h  a trans con f i gurat ion  ( 46 )  
( Scheme I ) .  Bot h  preparations began w i t h  5-hydroxyme t h y l-
6-met h y lura c i l (�) made from 6-methy l urac i l  (1) w i t h  forma l ­
dehyde an d aqueous sodium hydro x i de . When t he hydroxy­
meth y l  urac i l  2 was t reat ed w it h  h ydrobrom i c  a c i d  i n  g l a c i a l  
acet i c  a c i d , the  a l k y l  bromide 7 resul ted , wh i c h  coul d  b e  
converted i n t o  t h e  phospho n i um s a l t  8 by reac t i n g  2 w i t h  t r i ­
pheny lphosph i n e  i n  d imethy l formamide. A W it t i g  reac t ion o f  
t h e  phosphon ium s a l t  � and �-but y l  g lyoxy l ate  a f f orded a 
l ow y i e l d  of� .  Th i s  approach was aban doned when an a l t er­
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a l cohol 2 was o x i d i zed  to the a ldehyde 1 w i t h  potass i um per­
sul fate and a trace of s i lver n i t rate . I n  an inverse W i t t i g  
react ion , t h e  a l dehyde 3 was coup led w i th carbethoxymethy l­
ene t r iphen y l phosphorane i to form the  ester 5 in  the  t rans 
con f i gurat ion . Alkal ine  hydro l y s i s  of  the e s t er i n  d ioxan e , 
methan o l , and wat er , fol lowed by ac�d i f icat ion gave the  a c i d  
6 ( Scheme I ) .  
The second key in termediate  B ,  the protected ami n o  al­
coho l mo i e t y  ( 16 )  of  sparsomy c i n , was cons idered as an �­
al kylated der i vat ive of cyste i n e  ( Scheme I I  and I I I )  ( 45 , 4 7 ) . 
Syn thes i s  o f  t h i s  port ion of  the mo lecule began by t reat i n g  
�-ben z y loxycarbo n y l  �-cyst i ne met h y l  e s t e r  10 ( R  con f i gurat ion ) 
w i th c h l o r i n e  i n  the presence of  ace t i c  anhydr i de to give  
the  su l f i n y l  ch lor i de 1 1 . Th e sul f i ny l  chlor i de 1 1  was  re­
acted w i t h  d i azomet hane t o  gi ve the ch loromet hyl sul foxide 12 . 
Sub s t i tut i o n  o f  the  chloro funct ion i n  12  w i t h  meth y l  me r­
capt ide had to occur a f t e r  reduction of  the ester  fun c t ion , 
t o  avo i d  c leavage o f  the thioacetal  s i de chain . Th e ester  
fun c t ion of  12  was  reduced w i t h  l ith ium borohyd r i de produc i n g  
the  a l coho l 1 3 . T o  c i rcumvent prob lems w i t h  cyc l izat i on, 
the a l coho l funct ion of 13 was protected w i t h  the tet rahy­
dropyran y l  group form i n g  li. Treatment  o f  t h e  protected 
a l cohol  14 with sod ium meth y l mercapt i de i n  e t hano l  gave the  
des i red  mono-oxo d i t h ioacetal  15 . The  prob lem of  select ive 
removal of  t h e  benzy l oxycarbon y l  group was surmounted by 
t reat i n g  a s o lut i on of  1 5  i n  l i qu i d  ammon i a  with sod ium . 
The des i red ami n e  16 was i s o l at ed b y  co lumn chromatography . 
o C�CH3 
II I 0-CH2-0-C-N-C-H 
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SYNTH ESIS OF FRAGM ENT 8 
SCHEME I I I  
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The two i n t ermediates  of  the  convergent  synthes i s , the 
acry l i c  acid � and the amine  16 , were coup led us i n g  dicyclo­
hexy l c arbod i im i de and hydroxybenz t r i azole to g ive 1 7  
( Scheme I V ) . The t et rahydropyran y l  group of  1 7  was re­
moved by heat i n g  at ref lux an a c i d i f ied e t hano l  solut ion 
o f  1 7  for  fifteen m i nutes t o  g ive the  f in a l  product , enan t io­
mer i c  sparsomy c i n , 18 . 
The comp l et ion o f  the  t o t a l  synth e s i s  o f  sparsomy c i n  
was a s i gn i f i cant accompl i shmen t  as it provi ded  access t o  
greater quan t i t i es of  the  mat e r i al f o r  inve s t i gat ional  use . 
Sparsomy c i n  has aroused the  i n terest of  i n ve s t i gators not 
2 1  
o n l y  f or i t s  synthet i c  challenge and va lue as a tool  for 
b iochem i c a l  s t ud i es prob i n g  the  mechan i sm of  prote i n  syn­
t h e s i s , but  also  for  its  act i v i t y  as an  ant i tumor agent . 
Spars omy c i n  has been of  l im i t ed va lue in  the  t reatment of  
cancer in  man , however , due to its  t ox i c i t y  ( 33 , 48 ) . Dur i n g  
p h a s e  I c l in i c a l  t r i a l s , sparsomy c i n  caused unusual ocu l ar 
tox i city wh i c h  h in dered i t s  deve lopment as an an t i tumor agent . 
Analogues o f  sparsomy c i n , ob ta ined by st ruct ural l y  mod i fy in g  
t h e  chem i c a l  compos i t ion o f  t he mo lecule , may reduce o r  
erad i cate  t h e  t o x i c  ef f e c t s  o f  sparsomy c i n  wh i le ma i n t a i n i n g  
i t s  an t i t umor act i v i t y . Preparat ion and evaluat ion o f  such 
agen t s  are the a im of t h i s  research . 
o 
OH H II � I ..... C-OH 
N ::;;o- C=C 
I 'H 
HO�N C H3 
6 
+ N H2 - � � H 
I DCC C H2-&-CH2 -S-C H3 , 16 
CO NVERG E N T  S Y N T H E S I S OF SPA R S OM YCI N 
SCHEME IV  
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I I . RESEARCH A I M  
Pharmaco l o g i c a l  studies  have revealed that sparsomy c i n  
possesses a broad spect rum of  b io l o g i c a l  act i v i t y , i n c l ud i n g  
ant i tumor , ant i fungal , a n d  ant ibact e r i a l  propert ies . On 
the  bas i s  of i t s  s i gn i f i cant ant i t umor act iv i t y , sparsomy c i n  
was selected  for  phase I c l i n ical  t r i a l s . A s  d iscussed in  
t h e  previous chapt e r , the  study was t ermi n ated due t o  t he 
occurrence of  ocu lar tox i c i t y  ( 48 ) . The des ire  t o  nul l i fy 
t h e  t o x i c  prope rt i e s  and c l ar i f y  t he b iochem i c a l  mode of  
act i on prompted t h e  devel opment o f  sparsomy c i n  analogues 
( 49- 52 ) .  
2 3  
The f irst  act ive  analogue of  sparsomy c i n  was reported b y  
V ince , Browne l l , and Lee ( 52 )  in  1977 . The s t ructure o f  
t h i s  analogue ( F i gure V I I I )  incorporat ed  a n  �- deoxo -�- propyl 
mo i e t y  i n s t ead o f  t h e  mono-oxod i t h ioace t a l  s i de chain  of  
sparsomy c in . The  � - deoxo-�-propy l sparsomy c i n  an alogue 
s i gn i f i c an t ly inh ib i t ed prot e i n  synthes i s  by �. co l i  
r ibosomes. The act i v i t y  exh ib i t ed by t h i s  s imp l i f ied sparso­
myc i n  mo lecule  led to the synthes i s  of  add i t ional  analogues 
to e s t ab l i s h  a more extens i ve st ructure-act i v i t y  r e l at ion­
ship f or t h e  ant ib i ot i c . 
Lee and V in ce ( 50 )  reported  the  synt hes i s  o f  several 
sparsomy c i n  an a logues wh i c h  con t ained  mod i f i cat ioffiof the 
amino a l cohol  port ion o f  sparsomy c i n  ( Tab le  I ) .  I n  t h e i r  
F I GURE VI I I . S- DEOXO- S-PROPYL SPARSOMYC I N  ANALOGUE 
25  
TABLE I :  COMPET I T I VE I NH I B I TION OF  N-ACETYL [ 14C ]  PHENYLALANYL­
PURO�YC I N  SYNTHES I S  BY E .  COL I R IBOSOMES W I TH SPARSO­
MYC I N  ANALOGUES (49 ) 
-
--
OH 0 CH20H H II I 
N / 'H I I :)C=C-C-N -CH 
1"" I H CH2R 
HO�N CH3 
R STEREO- K. (\.1M )  
CHEMI STRY 1 
SPARSOMYC I N  12 0 . 50 ± 0 . 0 1 
SCH2SCH3 .IlL 1 .  09 ± 0 . 13 
S(CH2 ) 2CH3 DL 2 . 00 ± 0 . 19 
S(CH2 ) 2CH 3 D 1. 10 ± 0 . 1 3 
S(CH2 ) 2CH3 L I NACT I VE -
SCH2C6H5 DL 1 . 2 1 ± 0 . 14 
H DL I NACT I VE 










work , Lee and V i n c e  assessed the  s t e reochem i c a l  spec i f i ­
c i ty o f  b in d i n g  of  t h e  �-deoxo-�-prop y l  analogue by  pre­
pari n g  t he D and L i somers 18b , 18c , 18d . S in ce the  ch i ­
ra l i t y  o f  t h e  asymme t r i c  carbon o f  sparsomy c i n  was i dent i c a l  
to the  ch i ra l i t y  of  Q cyste i n o l  ( 5 ) ,  V i nce a n d  Lee an t ic i­
pated  o n l y  the D i s omer o f  the  racem i c  an a logues wou l d  be 
capab le  of r ibosoma l b in d i n g . As  expected , the  Q i somer 
18c  of  t h e  �-deoxo-�-prop y l  analogues was about wice  as 
act i ve as the DL mixture 18b i n  i n h ib i t i n g  the  puromyc i n  
react ion in  E .  co l i  ribosomes . Lin  and Dubo i s  ( 51 )  sub­
s t an t i at e d  the con c lus ion that t he act i v i t y  of sparsomy c i n  
analogues h a d  a Q con f i gurat ional depen dency . 
I n  add i t i on t o  the  st ereochemical  requiremen t s , Lee 
and Vince stud i e d  the  con t ri but ion to r ibosoma l b in d i n g  by  
26  




port ion of  sparsomy c in (50 ) . 
A comp a r i son o f  �- deoxosparsomyc i n  ( 18a ) and t h e  S- deoxo- S­
p ropyl  analogue ( 18b ) showed a two f o l d  decrease i n  b in d i n g  
when a sul fur was rep l aced by  o n e  met h y lene  un i t . Th i s  
resu l t  i n d i cated t h e  sul fur atom d i rect l y  con t r ibuted t o  
b in d in g  o f  �. co l i  r ibosomes . Further mod i f i cat ions o f  t h e  
d i t h ioac e t a l  port ion  of t h e  mo lecu le  resu l t e d  in  t h e  pre­
parat ion o f  a compoun d i n  whi ch the  ent i re mono-oxodi t h io­
ace t a l  s i de chain  was rep l aced by  a hydrogen atom ( 18f ) . 
Thi s  analogue was comp le t e l y  i nact ive . Conver s e l y , repl ace ­
men t o f  t h e  mono-oxodi t h ioacetal s i de chain by an �-deoxo-�­
benzyl  group ( 18e ) resul t e d  i n  a der ivat ive wh i ch d i s p l ayed  
b in d i n g  comparab le t o  �- deoxosparsomy c i n . The exper imen t a l  
data sugge s t e d  h ydrophob i c  groups exten d i n g  i n t o  the region 
o ccup ied by the  -CH -S-CH ch a i n  o f  sparsomyc in  were t o lerat -2 3 
ed . 
Another  s t ructural parameter examined by Lee and V ince 
was t h e  s u l fox i de mOi e t y  of  sparsomyc i n . A compar i son of 
the K .  va lues der ived f rom E .  co l i  r ibosomes for D sparso-1 - ---- -
myc i n  ( 18 )  and DL-�-deoxosparsomy c i n  ( 18a ) showed the  c a l cu-
lated value for  Q-deoxosparsomy c i n  was equ i valent  t o  the 
0 . 5  �M  value of sparsomy c i n . Th i s  led to t he conc lus ion 
that the  sul f o x i de oxygen did not s ign i f ican t ly con t r ibute 
t o  b in d in g .  Moreover , the  �-deoxo-�-propyl analogue 18b 
and the  analogue � wh i ch lacked both sul fur atoms d i s-
p l ayed equivalent  b in d i n g  af f i n i t i e s  i n d i cat i n g  t hat r e l a-
t ive l y  l it t l e  b i nd i n g  was a t t r ibuted t o  the  sul fox i de sul fur . 
Other  expe r ime n t s  demons t rated , however , that the sul fox i de 
moi e t y  s i gn i f i cant ly con t r ibuted to sparsomy c i n ' s  ab i l i t y  
t o  i n h ib i t  t h e  puromy c i n  react i on . When sparsomy c i n  was 
i ncubated w i t h  t h e  r ibosomes p r i o r  to the add i t ion of puro-
myc i n , an i ncreased i n h i b i t ion o f  the puromy c i n  react i on 
was noted . Convers e l y , preincubat ion of  the  �-deoxosparso-
my c i n  an a logue 18a  w i t h  r ibosomes did not a f f ect the  l evel 
o f  inh i b i t ion of  t h e  puromyc i n  react ion . Lee and Vince 
suggested t hat the  i n i t i a l  reve r s i b le sparsomy c i n- r ibosome 
comp l e x  ( SR )  changed i t s  conformat ion . The conformat ional  
chan ge , wh i c h  may  have i nvolved t h e  format ion o f  an  i rrever-
s ib l e  comp l e x  ( SR ) , en ab led  sparsomy c i n  to b ind more t ight­
ir 
l y  t o  the  r ibosomes t han �-deoxosparsomy c in ( Equat ion I ) . 
2 7  
S + R1.,.j41======��SR __ �k_--,... SR 
K i r  
i 
EQUAT I ON I 
2 8  
S ince  the K i values  reported b y  V i nce and Lee represented 
the  d i ssoc i at i on cons tan t  of  the  i n i t i a l  reve r s i b le complex , 
t h e  con c l us ion t h at the  sul f ox i de mo i e t y  of  sparsomy c i n  was 
not i n vo l ved  in the  i n i t i a l  b in d i n g  to the  r ibosome was 
29 
val i d .  The results  sugge s t , however ,  that a sul fox i de mo i e t y , 
or  equivalent subst i t ut ion , may enab le  t h e  sparsomy c i n  mo le­
cule t o  undergo add i t i on a l  react ion at the  b in d i n g  s it e  
w h i c h  re sults  i n  i r revers i b l e  i n h i b i t ion of  t h e  puromy c i n  
react i on . 
The f in a l  s t ructural feat ure o f  the  spars omy c i n  mo lecule  
examined by the  i nves t i gators prepar i n g  an alogues was the  
urac i l  r i n g . Dubo i s , et  a l . (49 ) repl aced the  urac i l  r i n g  
b y  numerous h eterocy c l i c  r i ngs . None o f  t h e  het e rocy c l i c  
analogues d i s p l ayed an t i tumor act i v i t y  when assessed i n  
systems us ing  P388 l ymphocyt i c  o r  L-1210 lympho i d  leukemia . 
The data sugge s t e d  t h at the  urac i l  r i n g  was requi red for 
opt ima l act i v i t y . 
Overa l l , the  smal l  n umber of  sparsomy c i n  ana logues 
prev ious l y  prepared and evaluat e d  l im i t e d  de f i n i t i ve 
s t at emen t s  con cern i n g  t h e  spec i f i c funct i onal  groups requ i red 
for  an t i tumor act i v i t y . I n  order to expand and c l a r i f y  t h e  
s t ruct ure- act i v i t y  re l at i on s h ips f or sparsomy c i n , t h e  s y n ­
thes es o f  f o u r  ser ies  o f  nove l an alogues o f  sparsomy c i n were 
proposed (Fi gure IX and X ) . The compounds of Series  I and I I  
were des i gned to e luc i date the  e f fect on act i v i t y  of  rep lac­
i n g  t h e  mono-oxo d i t h ioace t a l  s i de cha i n  o f  sparsomy c i n  with  
hydrophob i c  groups . To mo re c le a r l y  de f ine the  i n teract ion , 
F I GURE I X . PR0POSED C0MPOUNDS OF SERIES I AND I I  
OH 0 CH20H � I I  I 
N :7 CH=CH-C-N-CH � I � tH2-o� R HO N CH3  -
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S E R I E S II 
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F IGURE X .  PROPOSED COMPOUNDS OF SERIES I I I  AND I V  
o H O H  II I :r C H = C H - C- N -C H  N :;;.-- I I h I H C H2 - C- N - C H 2 �R H O  N C H 3  II I -o H 
R = H 
C H3 
OCH3 
B r  
3 , 4 d i CI 
S E R I ES ill 
O H  0 C H 20H 1 \  , :tC H = C H - C - N - C H  N /  I I 'I � I H C H 2 -C - N - C H 2�R H O  N C H 3 I I  1 -"==-/- -
o H 
R = H 
C H 3  
O C H 3  
B r  
3, 4 d i CI 
S E R I ES I.1l 
3 1  
subs t i tut i o n s  on t h e  phen y l  r i n g  were made wh i ch varied the  
e le c t ron ic  and hydrophob i c  charact e r i s t i c s  o f  the  phenyl s ide 
chain . To further an a lyze t h e  requi reme n t s  for act i v i t y ,  
t h e  two s e r i e s  were des i gned to i n c l ude (Ser i e s  I )  or ex­
c lude (Se r i e s  I I ) ,  the h ydroxyme t h y l  fun c t ional  group found 
32 
i n  sparsomy c i n . The compounds o f  Ser ies  I I I  and IV were pro­
posed to i nves t i gate  the poten t i a l  i n t eract ion o f  an amide 
oxygen i n  con t rast to the  sul foxide oxygen o f  sparsomy c i n . 
Analogous t o  S e r i e s  I and I I , a hydrophob i c  phe n y l  r i n g  w i t h  
d i ve r se sub s t i tuen t s  was i n c l uded to e l aborate the  s t ructure­
act iv i t y  r e l at ionsh ips o f  sparsomy c i n . As i n  Ser i e s  I and I I , 
t h e  feature d i s t i n gu i sh i ng between Series  I I I  and IV  was 
t h e  i n c l us i on or exc lusion  of the hydroxyme t h y l  mo i e t y . 
Upon comp let ion o f  the  synthet i c  phase o f  t h i s  proj ect , 
pharmaco l o g i c a l  studies  u s i n g  bone  marrow ce l l s , P388 l ymphoma 
ce l l s , an d P 8 1 5  mastocytoma ce l l s  wi l l  be performed to assess 
the  ab i l i t y  o f  sparsomy c i n  and t h e  proposed analogues to 
i n h ib i t  prote in synthes i s , DNA synthes i s , and ce l l  growth . 
I I I . D I SCUSS I ON OF SYNTHE S I S  
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Analogous to t h e  approach for the  t o t a l  syn t hes i s  o f  
sparsomyc i n , t h e  st ruct ure of  t h e  t arget sparsomy c i n  ana­
l ogues was v iewed as con s i st i n g  of two f ragme n t s  wh ich  cou l d  
be  coupled  in  t h e  f in a l  s t e p  of  a convergent synthes is . The 
synthes i s  of each t arget analogue ut i l ized the s ame fragment 
A ,  t h e  8 -urac i lacry l i c  acid Q .  The second f ragmen t , the 
amino mo i e t y  o f  t h e  analogues , i n t roduced the  port ion of 
t h e  mo l e cu l e  wh i ch made t h e  ana logues un i que . A l l  of  the  
amino fragmen t s  were prepared f rom racemic start i n g  mater­
i a l s , wh i ch after  coupl i n g  with  acid  Q,  led to racemic 
f in a l  produc t s . 
The preparation o f  the  a c i d  Q (Scheme V )  was we l l  docu­
men t e d  in t he l i terat ure (4 , 5 , 4 5-47 ) and began w i t h  5-hy­
droxyme t h y l -6-me t h y l urac i l  (�) prepared b y  reac t i n g  6-methy­
l urac i l  (1)  with  formaldehyde and aqueous sodium hydrox i de . 
The a l cohol 2 was oxidized t o  the  a l dehyde � w i t h  pot ass i um 
persu l fate  and a c a t a ly t ic amount of  s i lver n it rat e . I n  
a W i t t i g  react ion , the a l dehyde � was condensed w i t h  carb­
e t h o�thY l en e t r iphenylphosphorane (4 ) ,  wh ich  was synthe­
s ized by the  method of I s le r , e t  a l . ( 53 ) , us i n g  t r iphen y l ­
phosph ine  a n d  e t h y l  bromoace t at e . The product of  t h e  W i t t i g  
react i on , e s t e r  �, con t ained  a t rans doub l e  bond a s  deter­
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3 5  
protons i n  t h e  NMR , J = WH z  (54 ) . Alka l i n e  hydro l y s i s  o f  t h e  
e s t e r  5 i n  d i oxane , methanol , a n d  water , f o l lowed by ac i di f i­
cat ion , gave the  a c i d  � i n  quan t i t at ive yie ld . 
I n  t h e  f in a l  step  of  the  s y n t hes i s  of  each novel com­
poun d ,  the  a c i d  � was coup led  w i t h  an amino fragme n t  v i a  an 
amide bon d . �-Ethoxycarbony l -2-et hoxy- 1 , 2-dihydroquino l i n e  
(EEDQ ) ( 5 5 ) was the  reagen t chosen to e f f ect the  coupl i n g . 
The mechan i sm for t h e  coup l i n g  react ion  u s i n g  EEDQ i nvolved 
the  f o rmat ion  o f  a m i xed carbo n i c  anhydr i de of  t he ethoxy­
c arbon y l  segmen t  of EEDQ w i t h  the  a c i d  6 .  The anhydr i de was 
subsequen t ly a t t acked by the nuc leoph i l i c ami n e  of t he ami n o  
f ragme n t  form i n g  a n  amide bon d .  Prior  t o  t he synt he s i s  o f  
t he t arget analogues , t h e  feas ib i l i t y  o f  t h e  coup l i n g  re­
act i on was t e s t ed in a model system . Us i n g  the method of 
Lin and Dub o i s  ( 51 ) , 2-aminoheptane was reacted w i t h  a c i d  6 
t o  form compound 19 . S i nce  t h e  react ion  was success f u l  i n  
a f for d i n g  a good y ie l d  of  a read i l y  obt a i nab le f in a l  pro­
duct , EEDQ was chosen as the coupl i n g  reagent for the syn­
t hes i s  of a l l  of t h e  f i n a l  compounds . 
I n  the f i rs t  ser i es o f  analogues , 22 , 24 , 28 , and 35 , 
the  ami n o  f r agment s  of  the  an alogues were der ived f rom sub­
s t i t ut e d  phen y l a l an ine  compoun ds . To prepare the amino 
f r �gmen t  for  compound 22  (Scheme V I ) ,  pheny l a l an i ne was 
e s t e r i f i e d  by t h e  procedure of Dubo i s , et  a l . (49 ) , a f ford­
i n g  t he met h y l  ester  20 . Us i n g  the  method o f  B i rkofer and 
E r l enbach ( 56 ) , the  ester 20 was reduced w i t h  l i t h ium alum­
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n a l  s t ep in  t h e  synthes i s  o f  compound 22  was the  coup l i n g  
o f  ami no-a l coho l 2 1  w i t h  aci d  � using  EEDQ . 
The second compound o f  Series  I ,  the  bromo sub s t i tued 
an alogue 2 4 , was prepared b y  the met hod o f  Anhoury , et  al . 
( 57 ) , whi c h  shortened t h e  synthet i c  approach b y  one step . I n  
t h i s  syn t hes i s  ( Scheme V I ) ,  4-b romopheny l a l an i ne was d i re c t ­
l y  reduced w i t h  borane in tet rahydrofuran ( 58 , 59 )  t o  a f f ord 
t he amino-a l cohol  2 3 . As  in  t h e  synthes i s  of  ana logue 22 , 
the  ami n o - a l cohol 2 3  was coupl e d  w i t h  a c i d  � using  EEDQ 
to a f ford t h e  des ired bromo sub s t i tuted analogue 24 . 
The pheny l a l an ine der ivat i ves  needed  for the  synth e s i s  
of  t h e  met h y l  ( 2 8 )  a n d  met h oxy ( 35 )  subs t i tuted an a logues 
of S e r i es I were not comme rc i al l y  ava i l ab l e , which necess i­
t ated t h e  i n c l us ion o f  add i t ion a l  synthet i c  s teps in  t h e  
preparation of  these  compounds . The synthes is  of  the  
methy l s ubs t i t ut e d  amine f ragment  for  compoun d 28  ( Schemes 
V I I an d V I I I )  was per formed us i n g  t h e  procedure of  A lbert son 
and Archer ( 60 ) . The synthes is  b egan w i t h  the  re act ion o f  
4-methy lbenzy l ch l o r i de and d i et h y l ace t am i domal onate i n  
sodium et hox i de to g ive t h e  d i e s t e r- am i de 2 5 . The ami de 
and both e s t e r  f unct i ona l i t i es o f  2 5  were hydrolyzed  w i t h  
4 8% hydrobromi c a c i d  t o  g i ve 4-methy lphen y l al an i ne 26 . Ny­
s t rom and Brown ( 6 1 )  reported t hat ami no a c i ds could b e  
reduced w i t h  l it h ium a l um inum h y dr i de to form amino a l co­
hols . Using the  procedure of  Lee an d V ince ( 50 ) , t h e  amino 
a c i d  26  was d i rect l y  reduced  w i t h  l i t h i um a l um i num hydr ide . 
The product o f  t he reduct ion , t he amino-a l coho l 2 7 , was cou­
pled  w i t h  a c i d  6 using  EEDQ to afford t he met h y l- sub s t itut ed 
product 2 8 . 
3 7  
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The synthes i s  of  t h e  met hoxy- sub s t ituted  compound  3 5  
(Schemes I X  a n d  X )  began b y  t reat i n g  4-met hoxybenzy l a l coho l 
w i t h  4 8% hydrobrom i c  a c i d  to af ford 4-methoxybenzy l b romide 
( 29 ) . U s i n g  the  met hod of  Yamamot o , et  a l . (62 ) ,  4-met hoxybenz y l  
b romide was reacted w i t h  d i ethyl  acet amidoma lonate  i n  sodi um 
ethox i de t o  g ive the  d i et h y l e s t er- amide compound 30 . To 
avo i d  pos s i b l e  c leavage of t he ether bond of 30 , a sequence 
of react i on s  emp loy i n g  base i n s t ead of  hydrobromic a c i d  as 
in the s y n t hes i s  of compound 2 8 , was used to ob t a in the  
ami n o-a l coho l 34 . The sequence b egan w i t h  the  procedure of  
Berl i n guet (63 ) i n  wh i ch compound  30 was  t reated w i t h  a 
0 . 3  N pot ass i um hydrox ide solut ion f o l l owed by ac i d i f i cat i o n  
w i t h  hydroc h lo r i c  a c i d  t o  af ford the  mono-ac i d  3 1 . Heat i n g  
3 1  under reduced pressure e f fect i ve l y  decarboxy lated  the  
mono-a c i d  � produ c i n g  the  ester  32 . Reduct ion o f  t he ester  
32  with  l it h ium aluminum hydr i de by the  procedure of  Ber­
l i guet (6 3 )  gave the a l cohol 33 . Hydro l y s i s  o f  the  ami de 
funct i on a l i t y  of  33  was e f f ected w i t h  2 N hydroch lor i c  a c i d  
t o  produce t he ami n o - a l cohol hydroch lor i de 34 , wh ich  was 
converted  to the f ree b ase  for coupl i n g  by t reat i n g  34 w i t h  
base . T h e  f ree b a s e  of  3 4  was coup led  with  the  a c i d  6 u s i n g  
EEDQ to af ford t he met hoxy - sub s t ituted  compound 3 5 . 
The compoun ds o f  Series  I I , 36 , 37 , 38 , and 39 , were 
e as i ly synthes i zed  by coup l i ng the commerc i a l l y- ava i lab le  
phen e t h y l amines  w i t h  the  ac i d  Q u s i n g  EEDQ (Scheme X I ) .  
Coup l in g  phenet h y l amine , 2- (4- t o l y l ) -ethy l ami n e , 4-met hoxy­
phenet hy l amine , and 4-bromopheneth y l amine  with the  acid Q 
o
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gave compounds 36 , 3 7 , 3 8 , and 39 , respect ive l y . 
Each o f  t h e  f ive compounds of  S e r i es I I I , 44 , 46 , 4 8 , 50 , 
and 52 , was prepared u s i n g  t h e  same procedure ( S chemes X I I and 
X I I I ) .  The ami no f ragme n t  o f  these  compoun ds was der i ved  from 
sub s t i t uted 6 -a l an i ne compounds . The s y n t h e s i s  began b y  pro­
tect i n g  the ami ne of 6 - a l an i ne w i t h  the t e r t -butoxycarbony l  
( BOC ) protect i n g  group . The t e r t-butoxycarbony l  group was 
chosen as i t  was s t ab le to a l ka l i  and rap id l y  c l e aved by 
m i l dly a c i d i c  con d i t ions ( 64 ) . To form BOC- 6- a l an i ne 
( 40 ) , 6 -a l an i ne was reacted accord i n g  to t h e  met h od of  Bent­
l y , et  al . ( 6 5 )  with  t e rt -but y l az i do formate i n  a mod i f i ed 
Schot t e n -Baumann react i on . To enhance the  reac t i v i t y  of  t h e  
prot ected  6 - a l a n i n e  40 , the  act ive ester  4 1  was synthes i zed 
us i n g  t h e  procedure of Pless  and Boi ssonnas ( 66 )  in  wh i c h  40 
was react ed  with 2 , 4 , 5 - t r i ch l orophenol  i n  the presence of 
d i cyc lohexy l c arbodi imide ( 67 ) . The t r i ch loropheny l  ester  
4 1  was reacted  with  b enzy l amine , 4-met hy lbenzy l ami n e , 4-
methoxybenzy l ami ne , 4-bromobenzy l ami n e , and 3 , 4 -dich loro­
benzy l amine  t o  g i ve the  i n t e rmed i at e s  42 , 45a , 4 7 a , 49a , and 
5 1a ,  respect i ve l y . Each of  t hese compounds was t re at e d  w i t h  
t r i f luoroacet ic ac i d  t o  e f fect t h e  f ac i le removal o f  the  tert­
buty loxycarbon y l  prote ct i n g  group to form t h e  t r i f luoroac­
e t a t e  s a l t s  4 3 , 45b , 4 7b , 49b , an d 5 1b , respect ivel y . Dur­
i ng the c l e avage by aci d ,  the evo l ut ion of  gas was not ed . 
The c l e avage o f  t e r t -but y l oxycarbo n y l  protect i n g  groups pro­
ceeds through the format ion of t ert-but y l  cat i on s , wh i ch 
are converted to i sobuty lene b y  the  e l iminat i on o f  a proton . 
The loss  of  t h e  t e rt -but y l  cat i on f rom the  BOC-de r i vat ive 
o 
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a f fords an �- carboxy i n t ermediate  wh i ch undergoes decarboxy­
lat i on to g ive the  t r i f luoroacetate s a l t  o f  the  amino a c i d  
der i vat ive (64 ) . The f ree bases o f  the ami n e s  were obt a i n e d  
by t reatment o f  the  t r i f luoroacetate  s a l t s  w i t h  sodium 
hydrox ide , fo l lowed by e t h y l  ace t a t e  extract ion . The f ree 
bases were coup led  with ac i d  6 us ing  EEDQ t o  af ford the  com­
pounds 44 , 46 , 4 8 , 50 , and 52 . 
The preparat ion o f  t he compounds o f  Series  IV , 55 , 56 , 
5 7 , 58 , and 59 , was approached us i n g  two synthet i c  routes 
( Schemes X I V  XV I I ) .  Both approach es invo lved t h e  use 
of aspart i c  a c i d  wh ich  served as the  precursor for the amine  
f ragme n t . I n  the f i rst at t empt t o  synthes ize t h e  com-
pounds o f  Ser i e s  I V  (Sch emes X I V  and XV ) ,  aspar t i c  a c i d  was 
reacted w i t h  phth a l i c  anhydr i de accordi ng to the  met ho ds o f  
Tann enbaum (68 )  and o f  Kidd and K i n g  (69 , 70 ) . The product 
47 
of t h i s  react ion was i s o l ated in a crude s t a t e  and dehydrated 
in ace t i c  anhydr i de t o  g ive �2-phtha l Y l -DL- aspart i c  anhydr i de 
( 53 ) . The n ext step  o f  t h e  sequence was to s e l ect i v e l y  
open the  anhy d r i de r i n g  w i t h  a subst i t ut e d  benzy l am i n e  t o  form 
the  a- benzy l am i de- a - a c i d  54 . Several repor t s  i n  the l it e ra­
ture (68 , 71 )  i n d i cated the  selec t i ve open i n g  cou l d  be ach i eved 
by con t ro l l in g  the so lvent used i n  the react ion . Tann enbaum 
(68 ) reported  that  under anhydrous condi t ions , t h e  nuc leo­
ph i le woul d  a t t ack the  a - carbony l ,  whereas , under prot ic  
so lvent cond i t ion s , such  as ethano l or wat er , the  nuc l eoph i le 
woul d  a t t ack t h e  a-carbon y l . I n  the case o f  t h e  Series  IV  
compounds , the  a - amide was  requ i red exc lus ive l y . As a con se-
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q u e n c e , a n h y dr o u s  c o n d i t i o n s  were ut i l i z e d  i n  t h e  p r o c e d u r e  
t o  e l i m i n a t e  a - am i de f o rma t i o n  a s  s u gge s t e d  by t h e  l i t er a -
t ur e  . .  I n  an a t t empt t o  prove u n e q u i vo c ab l y  t h a t  t h e  B - am i de 
h a d  b e e n  ob t a i n e d  e xc l u s i v e l y ,  t h e  p r o c e du r e  was r e p e a t e d  
u s i n g  e t h a n o l ,  i n s t ea d  o f  a n h y d rous e t h e r , t o  p r o d u c e  t h e  
a - am i de f o r  comp a r i s on . The p r o duc t s  o f  b o t h  p roc e d u r e s  w e r e  
i den t i c a l  a c c o r d i n g  t o  t h e  me l t i n g  po i n t s  a n d  s pe c t ro s c o p i c  
a n a l y s i s , i n c l u d i n g  I R ,  NMR , a n d  c arbon 1 3  NMR . Th e prob l em 
aro s e , t h e r e f o r e , o f  i de n t i f y i n g  wh i c h  i s ome r h a d  b e e n  ex­
c l us i v e l y  i s o l at e d . As a r e s u l t ,  t h i s  r o u t e was a b a n do n ed 
a n d  t h e  p r o p o s e d  r e ac t i o n s  i n c l u d i n g  remo v a l  o f  t h e  pht h a l y l  
p r o t e c t i n g  group w i t h  h y dr az i n e , r educ t i o n  o f  t he e s t e r  w i t h  
l i t h ium b o r o h y d r i de , a n d  coup l i n g  o f  t h e  am i no - a l coho l w i t h  
t h e  a c i d  £ ,  we r e  n o t  comp l e t ed as dep i c t e d  i n  Sch eme s X I V  
a n d  XV . 
The s e c o n d  approach t o  t h e  S e r i e s  I V  compou n ds ( S ch emes 
XV I an d XV I I ) , a l so b e gan w i t h  a s p ar t i c  a c i d . The f i r s t  
s t e p  i n vo l v e d  t h e  p ro t e c t i on o f  t h e  am i n o  f u n c t i o n a l i t y  o f  
a s p a r t i c  a c i d  w i t h  t h e  b e n zy l o xyc arbo n y l  ( Z )  p ro t e c t i n g  
group . The b e n z y l o x y c arbo n y l  d e r i va t i v e  o f  a s p ar t i c  a c i d  
w a s  r e ad i l y ob t a i n ab l e , s t ab l e , a n d  e a s i l y c o n ve r t e d  t o  t he 
deb l o c k e d  am i n o  a c i d  by a v a r i e t y  o f  m e t h o d s  (64 ) . To ob ­
t a i n  �- c arbobe n zoxy - DL- a s p ar t i c  a c i d  ( 60 ) , t h e  me t h o d  o f  
B e r gmann a n d  Z e r v a s  ( 7 2 )  w a s  f o l l owe d . A s p a r t i c  ac i d  a n d  
b e n z y l c h l o r o f orma t e  we re m i x e d  i n  t h e  p r e s e n c e  o f  magn e s i um 
o x i de an d wat e r  t o  a f f o r d  t h e  de s i r e d  p r o d u c t  60 . By de­
h y d r a t i n g  60 w i t h  a ce t i c  a n h y d r i de , a l s o  b y  the p r o c e d u r e  
o f  B e r gmann an d Z e r va s , t h e  a n h y d r i de 6 1  was o b t a i n e d . The 
n e x t  s t e p  was to s e l e c t i v e l y  o p e n  t h e  a n h y d r i de w i t h b e n z y l  
a l coho l t o  o b t a i n  t he a - b e n z y l e s t e r . O n c e  aga i n , t h e  p ro ­
b l em e x i s t e d  o f  i de n t i f y i n g  u n e q u i vo c ab l y  t ha t  t h e  a - e s t e r  
cou l d  b e  ob t a i n e d  e x c l u s i ve l y . B e r gman n ,  e t  a l . ( 72 , 7 3 ) , 
r e po r t e d  o n l y  t h e  a - i somer was ob t a i n e d  whe n �-b e n z y l oxy­
c arbon y l -�- as p ar t i c  a n h y d r i de was t re a t e d  w i t h  b e n z y l  a l ­
coho l i n  a s e a l e d  t ub e . LeQu e s n e  a n d  Young ( 74 , 7 5 )  s u g­
ge s t ed t h e  r e a c t i o n  o f  t h e  anhy dr i de w i t h  am i n o- compounds 
5 3 
cou l d  g i ve bo t h  a a n d  a d e r i v a t i v e s . I n  t h e i r  wo rk , LeQu e s n e  
a n d  Yo un g r e po r t e d  t h e y w e r e  ab l e  t o  s e p a r a t e  t h e  two der i v a­
t i ves by r e p e a t e d  f r a c t i o n a l  e x t r ac t i o n  w i t h  aqueous s o d i um 
c arbon a t e . B r y an t , e t  a l . ( 76 ) , a g r e e d  t h a t  a a n d  a i s ome r s  
w e r e  b o t h  po s s ib l e produ c t s  o f  t h e  r e a c t i o n  o f  a m i n o - com­
p o u n d s  w i t h  t h e  anhy d r i de a n d  prov i de d  a new s y n t h e s i s  o f  
t h e  r e s pe c t i v e  i s ome r s  b y  s e l ec t i v e  p a r t i a l  h y d r o l y s i s  o f  
t he d ib e n z y l  e s t e r . M a r k s  a n d  Neub e r g e r  ( 7 7 )  l a t e r r e po r t e d  
t he y  we r e  ab l e  t o  s ep a r a t e  t h e  a a n d  a i s ome r s  by i o n - ex ­
c h an ge chroma t o g r a ph y . 
I n  t h e  s y n t h e s i s  o f  t h e  Se r i e s  I V  compou n d  5 8 , t h e  
me t h o d  o f  B e r gma n n , e t  a l . ( 7 3 ) , w a s  u s e d  i n  wh i ch �-b e n z y l ­
o x y c a rb o n y l - D L- a s p � r t i c  a n h y dr ide 6 1  w a s  t r e a t e d  w i t h  b e n z y l 
a l coh o l . To p rove wh e t h e r  o r  n o t  t h e  a - e s t e r  ( 6 2 )  h a d  b e e n  
o b t a i n e d  e x c l us i ve l y , t h e  a - e s t er ( 6 2 a ) was s y n t h e s i ze d  b y  
ano t h e r  rout e , f o r  comp a r i s on w i t h  t h e  p r o po s e d  a - e s t e r  ( 6 2 ) . 
The p r o c e dure o f  B e r g e r  a n d  K a t ch a l s k i  ( 7 8 ) ,  wh i ch i n v o l v e d  
t h e  s e l e c t i v e  p ar t i a l  h y d r o l y s i s  o f  t h e  d i b e n z y l  e s t e r , w a s  
u s e d  t o  p r e p a r e  t h e  a - e s t e r ( 6 2 a ) . Th e two e s t e r s  ( 62 a n d  
6 2 a ) ob t a i n e d  f rom t h e  d i f f e r e n t  rou t e s  w e r e  comp a r e d  b y  
d e t e rm i n i n g  t h e  me l t i n g  pO i n t s , NMR s p e c t r a , an d d i s s o c i a ­
t i on con s t an t s  ( pKa v a l u e s ) o f  t h e compounds ( Tab l e  I I ) .  
The r e s u l t s  i n d i c a t e d  t h a t  t he a a n d  a e s t e r s  had b e en i so ­
l a t e d  e x c l u s i v e l y  f rom t he r e s p ec t i v e  rou t e s  o f  s y n t h e s i s , 
as t h e  o b s e r v e d  v a l ue s  f o r  t h e  t h r e e  p a rame t e r s  s t u d i e d  
we re d i s t i n c t l y  d i f f e r e n t . Moreover , t h e  o b s e r v e d  pKa 
va l u e s  w e r e  comp a r ab l e  to t h e  l i t e r a t u r e  va l ue s  r e p o r t e d  
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by B e r g e r  and Ka t c h a l sk i ( 7 8 ) . S i n c e  t h e  r e su l t s  i n d i c a t e d  
t h a t  t h e  a - e s t e r ( 6 2 )  w a s  i so l a t e d  e x c l u s i v e l y  b y  t h e  me t ho d  
o f  Bergma n n , e t  a l . ( 72 ) , f u r t h er s e p a r a t i o n  as p e r f o rme d 
b y  LeQu e s n e  a n d  You n g  ( 7 4 , 7 5 )  o r  Marks an d Neub e r g e r  ( 7 7 ) , 
was unwa r r a n t e d . 
To co n t i n u e t he s y n t h e s i s  o f  compound 5 8 , t h e  a - e s t e r  6 2  
was t r e a t e d  w i t h  4 -b romobe nzy l am i n e  a n d  EEDQ i n  d i met h y l ­
f o rmam i d e  a c c o r d i n g  t o  t h e  p r o c e dure o f  L i n  a n d  Dub o i s  ( 5 1 ) .  
The p r o du c t wh i c h  was i s o l a t e d  f r om t h i s  r e a c t i o n  d e p e n d e d  
u p o n  t h e  s o l v en t u s e d . Wh en d i me t hy l f o rmam i d e  was u s e d , 
t h e  d e s i r e d  p r o duc t , 6 3 , was ob t a i n e d . When t e t r a h y d r o f u r a n  
was u s e d , howe v e r , c y c l i z at i o n  o f  t he a s p ar t i c a c i d  mo i e t y  
o c c u r r e d , t o  f o rm t h e  i m i de 6 2b . 
The n e x t  s t e p  i n  t h e  s y n t h e t i c  approach was t h e  r e ­
duc t i o n  o f  t h e  b e n z y l e s t e r  o f  6 3  t o  t h e  a l coho l . Th i s  was 
a t t empt e d by t r e a t i n g  the am i de - e s t e r  6 3  w i t h  l i t h i um boro­
h y d r i de . O n c e  aga i n , i n s t e a d  o f  t he d e s i r e d  a m i d e  a l co h o l  
6 4 , t h e  i m i de 62b w a s  ob t a i n e d . Fu r t h e r  a t t emp t s  t o  r e duce 
TABLE I I : COMPAR I S I ON OF THE a AND 8 - BENZYL ESTERS OF N­
BENZYLOXYCARBONYL-DL-A SPART I C  AC I D  
5 5  
a - E STER ( 6 2 )  8 - E STER ( 6 2 a ) 
Ob s e r v e d  me l t i n g  po i n t  
L i t e r a t ur e  me l t i n g  po i n t  
NMR- sp l i t t i n g  p a t t e r n  f o r  t h e  
4 b e n z y l p r o t o n s  a t  5 . 1  ppm . 
Ob s e rv e d  pKa 
L i t e r at u r e  pKa 
Doub l e t  S i n g l e t  
6 . 7  6 . 2  
6 . 6  6 . 1  
t he e s t e r  o f  6 3  w e r e  n o t  p u r s ue d , an d t h e  p r o p o s e d  r e a c ­
t i o n s , i n c l u d i n g  t h e  remova l o f  t h e  b e n zy l o x y c a rb o n y l p r o ­
t ec t i n g  group , a n d  coup l i n g  o f  t h e  am i n o - a l c o h o l  6 5  w i t h  
t h e  ac i d  & '  were n o t  comp l e t e d  a s  dep i c t e d  i n  Schemes XV I 
a n d  XV I I .  
S i n c e  n e i t h e r  o f  t h e  appro a c h e s  d i s cu s s e d  we re s u c c e s s ­
f u l l y  comp l e t e d , t h e  p ro p o s e d  compounds o f  Ser i es I V  were 
n o t  s y n t h e s i ze d . 
56 
I V .  D I SCUSS I ON OF PHARMACOLOGI CAL RE SULT S  
5 7  
I n  t h e  e a r l y  p h armaco l o g i c a l  e v a l u a t i o n  o f  s p a r s omy c i n , 
e x p e r i me n t s  w e r e  p e r f ormed t o  me a s u r e  t h e  e f f e c t  o f  s p a r s o -
my c i n  on DNA , RNA ,  a n d  p rot e i n  s y n t h e s i s  i n  �. co l i  ce l l s 
( 9 -1 1 ) . Th e i n i t i a l  s t u d i es and s u b s e que n t , mo r e  det a i l e d 
i nve s t i gat i on s , i n d i c a t e d  s p arsomy c i n  i n t e r a c t e d  p r imar i l y 
by i nh ib i t i n g  p r o t e i n s y n t h es i s  at t h e  r i b o s oma l l e ve l . 
Th e t a r g e t  compo u n d s  s y n t h e s i ze d  f o r  t h i s  p r oj e c t  w e re 
e x p e r i me n t a l l y e x am i n e d  t o  i n ve s t i ga t e  t h e i r e f f e c t s on 
p ro t e i n  s y n t h e s i s , ce l l  grow t h ,  and DNA s y n t h e s i s  in b o n e  
m a r r o w  ce l l s , P 3 8 8  l ymph o c y t i c  l e u k em i a  ce l l s , and P 8 1 5  
mas t o c y t oma ce l l s . 
To me a s u r e  t h e  e f f e c t  on t h e  ce l l ' s  ab i l i t y  t o  s y n t h e -
s i ze p r o t e i n , t h e  compo u n d s  w e r e  i n c ub a t e d  w i t h  n o rma l ce l l s 
a n d  t umo r c e l l s i n  t h e  p r e s e n c e  of L- [ 7 5Se ] s e l e n ome t h i o n i ne 
( V I . C . 6 . c . ) .  The p ro t e i n  s y n t h e s i s  i n  t h e  c e l l s  was 
mon i t o r e d  b y  t he i n c o r p o r a t i o n  of L- [ 7 5 Se ] - s e l e nome t h i on i n e  
i n t o  t h e  ce l l s . A l t hough t h e  p ro c e du r e s  f o l l owed f o r  t h i s  
p roj e c t  w h i c h  emp l o y e d  [ 7 5 Se ] - s e l e n ome t h i on i ne d i d  n o t  d i f ­
f e r en t i at e  b e tween t h e  a c t u a l  i n c o r p o r a t i o n  o f  [ 7 5Se ] _ 
s e l e n omet h i on i ne i n t o  p r ot e i n s  and t h e  t o t a l  u p t ake i n t o  
7 5  
t h e  c e l l s , Thomas , e t  a l . ( 100 ) , h av e  s h own t h at [ Se ] -
s e l enome t h i o n i ne i s  i n c o r p o r a t e d  i n t o  t hy r o i d  t umor c e l l s  
i n  quan t i t i es wh i ch c o r r e s po n d  t o  t h e  r at e  o f  p ro t e i n  
s y n t h e s i s . Moreove r , Awwad , e t  a l . ( 101 , 102 ) , have s h own 
t h a t  [ 7
5
Se ] - s e l e nome t h i o n i n e  was r e a d i l y i n c o r po r a t e d  i n t o  
r a t  t i s s u e  p r o t e i n s  a n d  h uman p l a sma p r o t e i n s  f o l l o w i n g  a 
s i n g l e  i n t r av e n ous a dm i n i s t r a t i o n  o f  t h e  r a d i o a c t i v e  a m i n o  
a c i d  a n a l ogue t o  r a t  o r  human subj ec t s , r e s p e c t i v e l y . 
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Awwad , e t  a l . ,  f u r t h e r  s t a t e d  t h a t  t h e  maj o r i t y  o f  t h e  
r a d i o a c t i v i t y  w a s  d u e  t o  t ha t  wh i ch w a s  n e w l y  i n co r po r a t e d  
i n t o p ro t e i n s . B a s e d  upon t h e s e  f i n d i n g s , t h e  i n co r po r a t i o n  
o f  [
7 5
Se ] - s e l e nome t h i on i n e  i n t o  t h e c e l l s , a s  quant i t a t e d  
b y  t h e  a s s a y s  i n  t h i s  p roj e c t , w a s  u s e d  a s  a n  i n d i r e c t  mea-
s u r e me n t  of p ro t e i n  s y n t h e s i s . 
P r i o r  t o  q u a n t i t at i n g  t h e  a c t i v i t y  o f  t h e t ar g e t  com-
poun d s  in t he p ro t e i n  s yn t h e s i s  a s s a y , t ime - c o u r s e  exper i -
men t s  w e r e  con duc t e d  t o  a s c e r t a i n  t he o p t imal t ime f o r  
h a r v e s t i n g  t h e  c e l l s ( Vl C . 6 . b . ( 1 » . Th e t ime- co u r s e  s t udy 
f o r  the P 3 8 8  c e l l s s h own in F i gu r e  XI i n d i c a t e s  t h e r e  was 
a l i n e a r  i n c o r p o r a t i o n  o f  L- [ 7
5
Se ] - s e l e n ome t h i o n i n e  o v e r  a 
t wen t y - f o u r  hour i n cub a t i o n  p e r i o d . S im i l a r l y , t h e  t ime 
c o u r s e  s t u dy f o r  t h e  b o n e  mar row c e l l s shown i n  F i gure X I I  
a l so d i s p l ay s  a l i n e a r  i n co r p o r a t i o n  o f  t he i so t ope dur i n g  
t he twen t y- f o u r  hour s t u d y . B a s e d  upon t h e  f i n d i n gs o f  t h e  
t ime - co u r s e  e x p e r i me n t , t h e  c e l l s  we r e  i n c ub a t e d  f o r  
t wen t y - f o u r  h o u r s  p r i o r  t o  h a r v e s t i n g  i n  a l l o f  t h e  sub s e ­
q u e n t  p ro t e i n  s y n t h e s i s  s t u d i e s . 
The t ar g e t  compounds w e r e  t e s t e d  i n  t h e  p ro t e i n  s y n ­
t h e s i s  a s s a y  u s i n g  P 3 8 8  l ympho c y t i c  l e u k em i a  c e l l s  ( VI.C . 6 . b .  
( 3 » , P 8 1 5 mas t o c y t oma c e l l s  ( VL C . 6 . b . ( 4 » , a n d  b o n e  m a r row 
ce l l s  ( V . C . 6 . b . ( 2 » . Tab l e s  I I I  and IV s h ow the e f f ec t s  o f  
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F I GURE X I . CHARACTE R I ZAT I ON OF THE PROTE I N  SYNTHE S I S  AS SAY : 
T I ME COURSE FOR I N CORPORAT I ON OF [ 7 5 S e J - SE LENO­
METH I ON I NE I NTO P 3 8 8  CE LLS . 
A t yp i c a l  p ro t e i n  s y n t h e s i s  c u r v e  sho wing t h e  
i n c o r p o r at i o n  o f  L- [ 7 5 Se J - s e l enome t h i o n i n e  i n t o  
P 3 8 8  ce l l s . T h e  po i n t s  i n  t h e  f i gure r e p r e s e n t  
CPM / 6  X 1 0 5 ce l l s  a f t e r i n c ub a t i o n  w i t h  t h e  
p u l s e  l ab e l  f o r  1 ,  3 ,  6 ,  1 0 , 1 8 , 2 1 , a n d  2 4  
hou r s . Each po i n t  r e p r e s e n t s  t h e  mean a n d  
s t an da r d  e r r o r  f o r  s i x  r e p l i c a t e we l l s  a s  
d e s c r i b e d  i n  s ec t i o n  V I . C . 6 . b . ( 1 ) .  
F I GURE X I : CHARACTE R I ZAT I ON OF THE PROTE I N  SYNTHE S I S  ASSAY : 
LO o M 
X 
1 0 , 0 0 0  
� 5 , 0 0 0  
::g p. u 
T I ME COURSE FOR I NCORPORAT I ON OF [ 7 5Se ] - SE LENO­
METH I ON I NE I NTO P 3 8 8  CELLS 
1 3 6 1 0  1 8  2 1  2 4  
T I ME ( hour s ) 
6 0  
6 1  
F I GURE X I I .  CHARACTE R I ZAT I ON OF THE PROTE I N  SYNTHE S I S  
A SSAY : T I ME COURSE FOR I N CORPORAT I ON OF 
[ 7 5Se ] - SE LENOMETH I ON I NE I NTO BONE MARROW 
CE LLS 
A t y p i c a l  p r o t e i n  s y n t he s i s  c u r v e  show i n g  
t he i n co r p o r a t i o n  o f  L- [ 7 5 Se ] - s e l e n ome t h i o n i n e  
i n t o  b o n e  mar row c e l l s . The po i n t s i n  t h e  f i g­
ure r e p r e s e n t  CPM / 6  X 1 0 5 ce l l s a f t e r i n cubat i o n  
w i t h  t h e  pu l s e l ab e l  f o r  1 ,  3 ,  14 , 1 8 , a n d  2 4  
h o u r s . E a c h  po i n t  r e p r e s e n t s  t h e  me an a n d  
s t an d a r d  e r ro r  f o r  s i x r ep l i c a t e  we l l s as 
d e s c r i b e d  i n  s ec t i o n  V I . C . 6 . b . ( 1 ) . 
F I GURE X I I :  












::E 0.. U 
5 , 0 0 0  
1 3 
6 2  
CHARACTER I ZAT I ON O F  THE PROTE I N  SYNTHE S I S  A SSAY : 
T I ME COURSE FOR I NCORPORAT I ON OF [ 7 5 Se l - SE LE NO­
METH I ON I NE I NTO BONE MARROW CELLS . 
1 
1 4  1 8  2 4  
T I ME (hours ) 
TABLE I I I : I NCORPORAT I ON OF f5 Se ] - SE LENOMETH I ON l NE I NTO 
P 3 8 8  C E LLS 
COMPOUND a 
CONTRO L 
2 2  
2 4  
2 8  
36 
37 
3 8  
39 
4 8  
50 
1 9  
3 5  
1 %  ETHANOL 
PUROMYC I N  
VEH I CLEb 
EXPE R I MENT 1 
1 3 5 8 0  ± 1 1 6 8  
1 3 2 8 2  ± 7 5 0  
7 79 2  ± 4 59 c 
1 2 9 56 ± 6 4 9  
1 3 5 8 4  ± 9 3 8  
1 3 8 0 1  ± 4 4 7  
1 4 3 6 4  ± 2 4 3  
1 1 4 16 ± 5 6 8  
1 3 6 6 4  ± 2 0  
1 2 0 7 8  ± 3 1 8  
1 1 4 3 9  ± 2 54 c 
1 52 92 ± 39 3 
1 5 2 8 2  ± 2 2 0  
6 0 8 5  ± 1 0 1 c 
EXPER I MENT 2 
1 4 149 ± 4 9 2  
1 2 8 0 5  ± 3 6 2  
7 4 4 9  ± 9 6 9 c 
1 2 9 1 7  ± 8 3 0  
1 2 9 50 ± 146 
14664 ± 750 
1 3 70 6  ± 5 70 
9 0 2 9  ± 509 c 
1 2 5 2 7  ± 1 5 0  
8 4 6 5  ± 4 4 6 c 
1 1 304 ± 3 9 2 c 
1 4 4 4 8  ± 9 8 5  
1 7 3 70 ± 3 0 8  
3 9 6 5  ± 1 2 1
c 
1 4 4 7 9  ± 4 8 8  
EXPE R I MENT 3 
1 3 2 7 8  ± 5 2 3  
1 2 4 2 1 ± 1 2 5  
7 6 5 1  ± 1 2 1 c 
2 1 3 5 1  ± 2 8 9  
1 3 1 2 9  ± 5 3 2  
1 5 3 9 5  ± 3 1 5  
1 4 2 3 3  ± 1 1 0  
9 6 9 6  ± 3 39 c 
1 4 5 3 7  ± 4 9 5  
1 1 4 7 1  ± 2 5 2
c 
1 1 8 3 0  ± 4 3 6  
1 7 8 0 2  ± 2 6 8  
1 8 4 9 4  ± 2 8 5  
4 8 6 7  ± 3 2 4 c 
1 34 0 0  ± 6 5  
T h e  n umb e r s  r e p re s e n t  t h e  mean ± s t an da r d  e r ro r  f o r  s ix 
r e p l i c a t e  we l l s  con t a i n i n g  6 X 10 5 ce l l s as d e s c r i b e d  i n  
s e c t i o n  V I . C . 6 . b . ( 3 ) . 
aA l l  compoun d s  we re t e s t e d  a t  1 0 - 3M e x c e p t  3 5  wh i c h  
was t e s t e d  at 1 0 - 4 M i n  1% e t h an o l . 
b
D i s t i l le d  w a t e r  was u s e d  as t h e  ve h i c le . 
c p < 0 . 0 5 as comp a r e d  t o  con t ro l s . ( Se e  Sec t i on V I . C . 7 ) .  
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TABLE I V : I NH I B I T I ON OF [ 7 5Se ] - SE LENOMETH I ON I NE I N COR­
PORAT I ON I N  P 3 8 8  CELLS 
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COMPOUNDa EXPE R I MENT 1 EXPER I MENT 2 EXPE RI MENT 3 AVERAGE 
2 2  2 9 6 6 
2 4  4 3  4 7  4 2  4 4  
2 8  5 9 7 7 
3 6  0 8 1 3 
3 7  0 0 0 0 
3 8  0 3 0 1 
39 16 36 2 7  2 6  
4 8  0 1 1  0 3 
50 1 1  4 0  1 4  2 2  
1 9  1 6  2 0  1 1  1 6  
3 5  0 0 0 0 
1% E THANOL 0 0 0 0 
PUROMYC I N  5 5  72 6 3  6 3  
VEH I CLEb 0 0 
The n umb e r s  r e p r e s e n t  t h e  p e r c e n t  i n h i b i t i on f o r  s i x  r e p l i -
c a t e  we l l s  con t a i n i n g  6 X 1 0 5 P 3 8 8  c e l l s  as de s c r i b e d  i n  s e c -
t i on V I . C . 6 . b . ( 3 ) . 
a
A l l comp o u n d s  w e r e  t e s t e d at 1 0 - 3M e x c e p t  3 5  wh i c h  
w a s  t e s t e d  a t  10 - 4M i n  1% e t h a no l . 
bD i s t i l l e d  w a t e r  was u s e d  as t h e  ve h i c l e . 
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t he compou n d s  on the i n co rp o r a t i o n  o f  [ 7 5 Se ] - s e l e n ome t h i o n i n e  
i n t o  P 3 8 8  t umo r c e l l s . The r e su l t s  o f  t h e  t h r e e  expe r�nts 
i n d i c a t e  t he u n s ub s t i t u t e d  compoud s , 22 a n d  36 , t h e  me t hoxy­
s ub s t i t u t e d  a n a l ogue s , 3 5 , 3 8 , and 4 8 , a n d  t h e me t h y l  sub­
s t i t ut e d  a n a l o gue s , 28 a n d  3 7 , we r e  a l l  i n a c t i v e . C o n v e r s e l y , 
t he an a l o g u e s  c o n t a i n i n g  b rom i n e , 2 4 , 39 , an d 50 , were t h e 
mo s t  a c t i ve i n h i b i t o r s  o f  t h e  i n co r p o r a t ion o f  t h e p u l se 
l abe l . The aver age i n h i b i t i o n  b y  the mo s t  a c t i v e  compound , 
2 4 , was w i t h i n  t wen t y  pe r c e n t  o f  t h e  i n h ib i t ion o f  t h e  c o n ­
t ro l  drug , pu romyc i n . 
To more f u l l y  c h a r a c t e r i ze t h e  a c t i v i t y  o f  t h e  compoun ds , 
t h e  p r o t e i n  s y n t h e s i s  e x p e r imen t s  were r e p e a t e d  u s i n g P 8 1 5  
mas t oc y t oma c e l l s . The d a t a  i n  Tab l e  V i n d i c a t e  t he P 8 1 5  
c e l l s  we r e  mo r e  s e n s i t i v e  t o  t h e  t a r g e t  compounds t h an t h e 
P 3 8 8  c e l l s  ( Ta b l e s  I I I  and I V ) . I n  t he a s s a y w i t h  t h e P 8 1 5  
c e l l s , compo u n d s  2 4 , 39 a n d  50 were aga i n  t h e  mo s t  a c t i v e  
compoun ds . I n  t h i s  i n v e s t i g a t i o n , howe ve r , compoun d 2 4  
w a s  as a c t i v e  as t h e  con t r o l  i n h i b i t o r , p u romy c i n . The 
d i f f e r e n t  r e s p o n s e  t o  t he t a rge t compounds e xh ib i t e d  b y  t h e  
P 3 8 8  and P8 1 5  ce l l s m a y  b e  d u e  t o  a f u n d ame n t a l  d i f f e r e n c e  
i n  t h e  t w o  t yp e s  o f  t umo r c e l l s . The P 8 1 5  ma s t o c y t oma i s  
a mas t - c e l l  n e o p l asm wh i ch a r o s e  i n  DBA j 2  m a l e  m i ce whose 
s k i n  h a d  been se l e c t i v e l y  exposed t o  3-me t hy l ch o l an t h r e n e  
( 79 ) . A l t hough t h e  P 3 8 8  t umo r w a s  a l s o i n du c e d  by t re at ­
men t  o f  DBA j 2  m i ce w i t h  3-me t h y l ch o l an t h re n e , t h i s  t umor 
is a l ymph o i d  n e o p l asm ( 80 ) . The d i f f e r e n t  r e s pon s e s  to 
t he t arge t compo u n d s  may r e f l e c t  t h e d i f f e re n c e  in t h e  
TABLE V :  I NH I B I T I ON OF [ 7 5 Se ] - SE LENOMETH I ON I NE I NCORPORA­




2 2  
2 4  
2 8  
3 6  
3 7  
3 8  
39 
4 8  
50 
19 
3 5  
1 %  ETHANOL 
PUROMYC I N  
VEH I CLEb 
MEAN CPM + STANDARD ERROR 
2 3 6 4 7  ± 9 2 0  
1 14 2 1  ± 1 4 6 c 
1 5 1 4  ± 3 4 9 c 
8 3 6 1  ± 704 c 
2 3 1 6 3  ± 3 7 3  
2 1 0 3 5  ± 694 c 
2 4 1 4 7  ± 2 9 9  
2 5 1 1  ± 7 4 8 c 
2 8 4 4 2  ± 4 4 7  
7 4 0 0  ± 3 6 5c 
1 6 3 0 3  ± 4 8 8 c 
2 8 4 0 7  ± 2 7 2  
2 5 2 1 7  ± 4 1 3  
4 0 5  ± 8 2 c 
2 70 4 6  ± 5 3 7  
% I NH I B I T I ON 
52 
9 4  
6 5  
2 
1 1  
o 
8 9  
o 
6 9  
3 1  
o 
o 
9 8  
o 
66 
Th e n umb e r s  r e p r e s e n t  t h e  mean ± s t a n d a r d  e r r o r  and t h e  
p e r c e n t  i n h i b i t i o n  f o r  four r e p l i c a t e  we l l s  con t a i n g  6 X 1 0 5 
P 8 1 5  c e l l s  as de s c r i b e d  i n  s e c t i on V I . C . 6 . b . ( 4 ) . 
a 
A l l  compoun d s  w e r e  t e s t e d  a t  10- � e x c e p t  3 5  wh i c h  
w a s  t e s t e d  a t  1 0 - 4M i n  1% e t hano l . 
bD i s t i l l e d  w a t e r  was u s e d  a s  t h e  ve h i c l e . 
cp � 0 . 0 5 as comp a r e d  t o  co n t r o l s . 
ab i l i t i e s  o f  t h e  t wo ce l l u l ar t y p e s  t o  s y n t h es i z e p ro t e i n  
o r  t ak e  u p  t he [ 7 5 Se ] - s e l e n ome t h i o n i n e . 
F u r t h e r  c l ar i f i c a t i o n  o f  t h e  i n h ib i t o r y  a c t i v i t y  o f  
6 7  
t he compou n d s  w a s  o b t a i n e d  f r om e xpe r ime n t s  c o n du c t e d  t o  
a s ce r t a i n  t h e  p o t e n t i a l  i n t e r f e r e n c e  w i t h  n o rmal c e l l u l a r  
p rot e i n  s y n t h e s i s . To quan t i t at e  t h e s e  e f f e c t s , t h e  p r ot e i n  
s yn t he s i s  a s s ay w a s  r e p e a t e d  u s i n g  bone mar row ce l l s . The 
r e su l t s  s hown in Tab l e  VI sugge s t  a l l  of the c ompounds ex­
cept 35 i n h i b i t e d  t h e i n co rp o r a t i o n  o f  [ 7 5 Se ] - s e l e n ome t h i o -
n in e  i n t o  b o n e  mar row ce l l s . On c e  aga i n , t h e b romo - c o n ­
t a i n in g  an a l o gue s , 24 , 39 , a n d  50 , w e r e  amon g  t h e mo s t  
a c t i ve i n h ib i t o r s . I n  t h i s  a s s a y , howev e r , a n a l o gu e s  2 8 , 
3 8 , a n d  19 , a l t h ough s t ru c t ur a l l y d i s s im i l ar , w e r e  a l s o  
a c t i ve i n h ib i t o r s . A s  i n  t h e  p r o t e i n  s yn t h e s i s  s t udy w i t h  
t umo r c e l l s , t h e  me t ho x y - s ub s t i t ut e d comp o u n d s  4 8  a n d  3 5  
w e r e  i n a c t i ve . 
Comp o u n d s  24 , 39 , a n d  50 w e r e  c o n s i s t en t l y a c t i v e  i n ­
h ib i t o r s  o f  [ 7 5 Se ] - s e l e n omet h i on i n e  i n c o r p o r a t i o n  i n t o  P815 , 
P 3 8 8 , and b o n e  mar row ce l l s . I n  o r d e r  t o  e s t ab l i s h  a mo re 
accurate de s c r i pt i o n  of t h e  a c t i v i t y  o f  t h e s e  an a l ogue s , 
a re l at i on s h i p  was sought b e t w e e n  t he c o n ce n t ra t i o n  o f  t he 
t e s t  compou n d s  a n d  t h e  i n h ib i t i o n  o f  [ 7 5Se ] - s e l e n omet h i o n i n e  
i n c o r p o r a t i on . Th e r e s u l t s  o f  t h e e xper imen t s  wh i c h w e r e  
c o n du c t e d  a r e  t ab u l a t e d  i n  Tab l e s  V I I ,  V I I I ,  a n d  I X . Th e 
dat a f a i l e d  t o  d i s p l ay a c l e a r l y  de f i n e d  do s e - r e s pon s e  r e ­
l at i o n s h i p  i n  P388 c e l l s  o r  b o n e  mar row c e l l s .  As a r e s u l t , 
f u r t h e r  e xpe r ime n t a t i o n  was w a r ran t e d  i n  o r der t o  quan t i t at e  
TABLE V I : I NH I B I T I ON OF [
7 5
Se ] - SE LENOMETH I ON I NE I NCORPORA­
T I ON I N  BONE MARROW CELLS 
6 8  
COMPOUND a MEAN CPM + STANDARD ERROR % I NH I B I T I ON 
CONTROL 
2 2  
2 4  
2 8  
3 6  
3 7 
3 8  
39 
4 8  
5 0  
1 9  
3 5  
1 %  E THANOL 
PUROMYC I N  
8 2 0 3  ± 2 1 9 
5 4 0 1  ± 1 5 3b 
2 9 2 0  ± 6 6b 
4 8 9 1  ± 1 3 6b 
5 3 7 5 ± 1 3 8b 
5 3 1 1  ± 1 76
b 
4 6 1 4  ± 7 7b 
4 74 4  ± 1 5 3b 
72 76 ± 3 6 3  
5 8 3 7 ± 2 4 0
b 
4 5 70 ± 3 4 1b 
6 8 0 8  ± 9 9 b 
6 5 2 6  ± 2 6 8b 
3 2 1 8  ± 1 0 0b 
34 
6 4  
4 0  
34 
3 5  
4 4  
4 2  
1 1  
2 9  
44 
o 
2 0  
6 1  
The n umb e r s  r e p r e s e n t  t h e  mean ± s t a n d a r d  e rr o r  an d t he 5 
p e r c e n t  i n h ib i t i o n  f o r  s i x r e p l i c a t e  we l l s  con t a i n i n g  6 X 1 0  
b o n e  marrow ce l l s as d e s c r i b e d  i n  s e c t i o n  V I . C . 6 . b . ( 2 ) . 
a - 3 A l l  compo u n d s  w e r e  t e s t e d  at 10 M e x c e p t  35 wh i ch 
was t e s t e d  at 1 0 - 4M i n  1% e t h an o l . 
bp < 0 . 0 5 as comp a r e d  t o  con t ro l s .  
TABLE V I I :  RELAT I ON SH I P  BETWEEN DOSE AND [ 7 5Se ] - SELENOMETH I ON I NE I NCORPORAT I ON 
COMPOUND 
CONTROL 
PUROMYC I N  
2 4  
SPARSOMYC I N  
I N  P 3 8 8  CELLS 
CON CENT RAT I ON 
5 6 X 1 0  c e l l s / mL 
1 0 - 3  M 
5 X 1 0 - 4  M 
1 0 - 4  M 
1 0 - 5  M 
10 - 3  M 
5 X 1 0
- 4 M 
10 - 5  M 
10 - 3  M 
1 0 - 4  M 
10 - 5  M 
10 - 6  M 
1 0 - 7  M 
EXPER I MENT 1 
2 19 0 7  ± 4 7 7  
9 8 7 5  ± 1 9 4  
1 0 3 5 3  ± 1 6 0  
9 7 0 5  ± 3 1 0  
1 8 0 3 5  ± 5 8 8  
1 5 9 9 6  ± 7 5 4  
1 5 8 5 0  ± 1 2 7  
1 6 7 2 5  ± 2 70 
1 12 9 0  ± 1 1 3  
1 0 7 3 7  ± 1 9 7  
1 2 0 9 5  ± 4 8 3  
1 8 6 2 3  ± 13 7 3  
2 0 0 9 9  ± 9 7 1  
EXPE R I ME NT 2 E XPER I MENT 3 
2 1 3 3 2  ± 4 8 3  2 0 1 2 7  ± 2 5 7  
1 5 9 3  ± 1 8 1  8 2 8 7  ± 5 4 2  
1 1 1 0 1  ± 4 70 
8 0 3 9  ± 5 4 9  1 0 0 3 1  ± 8 4 8  
1 5 7 2 4  ± 50 8 1 7 8 4 3  ± 5 4 5  
9 0 5 9  ± 1 8 6  1 1 7 7 9  ± 6 5 7  
1 1 5 2 2  ± 6 3 7  1 5 3 4 6  ± 5 3 3  
1 9 1 3 3  ± 5 4 2  2 0 7 9 5  ± :n O O  
8 74 2  ± 2 3 6  1 0 2 9 5  ± 3 0 2  
84 1 7  ± 2 3 2  9 8 5 6  ± 3 9 0  
1 19 86 ± 3 1 3  1 19 9 9  ± 2 1 5  
1 8 0 5 5  ± 9 0 5  1 71 4 8  ± 2 84 
1 7 866 ± 3 7 7  
The n umb e r s  r e p r e s e n t  t h e  me an ± s t andard e r r o r  f o r  t r i p l i c a t e  we l l s  con t a i n i n g  
6 x 10 5 P 3 8 8  ce l l s as de s c r i b e d  i n  s e c t i o n  V I . C . 6 . b . ( 3 ) .  
(5) 
to 
TABLE V I I I :  RELAT I ONSH I P  BETWEEN DOSE AND I NH I B I T I ON OF [
7 5
S e ] - SE LE NOMETH I ON I NE 
I NCORPORAT I ON I N  P 3 8 8  CELLS 
COMPOUND CONCENTRAT I ON E XPER I MENT 1 E XPER I ME NT 2 EXPE R I MENT 3 AVERAGE 
CONTROL 6 X 1 0 5 c e l l s / mL 
PUROMYC I N  1 0 - 3  M 5 5  9 3  59 6 9  
5 X 1 0 - 4  M 5 3  4 5  4 9  
1 0- 4 M 56 62 50 5 6  
1 0- 5 M 1 8  2 6  1 1  1 8  
2 4  1 0 - 3  M 2 7  56 4 1  4 1  
5 X 1 0- 4  M 2 8  4 6  2 4  3 3  
1 0- 5  M 2 4  1 0  3 1 2  
SPARSOMYC I N  1 0- 3  M 4 8  59 4 9  5 2  
1 0- 4  M 5 1  6 0  5 1  5 4  
1 0- 5  M 4 5  4 4  4 0  4 3  
1 0- 6  M 1 5  1 5  1 5  1 5  
1 0 - 7 M 8 1 1  1 0  
The n umb e r s  r e p r e s e n t  t h e  p e r c e n t  i n h i b i t i o n  f o r  t r i p l i c a t e  w e l l s  con t a i n i n g  6 X 10 5 
P 3 8 8  ce l l s  as de s c r i b e d  i n  s e c t i o n  V I . C . 6 . b . ( 3 ) . 
-.J 
o 
7 1  
TABLE I X : RELAT I ONSH I P  BETWEEN DOSE AND I NH I B I T I ON OF [
75
Se J _ 
SELENOMETH I ON I NE I NCORPORAT I ON I N  BONE MARROW CELLS 
COMPOUND 
CONTROL 
PUROMYC I N  
2 4  
CONCENTRAT I ON MEAN CPM ± STANDARD ERROR 
6 X 1 0 5c e l l s /mL 8 8 5 5  ± 1 5 8  
1 0 - 3 M 8 0 7 7  ± 1 5 70 
5 X 1 0 - 4  M 
1 0 - 4  M 
1 0 - 5  M 
1 0 - 3  M 
5 X 1 0- 4  M 
1 0 - 4  M 
1 0 - 5  M 
6 4 4 9  ± 3 3 4  
64 8 1  ± 7 7 7  
7 5 6 2  ± 6 1  
6 6 6 6  ± 5 0 0  
7 5 74 ± 1 6 8  
8 7 6 1  ± 5 3 4  
7 9 8 1  ± 5 1 4  
SPARSOMYC I N  1 0 - 3 M 6 2 6 0  ± 1 8 6  
1 0 - 4  M 
1 0 - 5  M 




6 2 6 5  ± 6 12 
8 1 8 1  ± 85  
8 8 5 8  ± 3 1 3  
8 7 9 7  ± 1 5 0 0  
% I NH I ­
B I T I ON 
9 
2 7  
2 7  
1 5  
2 5  
1 4  
1 
10 
2 9  




The numb e r s  r e p r e s e n t  t h e  mean ± s t a n d a r d  e r ro r  a n d  t h e  p e r ­
c e n t  i n h i b i t i o n  f o r  t r i p l i c a t e  we l l s con t a i n i n g  6 X 1 0 5 b o n e  
m a r r o w  ce l l s a s  de s c r i b e d  i n  s e c t i on V I . C . 6 . b . ( 2 ) . 
the  re lat ion s h i p  between dose an d response to the  test  com-
pounds . The i n ve s t i gat ion o f  a dose-respon se re lat ion s h i p  
was con t inued by conduc t i n g  severa l ce l l  growth exper ime n t s  
w i t h  P 8 1 5  mastocytoma ce l l s . As seen i n  F i gure X I I I ,  P8 1 5  
mastocytoma ce l ls grew exponent i a l l y  over a 48 hour t ime 
period ( V I . C . 6 . c . ( 1 ) . The three most act ive compoun ds i n  
the  prot e i n  synthes i s  s t u d i e s  i n  P815  ce l ls , 24 , 39 , a n d  50 , 
72 
and t h e  con t ro l  drugs , puromy c i n  and sparsomy c i n , were t ested  
to determ in e  t h e i r  e f fect  on t he ce l l  growth o f  P815  masto-
cytoma ce l l s . U s i n g  t h e  resu l t s  of  t he t ime- course expe r i -
men t  i n  F i gure X I I I  a n d  the  d a t a  i n  Tab l e  X ,  t he opt imal 
t ime for enumerat i n g  ce l l  popu l at ions  dur i n g  the exper iment 
was chosen t o  be twen ty- four hours . The resu l t s  o f  t he ce l l  
growth studies  i n  P815  ce l l s were t abu l at e d  i n  Tab l e s  X I , 
X I I ,  X I I I ,  X IV , and XV . These dat a  d i s p l ayed a dose- re-
spon se re lat ionsh i p  an d were used t o  det ermi n e  approximate 
ED 50 values by l ine ar regress ion an a l y s i s . The accuracy of  
t h e  value s  was l im i t e d  by the  n umber of  data  po i n t s  co l lected 
for  t h e  l in ear regress ion analys i s . As a con sequence , the  
values for compounds 39 and 50 were not  as re l iab l e  as t he 
ED 50 values for  compound 2 4 . The f o l low i n g  ED values -- 50 
were obt a ine d : ( See page 8 1 ) . 
73 
F IGURE X I I I : CHARACTE R I ZAT I ON OF THE P8 1 5  CELL GROWTH 
ASSAY : T I ME COURSE FOR P8 15  CELL GROWTH 
A t y p i c a l  growth curve for P8 15  ce l l s  
i n  CDMEM i s  shown . The po i n t s  represent  
- 5 
t h e  l og cel ls jmL X 10 a f t er i ncubat i on 
for 9 ,  24 , 33 , and 4 8  hour s . Each po i n t  
represen t s  t he mean and s t andard error 
for four rep l i cate we l ls as described 
i n  sec t ion V I . C . 6 . c . ( 1 ) . 
F IGURE X I I I : CHARACTERI ZAT ION OF THE P815  CELL GROWTH 







10 20  30  40  50 
T I ME (hours ) 
74 
75 
TABLE X :  T I ME COURSE STUDY OF THE EFFECT OF PUROMYCIN AND 
COMPOUND 24 ON P815  CELL GROWTH 
COMPOUND 9 HOURS 24 HOURS 33 HOURS 48 HOURS 
CONTROL 1 . 3  ± 0 . 2  3 . 6  ± 0 . 1  6 . 9  ± 0 . 3  19 ± 1 
VEH I CLE
a 
1 . 4  ± 0 . 2  3 . 3  ± 0 . 4  
PUROMYC I N  
1 X 10- 3 M 0 . 9  ± 0 . 1  0 
24  
1 X 10- 3  M 0 . 75 ± 0 . 1  0 
24  
5 x 10- 4  M 0 . 71 0 . 02 0 
24 
1 x 10- 4  M 0 . 77 0 . 05 0 
The n umbers  represent t h e  concent ra t i on of  ce l l s jmL X 10- 5 
± s t andard error for four rep l i cate we l ls of  P815  ce l l s  as 
descr ibed in sect ion V I . C . 6 . c . ( 1 ) .  
a 
D i s t i l led  wat e r  was used as t h e  veh i c l e . 
TABLE X I : RELA T I ONSH I P  BETWEEN THE CONCENTRAT I ON OF COMPOUND 2 4  AND P 8 1 5  CELL GROWTH . 
CELLSLmL % I NH I B I T ION CELLSLmL % I NH I B I T I ON CELLSLmL % I NH I B I T I ON 
CONTROL 9 . 1  ± 0 . 5  1 7- 1 9  ± 2 1 4  ± 1 
VEH I C LE
a 
19 ± 1 1 4  ± 1 
2 4  1 x 1 0 - 4  M 0 1 0 0  0 1 0 0  
2 4  5 X 10 - 5  M 0 1 0 0  
2 4  1 X 1 0 - 5  M 3 . 1  ± 0 . 2  6 2  7 . 8 ± 0 . 2  59 5 . 6  ± 0 . 3  6 0  
2 4  
7 . 5  X 10
- 6 M 5 . 5 ± 0 . 2  6 0  
2 4  5 X 1 0 - 6  M 9 . 7 ± 0 . 1 4 3  8 . 0  ± 0 . 4  4 3  
2 4  
2 . 5  X 1 0 - 6  M 1 0  ± 3 2 9  
2 4  1 X 1 0 - 6  M 6 . 9  ± 0 . 6  16 1 4  ± 2 1 8  1 1  ± 3 2 1  
2 4  5 X 1 0
- 6 
M 16 ± 4 6 
2 4  1 X 10 - 7 M 8 . 4  ± 0 . 6  0 
- 8 
2 4  1 X 1 0  M 8 . 8  ± 0 . 6  0 
The n umb e r s  r e p r e s e n t  t h e  c o n c e n t r a t i o n  o f  c e l l s j mL X 10 -
5 
± s t an da r d  e r r o r  an d t he p e r-
c e n t  i n h ib i t i o n  f o r  f ou r  r ep l i c a t e  w e l l s  o f  P 8 1 5  c e l l s wh i c h we r e  in c ub a t e d  f o r  2 4  h o u r s  i n  
t he p r e s e n ce o f  v ar y i n g  c o n c en t r a t i o n s  o f  2 4  a s  d e s c r i b e d  i n  s e c t i o n  V I . C . 6 . c . ( 2 ) .  
aD i s t i l l e d  wat e r  was u s e d  a s  t h e  veh i c l e . 
-..J 
(J) 
TABLE X I I :  RELAT I ONSH I P  BETWEEN THE CONCENTRATION OF 




PUROMYC I N  
PUROMYC I N  





PUROMYC I N  7 . 5x10- 6M 
PUROMYCIN 
PUROMYC I N  2 . 5x10- 6M 
PUROMYCI N  
PUROMYC I N  
CELLS/ML 




0 . 8  ± 0 . 3 
17  ± 0 . 5  
16 ± 1 
% I NH I - CELLS /mL B I TI ON 
14 ± 1 





9 5  a 
1 1  ± 7 
a 14 ± 4 
6 
77 
% I NH I ­






The n umbers  represent the concent rat ion o f  cel ls / mL X 10- 5  ± 
s t an dard error and the  perce n t  inh ib i t ion  f o r  four rep l icate  
wel l s  o f  P815  ce l l s  wh ich were  i n cubated 24  hours  i n  t he 
presence of  vary i n g  con cen t rat i on s  o f  puromy c in as descr ibed  
i n  sect ion  V I . C . 6 . c . ( 2 ) . 
a 
D i s t i l led  wate r  was used as the  veh i c l e . 
TABLE X I I I :  RELAT IONSH I P  BETWEEN THE CONCENTRATI ON OF 
SPARSOMYC I N  AND P 8 1 5  CELL GROWTH 
CELLS/mL % INH I B I T I ON 
CONTROL 14 ± 7 
VEH ICLEa 14 ± 7 
SPARSOMYC I N  1 X 1 0
- 5  
M 0 100 
SPARSOMYC I N  7 . 5  X 1 0-6 M 0 100 
SPARSOMYCIN  5 X 10-6 M 0 100 
SPARSOMYCI N  2 . 5  X 10
- 6 M 3 . 9  ± 0 . 2  72 
SPARSOMYCIN  1 X 10-6 M 5 . 7  ± 0 . 4  59 
78 
The n umbers represent t he concent rat ion of ce l l s /mL X 10- 5 ± 
s t andard error and t h e  percent i n h i b i t ion for four rep l ic at e  
we l l s o f  P 8 1 5  ce l ls which were i n cubated 2 4  hours in  t h e  
presence o f  vary i n g  con cen t rat i on s  o f  sparsomy c in as descr ibed  
in  sect ion V I . C . 6 . c . ( 2 ) .  
a 
D i s t i l led  wat e r  was used as the  veh ic le . 
TABLE X I V : RELATIONS H I P  BETWEEN THE CONCENTRAT ION OF COM­
POUND 39 AND P 8 1 5  CELL GROWTH 
CELLSLmL % I NH I B I T I ON 
CONTROL 1 3  ± 1 
VEH I CLEa 12 ± 1 
39 10- 4  M 4 . 4  ± 0 . 2  66 
39 10- 5  M 4 . 8  ± 0 . 4  6 3  
39 10-6 M 8 . 0  ± 0 . 9  38 
79 
The numbers represent  the concen t rat ion of ce l l s / mL X 10- 5 
± s t andard error and the percent i n h ib i t i on for four rep l i­
c a t e  we l ls o f  P 8 1 5  ce l l s whi ch were in cubated  2 4  hours in  
t he presence o f  vary i n g  concent rat i on s  of  compound 39 as  
described i n  sect ion V I . C . 6 . c . ( 2 ) . 
a 
D i s t i l le d  wat e r  was used as t he veh i c le . 
TABLE XV : RELAT IONSH I P  BETWEEN THE CONCENTRAT I ON OF COM­
POUND 50 AND P815  CELL GROWTH 
CELLSLmL % INH I B I T ION 
CONTROL 1 3  ± 1 
VEH I CLEa 1 2  ± 1 
50 1 0- 4 M 5 . 1 ± 0 . 3  60 
- 5  
50 10 M 7 . 4 ± 0 . 1  42 
50 10-6 M 9 . 1 ± 0 . 1 30 
The numbers represent the concent rat ion of ce l l s / mL X 10  
± s t andard error an d t he percent i n h i b i t i on for  four rep l i­
cate wel ls of  P815  ce l ls wh ich  were i n cubated 24  hours i n  
t h e  presence o f  vary i n g  concent rat ion of  compound 50 a s  
descr i bed i n  sect ion V I . C . 6 . c . ( 2 ) . 
a 
D i s t i l led  water  was used as t h e  veh ic l e . 
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TABLE COMPOUND APPROXI MATE 
ED 50 
X I  2 4  8 . 9  X 10
-6 
M 
X I I  PUROMYC I N  2 . 6  X 10
-6 
M 
X I I I  SPARSOMYC I N  2 . 2  X 10-7 M 
X I V  3 9  5 . 8  X 10-6 M 
XV 50 6 . 0  X 10- 5  M 
The resu l t s  show t h e  compounds 2 4 , 39 , and 50 were s i gn i f i-
can t ly act ive  compoun ds and h ave ED50 values comparab le  t o  
t h e  con tr o l  drug , puromy c i n . 
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S in c e  three of  t h e  fourteen t arget compounds i n h i b i ted 
prot e i n  synthes i s  as re f lected  i n  the  i n corporat ion o f  [
75Se J _  
s e lenome t h ion i n e  and ce l l  growth i n  concentrat ion s approach-
ing the con t ro l  drugs , studies  were conducted to detect  any 
e f f ect the compoun ds may h ave on DNA syn t hes i s . To measure 
the e f fect  on t he ce l l ' s  ab i l i t y  t o  syn thes i ze DNA , t h e  
compounds were i n cubat ed  w i t h  normal ce l l s  a n d  tumor cel ls 
i n  t he presence of  5_1 2 5 I - i Odo- 2-deoxyu r i d i n e  (
1 2 5
IUdR ) 
( V . C . 6 . a ) .  The DNA synthes i s  was mon itored b y  the  in corpor­
at ion  of 1 2 5 IUdR i n t o  the cel ls . As i n  the prot e in syn t hes i s  
studies , a prel i m i n ary  t ime- course exper ime n t  was conducted 
t o  asce r t a i n  t he opt ima l t ime f or harvest i n g  t h e  ce l l s . 
A n alogous to t h e  f i n d ings of  Wh i t e , et  a l . ( 81 ) , F i gure X IV 
shows there was a l inear i n corporat i on o f  1 2 5 I UdR over a 
two- hour i n cubat ion  per iod . Based on t h i s  i n f ormat ion , 
t he ce l ls were i ncubated two hours pr ior t o  harve s t i n g  i n  
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F I GURE X I V : CHARACTER I ZAT I ON OF THE DNA SYNTHES I S  'ASSAY : 
T I ME COURSE FOR INCORPORATION OF 
125
I UdR 
I NTO BONE MARROW CELLS 
A t y p i c a l  DNA synthes i s  curve showing  t he 
i n corporat i on o f  125  I UdR i n t o  bone marrow 
cel l s .  The po i n t s  i n  the  f i gure represent 
5 
CPM / 6  X 10 ce l ls after  i n cubat ion w i t h  the  
pul se l ab e l  for 15 , 30 , 45 , 60 , an d 120 m i n -
utes . Each po i n t  represen t s  t h e  mean and 
the s t an dard error for t r i p l i cate  we l l s  
a s  des c r ibed  i n  sect ion V I . C . 6 . a . ( 1 ) . 
F IGURE X I V : 
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CHARACTERI ZAT ION OF THE DNA SYNTH�S I S  ASSAY : 
T I ME COURSE FOR I NCORPORAT I ON OF 2 5 I UdR 
I NTO BONE MARROW CELLS . 
r 
1 5  30 45  60  120 
T I ME ( minutes) 
a l l  subseque n t  studies  on DNA synt hes i s . 
The t arget compounds were tested  i n  the  DNA synthes i s  
assay u s i n g  bone marrow ce l l s  ( V I . C . 6 . a . ( 2 »  and P388 t umor 
ce l l s  ( V I . C . 6 . a . ( 3 » . Tab l e  XV I shows t h e  resu l t s  w i t h  the  
bone marrow ce l l s  and i n d i cates on l y  one  compoun d , compound 
24 , i n h i b i t ed t he i n corporat ion o f  
125
IUdR . Th i s  i n h ib i -
t ion was much less  t h an the  con t r o l  i n h ib i tor , AraC , and 
was not  s t at i s t i ca l l y  s i gn i f i cant at p < O . 0 5 when compared 
t o  the con t ro l  ce l l s . Tab le  XV I I  d i s p l ays the resu l t s  
wi t h  P 3 8 8  ce l ls and ,  once again , shows t hat compoun d 24  
was  the  mos t  act ive i n h ib i tor , but  t he i n h ib i t ion was , 
a l t hough s t at i s t i c a l l y  s i gn i f ican t , very sma l l  when com­
pared t o  the  con t ro l  i n h ib i t o r , AraC . The dat a suggested  
t he t arget compounds have l it t le or no e f fect  on DNA syn­
thesis  as measured by the i ncorporat ion o f  1 2 5 I UdR i n t o  
ce l l s  or t h e  e f fect  cannot b e  detected  w i t h i n  the  two hour 
t ime f rame of  t he assay . 
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TABLE XV I :  I NH I B I T ION OF 125 IUdR I NCORPORATI ON I N  BONE 
MARROW CELLS 
COMPOUND a MEAN CPM ± STANDARD ERROR % I NH I B I T I ON 
CONTROL 20863  ± 662 
22  2 79 6 1  ± 3 52 o 
24  17672  ± 1 359 15 
2 8  2 5508 ± 4 1 8  o 
36 22900 ± 1 2 7 3  o 
3 7  2 5556 ± 461  o 
38  2 3 39 1  ± 565 o 
39 20978 ± 1004 o 
19 2 8074 ± 662 o 
AraC 148b 99 
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The numbers  represen t t h e  mean ± st andard error and the 
percent i n h ib i t ion for six rep l icate  we l l s  con t ai n ing  6 X 105 
bone marrow ce l l s  as descr ibed i n  sec t i on V I . C . 6 . a . ( 2 ) . 
a 
Al l compounds  were t e s t e d  at  10- 3 M .  
b 
p < 0 . 05 as compared t o  con t ro l s . 
TABLE XV I I :  INH I B I T I ON OF 125 IUdR I NCORPORATI ON IN P388 
CELLS 
COMPOUND a MEAN CPM + STANDARD ERROR % INH I B I T ION 
CONTROL 2 1592 ± 1196 
22  20605  ± 655  5 
2 4  142 72 ± 468b 34 
2 8  2 2 8 3 8  ± 2938 o 
36 19633 ± 1176 9 
37 2 3089 ± 955  o 
38 2 1 163 ± 783 2 
39 17960 ± 638  17  




The numbers  represent  the mean ± st andard error and the  
percent inh ib i t ion for s ix rep l i cate we l l s  con t a i n in g  6 X 105 
P388 ce l ls as desc r ibed in  sect ion V I . C . 6 . b . ( 3 ) .  
a - 3  
A l l  compounds were tested  a t  1 0  M .  
b 
p < 0 . 0 5  as compared t o  con t ro l s . 
V .  CONCLUS I ONS 
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The t arget compounds were anal yzed in t hree assay s , the  
prote i n  synthes i s  assay , t h e  DNA syn t hes i s  assay , and t he 
ce l l  growth assay u s i n g  P388 ce l l s , P8 1 5  ce l l s , o r  bone 
marrow c e l l s .  I n  the  DNA an d prot e i n  synth e s i s  assays , the  
125  75  i n corporat ion o f  t h e  pu l s e  l abe l s  IUdR and [ Se J - se l eno-
met h ion i n e , respect ive l y , were quan t i t ated . These measure-
men t s  were used as i n d i rect measureme n t s  of  DNA and prot e i n  
s y n t hes i s . Anal y t i cal  i n spect ion o f  the  dat a summarized in 
Tab l e  XV I I I , revea led  three of  t he fourteen t arget compounds , 
24 , 39 , and 50 , were s ign i f ican t l y  act ive i n h i b it ors o f  
[
7 5
se J _ s e lenomet h io n i ne i n corporat ion in  bone marrow cel l s , 
P388  l ymphoma cel ls , and P815  mastocytoma ce l l s  at p < 0 . 0 5 .  
Furthermore , t h e s e  t hree compounds i n h i b i t e d  P 8 1 5  ce l l  
growth w i t h  ED values near those o f  t h e  con t r o l  drugs , 
50 
puromyc in and sparsomy c i n . C loser examinat ion o f  the 
pharmaco l o g i c a l  data i n  an a t t empt to e s t ab l ish a s t ruc-
t ure- act i v i t y  re l at ionsh ip , d i s c losed compounds 35 , 38 , 
and 4 8 , were usua l l y  the least act ive analogues . Compounds 
19 , 2 2 , 2 8 , 36 , and 37  were moderate l y  act ive in most of 
the expe r imen t s . Seve r a l  con c l u s i on s  can be drawn re l at in g  
t he s t ructure of  t h e  an a logue s to t h e i r  b io log i c a l  e f fect ive-
n e s s  i n  P81 5 , P388 , and bone marrow cel l s . 
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TABLE XV I I I : SUMMARY OF THE RESULTS FOR THE PROTE I N  
SYNTHES I S  AND CELL GROWTH ASSAYS . 
The data wh ich  appears in  Tab le  XV I I I  summar izes t h e  
pharmaco l o g i c a l  resul t s  for t h e  f o l low i n g  t arget compounds 
wh i ch were synthes ized . 
R 






Ser i e s  I I  -H 
-H 
- H  
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R '  
-C6H4-X 
- C H -X 6 4 
-C6H4-X 
-C H -X 
6 4 
-C H -X  
6 4 
-C H -X 6 4 
-C � 4-X 
- C  H -X 
6 4 
- CO-NH-C H -X 6 4 





-CO-NH-C H -X 
6 3 2 
X COMPOUND 
H 22  
4-Br 24  
4 -CH 3 2 8  
4-0CH
3 
3 5  
H 36 
4-CH 3 37  
4-0CH 3 38  
4 -Br 39 
H 44 
4 -CH3 46 
4-0CH3 
4 8  
4-Br 50 
3 , 4  d i C l  52 
. . .  Cont inued 
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TABLE XV I I I :  SUMMARY OF THE RESULTS FOR THE PROTE I N  
SYNTHES I S  AND CELL GROWTH ASSAYS ( Con t inued )  
P388a 
ED50 FROM P815  
COMPOUND P815a BMa CELL GROWTH ASSAY 
22 6 52 34 
2 4  4 4  94 64 8 . 9  X 10-6 M 
2 8  7 65  40 
35 0 0 0 
36 3 2 34 
37  0 1 1  3 5  
3 8  1 0 44 
- 6 
39 26 89 42  5 . 8  X 10 M 
44b 
46b 
48 3 0 1 1  






The n umbers represen t the  percent i n h ib i t ion  of  [
75
Se J _  
se lenome t h ion ine  i n corporat ion i n  the prot e i n  synthe s i s  as­
says .  
b 
These compounds were i n so lub le at the requ ired concen t ra­
t ions in water or ethano l , wh ich  prec luded t e s t i n g .  
F i rs t , t h e  resu l t s  i n d i c at e  the  remova l of t h e  hydroxy­
met h y l  fun c t i o n a l  group as seen i n  sparsomy c i n  h as a vary­
ing e f f ect on act i v i t y . I n  the  P815 ce l l s , removal o f  the  
hydroxymet h y l  group decreased the  ab i l ity  o f  the  t arget 
compoun ds t o  i n h i b i t  [
75
Se ] -s e l enome t h i o n i n e  i n corporat ion . 
I n  support o f  t h i s , t h e  Series  I compounds 22  and 2 8  were 
act ive i n h i b i t ors , whereas , the Series  I I  analogues 36 and 
37  were i nact ive . I n  the  P388 ce l l s  and the  bone marrow 
ce l l s , i n c lus i on or exc lus ion of the h ydroxyme t h y l  func-
t i onal  group o n l y  e f f ected the bromophe n y l - an d methoxy­
phen y l -sub s t i t ut e d  an a logues ' ab i l i t y  to inh ib i t  [ 75Se ] _  
s e l enome t h ion i ne incorporat ion . I n  t h e  case o f  the  bromo-
90 
pheny l ana logues , i n c lus ion of the  hydroxymet h y l  group 
resulted  i n  an i ncreased i nh ib i t ion of [
75
Se ] - s el enometh ion i n e  
i n corporat i on i n  the  P 3 8 8  a n d  bone marrow ce l l s ( 24 versus 
39 ) .  Converse l y , the  add i t i on of  the hydroxymeth y l  group to 
the  met hoxypheny l - sub s t i t uted compound 38 e l iminated the 
i n h ib i tory act i v i t y  i n  the bone marrow ce l l s , as shown by 
the  i nact i v i t y  o f  compound 35 . I n  con t ras t t o  t h e  resu l t s  
w i t h  P 8 1 5 , P388 , a n d  bone marrow ce l l s  in  t h e  prot e i n  syn-
t hes i s  assay � t h e  resu l t s  of  t h e  P815  ce l l  growth stud ies  
indicated  t h e  presence or abs ence of  t h e  hydroxymet h y l  
f un c t i on a l  group h a d  no e f fect  o n  act i v i t y  a s  e v i denced i n  
t h e  compari son o f  t h e  s imi l ar ED50 v
a lues f o r  compound 24  
and 39 . 
Addi t io n a l  i n f ormation  for  expans ion of  t h e  s t ructure 
act i v i ty re lat ions h ip for  the t arget compounds evo lves f rom 
t h e  data on t h e  Series  I I  compounds in the  bone marrow 
9 1  
p ro t e i n  s y n t h e s i s  a s s a y . I n  these e x p e r i me n t s, t h e  va r i at i on 
o f  s ub s t i t ue n t s  o n  t h e  p h e n y l r i n g  d i d  n o t  c han ge t h e  ab i l i t y  
o f  t he comp o u n d s  t o  i nh i b i t  [ 75S e J - s e l e nome t h i on i ne i n c o r -
p o r a t i on . A l l  f o u r  o f  t h e  S e r i es I I  comp o u n ds , 3 6 - 3 9 , h a d  
a p p r o x i m a t e l y  t h e  s ame a c t i v i t y . 
I n  S e r i e s  I I I , t h e  on l y  s i gn i f i c an t l y ac t i ve c omp ound 
was 50 in the p ro t e i n  s y n t h e s i s  a n d  ce l l  grow t h  s t ud i es . 
Th i s  c o mp o u n d  was n o t  as a c t i ve as 2 4  o r  3 9  wh i ch s u gge s t s  
t h e  r e mo v a l  o f  t h e h y droxyme t h y l  f un c t i on a l  group an d s u b -
s t i t ut i on o f  t h e mon o - oxod i t h i o a c e t a l  s i de ch a i n  o f  s p a r s o -
my c i n  w i t h  a s ub s t i t u t e d  b e n zy l  am i de mo i et y  i s  n o t  b e n e f i -
c i a l  f o r  a ct i v i t y . 
Con t i n u i n g  t h e  a n a l y s i s  o f  t h e  d a t a  f r om t h e  p r o t e i n  
s y n t h e s i s  a s s a y s  reve a �d t h at t h e  b romo p h en y l - sub s t i t u t e d  
a n a l o g ue s  c o n s i s t e n t l y  i mp a r t e d  t h e  gre a t e s t  i n h i b i t o r y  a c -
t i v i t y . Fur t h e r mo r e , t h e  me t h o x y p h en y l s u b s t i t u t e d  an a l o gu e s  
were i n ac t i ve i n  mo s t  o f  t h e  s t ud i e s . Th e met h y l p h en y l  
an a l ogues were s l i gh t l y more a c t i ve t h an t h e  u n s ub s t i t u t e d  
p h e n y l compoun d s , an d o v e r a l l ,  t h e  m e t h y l p h en y l an d un -
s ub s t i t ut e d  p h en y l  an a l o gues fe l l  i n  b e t we e n  t h e  b romo p h en y l -
an d me t ho x y p h e n y l - s ub s t i t u t e d  compoun d s . T h e  a c t i v i t y  m a y  
c o r r e s p o n d t o  t h e  l i p o ph i l i c an d e l e c t ron i c  c h a r a c t e r i s t i c s  
o f  t he s ub s t i t ue n t s  o n  t h e  p h e n y l  mo i e t y  o f  t h e  an a l ogue s . 
Tab l e  X I X  l i s t  t h e  0 an d rr v a l ue s  f o r  t h e  f our sUbs t i t ue n t s  
i n ves t i gat e d .  I n  c o n c l us i on , i t  appears t h at t h e  b romo-
p h e n y l s ub s t i t ue n t  of h i gh l i po ph i l i cy an d e l e c t ron w i t h -
d r aw i n g  c h a ra c t e r  i s  o p t ima l f o r  i n h i b i t o ry a c t i v i t y  an d 
TABLE X I X : SUBSTI TUENT CONSTANTS ( 82 )  
SUBST ITUENT 
b romo 




0 . 2 3  
-0 . 1 7 
o 
-0 . 2 7 
11 ( PARA ) 
1 . 19 
0 . 60 
o 
-0 . 0 3 
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conversely ,  t h e  met hoxyphe n y l  s ub s t i t uent  o f  h ydroph i l ic 
and e l ec t ron  donat i n g  character  i s  least  des irab le .  These 
res u l t s  subs t an t i ate the  suppos it i on of  Lee and V ince  ( 50 )  
t hat hydrophob i c  groups ext ending  i n t o  t h e  region occup i e d  
by t he -CH - S-CH cha i n  of  sparsomy c i n  were tolerated , and 
2 3 
i n  t h e  case o f  several compounds ( S e r i es I :  22 ve rsus 24  
S e r i e s  I I : 36  versus 39 ) actua l ly e nhanced act i v i t y . 
9 3  
V I .  EXPERIMENTAL 
A .  General  
Me l t in g  po i n t s  were det e rmined  on a Thomas-Hoover me l t -
i n g  po i n t  apparatus and are reported as uncorrected  values . 
I n frared spe c t ra were obt ained  from a Beckman AccuLab 8 
spect rophotome t e r  us i n g  samp l e s  o f  the compounds as a solu-
t ion i n  the i n d i cated solvent or neat . The s t ron g ,  sh arp 
- 1  
band o f  polyst yrene f i lm a t  160 1 . 4  cm was used as a re fer-
e nce marke r for a l l  i n frared spect ra . Nuc l e ar magnet i c 
resonan ce ( NMR ) spectra were measured on  a Pek i n- E l me r  
Mode l R-2 4  spect rome te r . Chemical  sh i ft s  o f  the compounds 
in t he i n d i c ated so lvent are denoted i n  un i t s  o f  parts per 
mi l l ion  ( 6 ) , down f i e l d  o r  up f i e l d  f rom a knOffi re ference 
peak . When  t r i f luoracet i c  a c i d  was used as the s o l ve n t , 
t he t r i f l uoroace t i c  a c i d  proton at 1 1 . 3  ppm was used as 
the reference . I n  al l o t he r  so l ven t s , the sh i ft s  are re-
ported down f i e ld f rom tet ramethy l s i l ane  wh ich  was added 
as an i n te r n a l  s t an dard . Ult rav i olet  spectra  were gen e r-
ated f rom a Beckman Mode l 25  spect rophotometer  us i n g  s am-
p les  i n  a solut i on o f  the  i n d i c ated solve n t . 
React i on s o l ve n t s  were s tored over the appropr i at e  
s i ze mol e c u l ar s ieves ( 83 ) .  Dime t h yformami de was d i s t i l led  
ove r b ar i um oxide prior  t o  s torage over  mo lecular s ieves . 
94 
Tet rahydrofuran was re f lexed over cuprous ch lor i de , d i s ­
t i l led , an d f i na l l y  d i st i l le d  aga i n  ove r l it h ium alum i n um 
hydri de prior  to s torage over mo l ecu l ar s ieves . Ethanol  
was made super dry by d i s t i l l i n g  over magnes i um and a cata­
l y t i c  amoun t o f  iodine  prior t o  s t or age over mo l e cu l ar 
s i eves ( 84 ) .  Removal o f  s o l ve n t s  un der reduced pre ssure 
was done w i t h  a Buch l e r  F l ash  Evaporator at wat er asp i rator 
pressure . Dry i n g  was accompl i shed unde r a vacuum o f  less  
t h an one mm  H g  over  t h e  i n d i cated so l vent . 
The react ions  leading  to t h e  isolat ion  of  t h e  Series  
I I I  compounds were f o l lowed b y  t h in l ayer chromat ography on 
s il i ca gel p lates ( An a l tech , I n c , Newark , DE ) .  The p l ates  
were deve loped i n  a so lven t s ys t em con t a i n i n g  ch loroform , 
i sopropyl  e t he r , and acet i c  a c i d  ( 6 : 3 : 1 ) . The t arget com­
poun ds of e ach series  were a l s o  an alyzed by t h i n  l ayer 
chromat ography u s i n g  ch l oro form an d met h an o l  ( 8 : 2 ) . 
95  
A l l  compounds are  den ot e d  by unde r l i n e d  Arab i c  n umera l s . 
I n  add i t i on t o  spect roscop i c  character i zat ion , al l new com­
poun ds were iden t i f ied by e l emen t a l  an a l y s i s  ( At l an t i c  
M i cro l ab . , At lant a ,  Georg i a ) . 
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B .  Compounds Synt h es i zed 
2 , 4 -D i hydroxy- 5-hydroxymethy l - 6-met hy lpyrimid i ne ( 2 ) . 
The method o f  Ot tenhe i j m ,  vanN ispen , and S i n n i ge ( 46 )  was f o l ­
lowed . Sodi um hydroxi de ( 6 . 4  g ,  0 . 16 mo le ) was d issolved i n  
wat er ( 60 mL ) ,  coo led  t o  room t emperature , a n d  added to 2 , 4-
d i hy droxy-6-methy lpy r i m i d i ne ( 10 . 0  g ,  80 mmo l )  i n  an open 100-
mL roun d-bo t t omed f l ask , equi pped with a magnet i c  st irrer . 
Th i r t y- s even percen t forma l dehy de solut ion ( 19 . 2  g ,  0 . 24 
mo l e )  was added and s t i rred at room temperat ure for three 
hours . The wh i t e  p re c i p i t ate was f i l t ered and disso lved 
in bo i l in g  wat er ( 50-60 mL ) . One equivalent  of  g l ac i a l  
acet i c  a c i d  ( 4 . 8  g ,  80  mmo l )  was s lowly added . The solu-
t ion was coo led  i n  t h e  r e f r i gerator overn i ght . The prec i -
p i t at e  was f i l t ered , and d r i ed under reduced pressure 
( t o luen e , 1 1 10 ) t o  af ford 9 . 9  g ( 80% ) o f  � as a wh i t e  
s o l i d , m p  300 - 3 1 00 ( dec ) ; l i t erature ( 85 )  mp 305- 3 1 00 ( dec ) . 
I R  ( Nuj o l ) :  3 380 cm
- 1 ( broad , O-H ) ; 1 700 ( med i um , C=O ) . 
NMR ( Me2 S0- d6 /D2 0 ) : 8 2 . 5  ( s ,  2 ,  CH2 ) ;  2 . 1 ( s ,  3 ,  CH3 ) · 
( 2 , 4-D i hydroxy-6-methyl - 5-pyr i m i d i nyl) carboxal dehyde 
( � ) . The a l dehyde � was prepared v i a  t h e  procedure o f  
Brossmer and Z ie g l e r  ( 86 ) . Pot ass i um persu l fate ( 10 . 8  g ,  
40  mmo l )  was d i s so lved i n  wat er ( 150 mL ) i n  a 250-mL E r l e n -
meyer  f lask e qu i pped w i t h  a magn e t i c  st i rrer . The pre­
v i ou s l y  des cribed  h ydroxymet hy lpy r im i d i ne � ( 6 . 24 g ,  40 
o 
mmo l )  was added and heat ed  to 40 . A sma l l  amount of  un -
d i s so l ved  2 was f i ltered , an d s i l ver n it rate ( 0 . 1  g ,  0 . 6  
mmo l ) was added to t h e  f i l t rate . The f i lt rate so lut ion  was 
s t i rred at 400 for t h i r t y  minutes ( o i l  bat h , 400 ) ,  f o l lowed 
by coo l i n g  in t h e  re f r i gerat or overn i gh t . The pre c i p i t at e  
was co l lected  b y  f i lt rat i on , recry s t al l i zed  f rom wate r , 
and dr ied  un de r reduced pressure ( to luen e , 1 1 10 ) t o  a f ford 
4 . 0  g ( 6 5% )  o f  � as a whi t e  s o l id , mp above 2000 ( dec ) ; 
l it erature ( 5 )  mp above 2000 ( dec ) . - 1  I R  ( Nuj ol ) :  1740 cm 
( st ron g ,  C=O ) . NMR ( DMF , d-7 ) : 0 9 . 7  ( s ,  1 ,  CHO ) ; 2 . 2  
( s ,  3 ,  CH
3
) .  UV max ( H
2
0 ) : 232  nm ( E  = 6 3 00 ) ; 280 ( E  = 
9000 ) ; UV m i n  ( H20 ) : 250  ( E  = 3200 ) .  
Carbethoxymet hyl t r iphenylphosphon ium Brom i de (�) . 
The method des c ribed  b y  I s ler , et a l . ( 53 )  was used . Tri -
pheny lphosphi n e  ( 156 . 8  g ,  0 . 6  mo le ) and b enzene ( 730 mL)  
were p laced i n  a 2 00 0 -mL roun d-bot tomed f l ask equipped 
with a mech an i c a l  s t i rrer , thermomet e r , and 100-mL pres sure 
compensat i n g  dropp i ng fun n e l  w i th a dry i n g  tub e . To t h e  
so lut i on , ethy l b romacetate  ( 100 g ,  0 . 6  mo le ) was added 
dropw i s e  over a t h i rt y -m inute period . The t emperat ure 
o rose f rom room t emperature t o  35-40 . A f t e r  s t i rr i n g  over-
n i ght , t h e  phosphon i um b romi de was co l lected  by f i l t rat ion , 
washed w i t h  benzene and hexan e , an d dried under reduced 
pressure for s everal hours t o  give 257 g ( 10 0% )  of  4a as a 
wh i t e  s o l i d ,  mp 162
0
; l it e rature ( 5 3 )  mp 1580 . 
Carb e t hoxymet h y l e n e t r ipheny lphosphorane ( i ) . The pro-
cedure of I s l e r , e t  a l . ( 53 )  was used . To a so lut ion of 
carbet h oxyme t h y l t r i pheny lphosphon ium b romi de 4 a  ( 96 . 0  g ,  
9 7  
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0 . 22 mol e ) in  wate r  ( about 700- 800 mL ) , a f i ve percent solu-
t ion  o f  sodium hydroxi de was added dropw i s e  with  s t i r r i n g  
un t i l  a pH o f  8 . 7  was obt a i ned . The resu l t i n g  pre c i p i t at e  
was co l l ect ed  by f i lt rat ion , washed w i t h  wat e r , a n d  recrys-
t a l l ized f rom e t hy l acet at e / hexane t o  g ive 60 . 0  g ( 86% ) of  
4 as a wh i t e  sol i d ,  mp 1 16- 1 1 80 ; l it erat ure ( 53 )  mp 1 16 - 1 1 70 . 
NMR ( CDC1 3 ) :  0 7 . 55 ( m ,  15 , Ar-H ) ;  4 . 0  ( q ,  2 ,  CH2 ) ;  2 . 9  ( s ,  
1 ,  P=CH ) ; 1 . 0  ( t ,  3 ,  CH3
) .  
( E ) -Methyl 3-( 2 , 4-Dihydroxy-6-me t hyl- 5-pyr i m i d i ny l )  
propenoate (li) . The met hod described by W i l ey an d MacKel le r  
( 5 ) , was f o l lowed . A mixt ure of  � ( 3 . 08 g ,  20  mmo l ) , car­
bethoxymeth y lenet r ipheny lphosphorane ( i )  ( 14 . 0  g ,  40 mmo l )  , 
i n  d imeth y l formam i de ( 60 mL ) was pl aced i n  a 250-mL round-
bot t omed f l as k  an d heated at re f lux for s ix hours ( con -
denser , dry i n g  t ub e , oi l bath ) .  About 30 mL o f  t h e  di -
met h y l fo rmam i de was removed under reduced  pressure , an d 
wat e r  ( 30 mL ) was adde d . The w h i t e  sol id  was co l lected  
b y  f i lt rat i o n , recryst a l l i ze d  f rom ethy l ene g lyco l mono­
met h y l  e t her , an d d r i ed ( to luene , 1 1 10 ) ,  t o  g i ve 1 . 86 g 
o 
( 42% ) o f  � as a wh i t e  s o l i d ,  mp 298-300 ( de c ) ; l it erature 
o - 1  ( ( 5 )  mp 299-302  ( dec ) . I R  ( Nuj o l ) :  1750 em s t ron g , 
C=O ) ; 1680  ( st ron g , C=C ) . NMR ( Me2 SO , d-6 )  : 0 1 1 . 3 ( s ,  
2 ,  O-H , exchan geab le ) ; 7 . 2  ( d  o f  d ,  2 ,  t rans CH=CH , J=16 
Hz ) ; 4 . 2  ( q ,  2 ,  CH2 ) ; 
2 . 3  ( s ,  3 ,  pyrimidine-CH3 ) ;  1 . 2  ( t ,  
3 ,  CH3 ) . UV max ( Et OH ) : 303  nm ( E: = 
2 1 , 000 ) . 
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( � ) - 3- ( 2 , 4-D ihydroxy-6-met h y l -5-pyrimi d i ny l ) propeno i c  
A c i d  ( � ) . The procedure o f  Ot tenhe ij m ,  et  a l . ( 46 )  was f o l ­
lowe d .  A so lut i on o f  � ( 1 . 0  g ,  4 . 5  mmo l ) i n  a 1 : 1 : 1  ( v / v )  mix-
ture o f  d ioxan e , met h anol ,  and wat er ( 50 mL)  cont a i n i n g  sod i -
urn hydrox ide ( 0 . 54 g ,  1 3 . 5  mmo l ) was warmed on t h e  s team bath 
for two hours . The so lut ion was coo led to room temperature and 
t h e  d i oxane and met hanol were removed under reduced pressure . 
The rema i n in g  solut i on was a c i d i f ied w i t h  a f i ve percent solu-
t ion  o f  hydroc h l or i c  a c i d  and f lu f f y  wh i t e  crystals  prec ip-
i t ated . Th e pre c i p i t ate was co l lected by f i l t rat ion , re­
crys t a l l ize d  from wat e r , and dr i e d  ( to luene , 1 1 10 ) ,  to 
g ive 0 . 87 g ( 99% ) o f  6 as a wh i t e  sol i d , mp 267-2700 ( dec ) ; 
l it erature ( 5 )  mp 2650 ( de c ) . I R  ( Nuj o l ) :  3480 cm- 1  
( broad , O-H ) ; 1 740 ( s t ron g , C=O ) . NMR ( Me SO , d-6 ) : 0 1 1 . 4  2 
( s ,  1 ,  COOH ) ; 7 . 2 5 ( d  of  d ,  2 ,  t rans CH=CH , J=16 Hz ) ; 2 . 38 
( s ,  3 ,  CH
3
) .  UV max ( H
2
0 ) : 294 nrn ( £  = 1 1 , 500 ) . 
( E ) - ( + ) -N -(2-Hept anyl )- 3 - ( 2 , 4 - di hydroxy-6-rnethyl - 5-
p y r i m i d i ny l ) - 2-propenam i de ( lQ ) . The method o f  L i n  and 
Dub o i s  ( 5 1 )  was mod i f i ed . A m i xt ure of  � ( 1 . 0  g ,  5 mmo l ) 
and �_ et hoxycarbon y l - 2 - ethoxy - 1 , 2 - d ihydroqu i no l i n e  ( 1 . 56 
g ,  6 mmo l ) i n  dry d imet h y l formamide ( 32 rnL ) was mag­
net i c a l l y  s t i rred at 3 50 ( o i l  b at h , 350 ) unt i l solut ion 
f ormed . Subs equent l y , 2 - ami noheptane ( 0 . 58 g ,  5 mmo l ) i n  
dime t hy l formamide ( 5  mL ) was added , f o l l owed b y  wat er ( 4 . 2  
mL) . The so lut i on was s t i rred for four hours at 35
0 . The 
pre c i p i t at e  was co l lect ed  by f i lt rat ion , recry s ta l l i zed 
f rom ethano l , an d d r i ed under reduced pressure ( to luene , 
1 1 10 ) t o  a f ford 1 . 1 1 g ( 78% ) of  19 as a whi t e  so l i d ,  mp 
o - 1  194 - 1 9 5  ( de c ) . I R  ( Nuj o l ) :  3400 cm ( medium , N-H ) : 
1710  ( st ron g ,  C=O ) , 1650 ( s t ron g , C=C ) . NMR ( Me2 SO , d
-6 ,  
heated t o  e f f e ct so lut ion ) :  0 7 . 1 ( d  of  d ,  2 ,  t rans CH=CH , 
J= 16 Hz ) ; 5 . 5 ( s ,  3 ,  2 O-H , N- H , exchangeab le ) ; 2 . 3  ( s ,  3 ,  
CH
3
) ;  0 . 8- 1 . 4  ( m ,  15 , heptane C-H ) . 
An a l . Ca lculated  for  C15H2 3N 303
· H20 :  C ,  5 7 . 88 ;  H ,  
8 . 04 ;  N ,  1 3 . 50 .  Foun d : C ,  57 . 84 ;  H ,  8 . 10 ;  N ,  13 . 50 .  
Met hyl 2 -Ami n o-3 -ph enylpropanoat e  Hydrocholor i de ( 20 ) .  
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The procedure of  Dubo i s , et a l . ( 49 )  was used . Thi o n y l  chl or­
i de ( 3 . 9 5 mL , 55 mmo l ) was added dropwi se to f if teen mL of 
met h an o l  at _ 2 50 ( dry i ce , 2 - propan o l ) i n  a 50-mL round-
bot t omed f l ask . Subs equen t ly , phen y la l an ine  ( 8 . 3 g ,  50  
mmo l ) was added i n  sma l l  port ion s , wh i l e  t h e  t emperature 
o 
was mai n t a i n e d  b e l ow - 5 .  The m i xt ure was warmed t o  room 
t emperature , then  heated at 450 for four hours ( o i l  b at h , 
450 ) ,  and  f in a l ly s t i rred ( magnet i c )  at room t emperature 
overn i gh t . A f t e r  addi t ion  of  benzene ( 2- 5 mL ) ,  t h e  s o l -
vent was removed unde r  reduced pressure . The res i due was 
t ri t urated w i t h  ether  to g i ve 8 . 9  g ( 99% ) of 20 as a wh i t e  
so l id whi ch was recryst a l l ized f rom ethan o l / et h e r  an d dr i e d  
under reduced pressure ( to luene , 1 1 10 ) ,  m p  158- 1600 ; l i t -
- 1 
e rature ( 87 )  1 5 80 . I R  ( Nuj o l ) :  3400 cm ( broad , N-H ) ; 
1730  ( s tron g ,  C=O ) ; 1600 ( medium , C=C ) . NMR ( Me2 S0 ,  d-6 ) : 
o 9 . 0  ( s ,  3 ,  NH
2
· HC 1 ) ; 7 . 3 ( s ,  5 ,  Ar-H ) ; 4 . 2 5 ( t ,  1 ,  CH ) ; 
3 . 75 ( s ,  3 ,  OCH3 ) ;  3 . 3 ( m ,  2 ,  CH2 ) .  
2 - Amino-3-pheny l - 1-propan o l  ( 2 1 ) . The method of  B i r -
kofer  an d E r l enbach ( 56 )  w a s  us ed . A f t e r  f l ame- dry i n g  the  
system unde r a s t ream o f  n i t rogen , l i th i um alum i n um hydri de 
( 2 . 3  g ,  60 mmo l ) was suspended i n  anhydrous ether  ( 150 mL ) 
i n  a 500-mL t h ree- necked , round-bot t omed f l ask  equ ipped 
w i t h  a magnet i c  s t i rrer , re f l ux condenser , and one g l as s  
s t opper . To t h e  react ion mixt ure was added 20  ( 4 . 5  g ,  2 1  
mmo l ) suspended i n  100 mL o f  ether . The react i on mixture 
was st i rred overn i gh t . The excess l it h ium aluminum hy-
d r i de was  decomposed w i t h  a solut ion o f  ammon i um ch l o r i de 
( neut r a l ized t o  pH  7 ) .  The whi t e  pre c i p i t a t e  was col lected 
by  f i lt rat i on , and the  two l ayers o f  f i l t rate were sep arate d .  
The aqueous l ay e r  was extracted w i t h  ether  ( 3  x 25  mL ) .  A l l  
o f  t h e  e t h e r  extracts  were comb ined , washed w i t h  saturat ed  
sodium c h l o r ide so lut ion , dried  over anhydrous sodi um sul -
f at e , and con cen t r at e d  t o  dryness under reduced pressure 
to g ive 0 . 9  g ( 2 4%)  of 2 1  as a y e l l ow ,  waxy so l i d .  A sma l l  
amount was con verted  t o  t h e  hydroch l o r i de salt  b y  t h e  pro-
cedure o f  Matuszak and Matuszak ( 6 )  t o  g ive a wh i t e  sol i d ,  
mp 1 31 - 1 340 ; l it e r at ure ( 88 ) , mp 1 560 ; ( 89 )  mp 130- 13 30 . I R  
- 1  ) ( Nu j o l ) :  3 350 cm ( broad , O-H , N-H . NMR ( CDC1 3 ) :  0 7 . 2 5 
( s ,  5 ,  Ar-H ) ; 2 . 6- 3 . 7  ( m ,  5 ,  CH2CHCH2 ) ;
 2 . 1 ( s ,  3 ,  NH2 , OH ) .  
( E ) - ( ± ) -�- ( 1-Hydroxy- 3-pheny l -2-propy l ) - 3- ( 2 , 4-d i h y -
droxy - 6-meth y l - 5-pyrimidiny l ) -2-propenamide (�) . The pro-
cedu re of  Lin and Dub o i s  ( 51 )  was mod i f i ed .  A mixt ure o f  6 
( 1 . 0  g ,  5 mmo l )  and �- et hoxy-carbony l - 2 - et hoxy- 1 , 2-d ihydro­
quino l in e  ( 1 . 56 g ,  6 mmo l )  i n  dry d imet hy l formami de ( 35 mL ) 
1 0 1  
was magne t ical l y  s t i rred at 350 ( o i l  b ath , 350 ) unt i l  
so lut ion was e f fected . A so lut ion o f  2 -ami no- 3-phe n y l -
1-propan o l  ( 0 . 76 g ,  5 mmo l ) i n  dime t h y l formamide ( 5  mL ) 
was added , f o l lowed b y  wate r  ( 4  mL ) . The solut i on was 
s t i rred at 350 for s i x  hours . The prec i p i t a t e  was co l-
lected by f i l t r a t i on to a f ford 1 . 6 3  g ( 99% ) of  22  as a 
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wh i t e  so l i d . Recry s t al l i za t i on from ethanol  gave 22 , mp 
19 1 - 19 1 . 50 . I R  ( Nu j o l ) :  3350 cm- 1 ( b road , N-H ) ; 3100  ( b road , 
O-H ) ; 1 7 10 ( s t ron g ,  C=O ) ;  1650 ( st ron g , C=C ) . NMR ( Me2SO , 
d-6 ) : 6 . 7- 7 . 5  ( m ,  7 ,  Ar-H ,  trans CH=CH ) ; 4 . 7  ( s ,  4 ,  N-H , 
� O-H , exchangeab le ) ; 2 . 5- 3 . 5  ( m ,  5 ,  CH2CHCH2
) ;  2 . 3  ( s ,  3 ,  
CH3 ) ' 
Anal . Calculated  for C1 7H 19N304
' H20 :  C ,  58 . 78 ;  H ,  
6 . 05 ; N ,  12 . 10 .  Found : C ,  5 8 . 73 ;  H ,  6 . 1 1 ;  N ,  12 . 06 .  
2-Amino-3- ( 4-bromophenyl  ) propano l ( � ) . The proce­
dure of Anhoury , et  a l . (57) was fol lowed . A 100-mL three-
necked , round-bottome d f l ask equ i pped w i t h  a n i t rogen i n le t  
adapter , pressure compensat i n g  dropp i n g  fun n e l  w i t h  a sep-
t um ,  r e f l ux con den ser with a n i t rogen out let  adapter ,  and 
magnet i c  s t i r r i n g  bar , was assemb led and f l ame dried wh i le 
f lush i n g  the  system w i t h  ni trogen . Under a pos i t ive n i t ro-
gen pressure , the react ion f l ask was ch arged w i t h  4-bromo-
phen y l al a n i n e  ( 1 . 0  g ,  4 mmo l ) and f l ushed w i th n i t rogen 
for one minut e . Dry tet rahydro furan ( 2 5 m L )  was added . To 
t h i s  solut ion  was added dropwise , w i t h  st i r r i n g , 1 . 0  M 
borane-t e t rahydrofuran so l ut ion ( 5 . 7  mL) . The so lut ion 
was s t i rred at room t empe rature for 15  hours , after which 
addi t i onal  1 . 0  M borane- t e t rahydrofuran solut ion ( 5 . 7  mL ) 
was added . The react i on was s t i rred for another f i fteen 
hours . The excess borane was dest royed by add i n g  e t hanol 
( about 60 mL)  un t i l  evo lut i on o f  hydrogen gas ceased . The 
solut i on was a c i d i f ied  w i t h  3 N hydroch o l o r i c  ac i d  to pH 1 .  
A f t e r  add i n g  2- propanol  ( 10 mL ) to the f lask , the water  was 
azeotrop i c a l l y  removed  by d i s t i l la t i on under reduce d pres­
sure , l e a v i n g  a wh i t e  so l i d  wh i ch was recryst a l l i zed f rom 
e thano l / e t h e r  to g i ve 0 . 88 g ( 82% ) o f  2 3-HCl . A solut i on 
o f  2 3-HCl  ( 0 . 8 7 g ,  3 mmol ) i n  wat er ( mi ni mum amount )  was 
t reated w i t h  a f i ve pe rcent solut i on of sod i um hydroxi de 
t o  a pH o f  12- 14 . A f t e r  add i n g  2-propanol  ( 10 mL ) , the  
wate r  was  azeotrop i c a l l y  removed by d i s t i l lat i on under 
reduced pre ssure . The res i due was d i ssolved i n  ether 
( 50 mL ) ,  washed  w i t h  water  ( 2 5 mL ) , and saturated sodium 
ch lor i de solut i on , dr ied  over anhydrous sodium sul fate , 
and t h e  e t he r  removed under reduced pressure . The resu l t ­
i n g  ye l low o i l  cryst a l l i zed b y  dry i n g  under reduced pres­
sure , to  g i ve 0 . 56 g ( 75%)  of  23 as a pale y e l low sol i d ,  
mp 85-870 ; l i te rature (90 ) mp 9 3-940 . I R  ( Nu j o l ) :  3400 
cm- 1  ( b road , O-H , N-H ) . NMR ( CDC13 ) :  0 7 . 2  ( d  of d ,  4 ,  
Ar-H ) ; 2 . 5- 3 . 7  ( m ,  5 ,  CH2CHCH2 ) ;  2 . 1  ( s ,  3 ,  O-H , NH2 , 
exchangeab le ) .  
( E ) - ( ± ) -N- [ 1-Hydroxy- 3-( 4 -bromophe n y l /' -2-propyl ] - 3-
( 2 , 4  di hydroxy-6-me t hyl -5-pyr i m i d i nyl ) - 2-propenam i de ( 24 ) . 
The me thod o f  L i n  and Dub o i s  ( 5 1 ) was mod i f ied . A m i xture 
of 6 ( 0 . 3 82 g ,  2 mmo l )  and �-e t hoxycarbony l -2-et hoxy- 1 , 2-
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dih ydroqu i n o l ine  ( 0 . 556 g ,  2 . 2  mmo l ) in dry dime t h y l forma­
m i de ( 10 mL ) was magne t i ca l l y  s t i rred at 350 ( o i l  b at h , 
350 ) un t l' l  1 t "  so u lon was e f fected . A so lut ion o f  2 3  ( 0 . 45 
g ,  2 mmo l ) in  dime t h y l formam i de ( 5  mL ) was adde d .  After  
t he add i t ion o f  wate r  ( 1  mL ) ,  the solut ion was  s t i rred for  
t h ree  days , dur i n g  whi c h  t ime a wh i t e  pre c i p i t ate appe ared . 
The p re c i p i t at e  was co l lected  by f i l t rat ion and washed with  
e t he r  t o  g i ve 0 . 45 g ( 57% ) . Recryst a l l izat ion from abso­
l ut e  e thanol  a f forded 24 as a wh i t e  sol i d ,  mp 188- 189 . 50 . 
I R  ( Nu j o l ) :  3 300 cm- 1 ( weak , N-H ) ; 3050 ( broad , O-H ) ; 1710  
( med ium , ami de C=O ) ; 1650 ( me d i um , C=C ) . NMR ( Me2 SO , d-6 ) :  
o 6 . 7- 7 . 5  ( m ,  6 ,  Ar-H ,  CH=CH ) ; 5 . 0  ( s ,  4 ,  3 O-H ,  N-H ,  ex­
chan geab l e ) 2 . 5- 3 . 3 ( m ,  5 ,  CH2CHCH2
) ; 2 . 2  ( s ,  3 ,  CH3 ) .  
Anal . Cal c u l ated for C 17H 18BrN304
· 1 . 25 H20 :  C ,  4 7 . 40 ;  
H ,  4 . 50 ;  N ,  9 . 75 .  Foun d : C ,  4 7 . 37 ;  H ,  4 . 82 ;  N ,  9 . 7 3 .  
D i e t h y l  2- Ace t amido-2- ( 4-methy lbenz y l  ) ma lonate ( � ) . 
The procedure of  Albert son and Archer ( 60 )  was fol l owed . 
Sodi um me t a l  ( 1 . 15 g ,  50 mmol ) was r i n sed in met h an o l , then 
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washed i n  a benzene-met hano l  solut ion , and we i ghed in  a f l ask 
con t a i n i n g  pet ro leum e t her . The sodium was t ran s fe rred t o  
a f l ame- dri e d ,  250 m L  , three-necked , round-bot tomed f l ask , 
equipped w i t h  a mechan ical  st i rrer , con denser and pressure-
equa l i z i n g  funne l ,  cont a i n i n g  abso lute e t hanol ( 100 mL ) . 
D i e t h y l  ace t ami doma lonate ( 10 . 9  g ,  50 mmo l ) was suspen ded  
i n  abso lute e thanol  ( 20 - 30 mL ) and  added to t he solut ion . 
The m i xt ure was heated t o  re f lux and 4-me thylbenzyl  ch l o r i de 
( 9 . 1 g ,  6 5  mmo l ) was added dropwise . Th i s  solut ion was 
heated at re f l ux for two hours . A f t e r  coo l i n g  t o  room 
tempe rature , t he so lut i on was con cent rated un de r  reduced 
pressure , an d water  ( 2 5 mL ) an d c h loroform ( 25 mL ) were 
added . The aqueous l ayer was extracted with ch l oro form 
( 3  x 100 mL ) ,  dri e d  over sodium s u l f at e , an d conce n t rated 
under reduce d pressure to g ive a ye l low , o i l y  re s i due wh i ch 
c rys t a l l i ze d  a f t e r  s t an d i n g  overn i gh t . The wh i t e  so l i d  
was recrys t a l l i zed  from ethanol  t o  give 8 . 2  g ( 5 1% )  o f  
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2 5 , mp 1 1 1- 1 12 0 . I R  ( CHC1 3 ) :  3400 cm
- 1 ( weak , N-H ) ; 1740 
( s t ron g , e s t er C=O ) ; 1680 ( stron g , ami de C=O ) . NMR ( CDC 1 3 ) :  
o 7 . 05 ( m ,  4 ,  Ar-H ) ; 6 . 6  ( 1 ,  s ,  NH ) ;  4 . 3  ( q ,  4 ,  2 0CH2 ) ;  
3 . 65 ( s ,  2 ,  Ar-CH2 ) ;  2 . 34 ( s ,  3 ,  Ar-CH 3 ) ;  2 . 05 ( s , 3 ,  
CH 3C=O ) ; 1 . 35 ( t ,  6 ,  C-CH3 ) ' 
A n a l . Calculated  for C 17H2 3N05 : C ,  6 3 , 5 5 ;  H ,  7 . 16 ;  
N ,  4 . 36 .  Foun d :  C ,  6 3 . 6 7 ;  H ,  7 . 2 1 ;  N ,  4 . 35 .  
2 -Ami no- 3- ( 4- t o l y l ) prop i on i c  Ac i d  ( � ) . The method 
of A lbert son and Archer (60 ) was fol lowed . A m i xt ure of  
2 5  ( 11 . 0  g ,  30  mmo l ) an d h y drobrom i c  ac i d  ( 48% , 2 8  mL ) , 
i n  a 100-mL roun d-bot t omed f l ask equipped w i t h  a ref lux 
condenser and a magnet i c  s t i rrer , was heated at ref lux for 
7 . 5  hours . The s o l ut ion was decolor i zed  with charcoal an d 
f i l tered . The f i l t rate was t reated w i t h  concen t rated 
ammon i um hydro x i de to pH 6 an d p laced in the re f r i gerator 
overn i gh t . The wh i te sol i d  was f i l tered an d dried  under 
reduced pressure ( to l uene , 1 1 1
0 ) to  a f ford 6 . 0  g ( 98% ) 
o f  26 , mp 207-2090 ( dec ) ; l i t erature ( 9 ·1 ) ,  2 1 1-2 1 8
0 . IR  
-1  
( Nuj o l ) :  3 100 cm ( broad , O-H ) ; 1620  ( st ron g , C=O ) ; 1590 
( st ron g ,  C=C ) . NMR ( TFA ) : 0 7 . 2  ( 8 ,  4 ,  Ar-H ) ; 4 . 7  ( m ,  1 ,  
CH ) :  3 . 5  ( d ,  2 ,  CH2
) ;  2 . 4  ( s , 3 ,  Ar- CH 3 ) .  
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4 - ( 2 -Ami no - 3- hydroxypropy l ) toluene ( 27 ) . The proce­
dure of  Lee and V i n ce ( 50 ) was used . A 100-mL three-necked , 
roun d-bot t omed f lask , equipped w i t h  a condenser and n i t ro ­
g e n  i n le t  a n d  out let  valves , was f lame-dr i ed under a s tream 
o f  n it rogen . A m ixture of  l i t h i um a lumi num hydr i de ( 1 . 0  g ,  
26  mmo l )  and dry t e t r ah y drofuran ( 75 mL ) was h eated at re-
f lux f o r  two hours under n i t rogen . The m i xt ure was cooled 
in  an ice bath and 26  ( 2 . 0  g ,  1 1  mmo l ) was added in  sma l l  
port ions . The m ixture was heat e d  at ref lux for twelve 
hours under n i t rogen . The excess l i th i um alum i num hydr i de 
was decompo sed by add i ng i n  succe s s ion , wat er ( 2  mL) , 
aqueous sodium hydroxide ( 10% , 20 mL ) ,  and water ( 5  mL ) . 
The m i xture was f i l t e red , and the  prec i p i t a t e  was washed 
w i t h  t e t r ahydro furan . The f i l t rate was concent rated un-
der reduced pres sure to leave a yel l ow o i l  wh i ch was 
d i ssolved in ch loroform ( 50 mL) . The ch loro form l ayer 
was washed with aqueous sodi um hydroxi de ( 5% ,  25 mL ) , 
wat e r  ( 2 5 mL) , and saturat ed  aqueous sod i um ch lor i de 
solut i on ( 2 5 m L ) . The ch loroform ext ract was dr i ed over 
anhy drous sodi um sul fat e , f i lt ered , and evaporated under 
reduced pressure t o  g i ve 1 . 2 3 g ( 67% ) of  2 7  as a pale ye l -
low o i l . A smal l  amount was converted to t h e  hydroch lor i de 
s a l t  by t he procedure o f  Matus zak an d Matus zak ( 92 )  t o  
g ive a whi t e  sol i d , wh i c h  was recrysta l l i zed f rom e thano l /  
o - 1 
ether , mp 1 7 3 - 1 75 . I R  ( Nuj ol ) :  3350  cm ( st ron g , O-H ,  
N-H ) . NMR ( D2
0 ) : 7 . 35 ( s ,  4 ,  Ar-H ) ; 3 . 8  ( m ,  3 ,  O-CH2
- CH ) ;  
3 . 0  ( d ,  2 ,  CH2- Ar ) ; 2 . 4  ( s ,  3 ,  CH 3 ) .  
An a l . C ,  59 . 56 ;  H ,  8 . 00 ; 
N ,  6 . 94 .  Foun d : C ,  59 . 6 1 ;  H ,  8 . 00 ;  N ,  6 . 94 . 
( E ) ( ± ) -N- [ 1-Hydroxy- 3- ( 4-methy lphen y l ) - 2 -prop� I ] - 3-
( 2 , 4-d i hy droxy-6-met h y l - 5-pyr imi d i n y l ) -2-propenamide ( 28 ) . 
The method o f  L i n  and Dub o i s  ( 51 )  was mod i f i ed . A mixture 
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of � ( 0 . 22 g ,  1 . 1  mmo l ) and �-e thoxycarbon y l -2-ethoxy- 1 , 2-
d i h ydroqu i no l i ne ( 0 . 3 3 g ,  1 . 3  mmo l ) i n  dry dime t h y l formami de 
( 10 mL ) was magne t i c a l l y  s t i rred at 350 ( o i l  bath , 350 ) un-
t i l  s o l ut i on formed . Subsequent l y , 4- ( 2- amino- 3-hydroxy­
propy l ) - t o luene 2 7  ( 0 . 18 g ,  1 . 1  mmo l ) i n  dime t h y l formami de 
( 5  mL ) was added , f o l l owed by wate r  ( 1  mL ) . The solut i on 
was s t i rred for f i ve hours at 3 50 . The prec i p i t ate was 
c o l l e c t e d  by f i l t rat ion and recryst a l l i zed  from ethano l /  
e t he r  t o  g i ve 0 . 24 g ( 62% ) o f  2 8  as a wh i t e  so l i d , mp 
1 8 7- 187 . 5 0 . I R  ( Nu j o l ) :  3320  cm- 1 ( me d i um , N-H ) ; 3150 
( broad , O-H ) ; 1 7 10 ( s t ron g , ami de C=O ) ; 1655 ( s tron g , C=C ) . 
NMR ( TFA ) : 0 6 . 2 - 7 . 8  ( m ,  1 0 , Ar-H ,  CH=CH , 3 O-H ,  N-H ) ; 
3 . 7-4 . 1  ( m ,  3 ,  O-CH
2
- CH- ) ; 2 . 7  ( 2 ,  m ,  Ar- CH2 ) ;  2 . 3  ( s ,  J ,  
p y r i m i d i n e-CH3 ; 2 . 1 ( s ,  3 ,  Ar-CH 3 ) · 
Anal . Calculated  for C18H2 1N304
· H20 :  C ,  59 . 8 3 ;  H ,  
6 . 37 ; � , 1 1 . 6 3 .  Found : C ,  59 . 80 ;  H ,  6 . 44 ;  N ,  1 1 . 6 3 .  
4 -Methoxybenzy l Bromi de ( 29 ) . The procedures of  B i rch , 
e t  a l . ( 9 3 ) , and Fuj o , e t  a l . ( 94 )  were used . Ice-coo led  
h ydrobromic a c i d  ( 48% , 15  mL ) was  added t o  i ce -cooled 4-
met hoxyb enzy l a l cohol ( 8 . 6  g ,  62 mmo l )  , and the mixture 
was v i gorous ly s t i rred ( magne t i c )  in a 50-mL round-bot t omed 
f l as k  for  t h i r t y  m i nutes t o  separate a color less  heavy o i l . 
The o i l  was ext racted w i t h  benzene and washed success ively  
w i t h  wate r , saturated  aqueous sod ium b icarbon at e , and  satu-
rated sodium ch lor i de . The comb i ned  b enzene extracts were 
dried  over anhydrous sodium sul fat e , f i l t ered , and evapor­
ated under reduced pressure t o  g i ve an o i l  wh i ch was d i s-
t i l led i n  vacuo to a f ford 7 . 3 g ( 58% ) o f  29  as a color­
less l i qu i d , bp 880 / 1  mm ; l it erature ( 9 5 )  bp 1 3 10 / 19 mm . 
I R  ( CHC1
3 ) :  1610  and 1590 cm
- 1  ( stron g , C=C ) ; 1240 ( broad , 
Ar-O-C ) ;  740 ( st rong , CH2-Br ) .  NMR ( CDC1 ) :  6 7 . 0  ( d  o f  3 
d ,  4 ,  Ar-H ) : 4 . 4  ( s ,  2 ,  CH2 ) ;  3 . 7  ( s ,  3 ,  OCH3 ) .  
E t hyl  2 -Acet amido- 2-c arbet hoxy- 3-(4-methoxyphenyl ) 
propanoate ( lQ) . The met hod of  Yamamo t o , e t  a l . ( 62 )  was 
used . A sodium e thoxi de solut i on was prepared i n  a 250-mL 
t hree-necked , round-bot t omed f l as k  equipped w i t h  a mechan i -
c a l  s t i rrer , condens e r , and pressure compens at i ng drop p i n g  
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funne l . Sod i um met a l  ( 0 . 8 3 g ,  36 mmo l ) was r i nsed in  ethano l , 
and b e nzen e , we i ghed i n  a f l ask con t ai n in g  pet ro leum ether , an d 
t rans f erred t o  t h e  2 5 0 -mL f l ask  con t a i n i n g  super dry e t h an o l  
( 100  mL ) ( 84 ) . To t h e  f l ask was added d i e t h y l  acet amidoma lon-
ate ( 8 . 5  g ,  39 . 2  mmo l ) .  The solut ion was coo led in an 
i c e  bath whi le 4 -met hoxybenzy l brom i de ( 29 )  ( 7 . 3 g 36 . 3  
mmo l ) was s lowl y  added dropw i s e . A f t e r  s t i r r i n g  for  f i ve 
hours at room t emperature , wate r  ( 375 mL ) was added to 
pre c i p i t at e  30 as a wh i t e  so l i d ,  wh i ch was col lected  b y  
f i l t rat ion , an d dr ied  t o  g ive 10 . 37 g ( 85%)  o f  30 , mp 
o 0 9 3 - 9 5  ; l it erature ( 62 )  mp 96-9 8  . I R  ( CHC13 ) :  3400 
- 1  ( cm ( medi um , N-H ) ; 1740 ( st ron g ,  e s t e r  C=O ) ; 1640 st rong , 
amide ( C= O ) ; 16 10 ( st ron g , C=C ) ; 1250 ( st rong , Ar-O-C ) . NMR 
( CDC1 3 ) :  6 6 . 9  ( m ,  4 ,  Ar-H ) ; 4 . 3  ( q ,  4 ,  2 CH20 ) ; 3 . 8  ( s ,  
3 ,  O-CH3 ) ;  3 . 6  ( s ,  2 ,  CH2Ar ) ;  2 . 05 ( s ,  3 ,  CH3-C=O ) ; 1 . 3  
( 6 ,  t ,  2 CH
3-C ) . 
2 -Acet am i do-2- carbethoxy-3- ( 4-met hoxyphenyl ) propan o i c  
Ac i d  ( � ) . The procedure o f  Ber l i n guet ( 63 )  was f o l lowed . 
To a 500-mL round-bot tomed f l ask  con t a i n i n g  0 . 3  N alcoho l i c  
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pot ass i um hydrox i de ( 250 mL)  was added 30 ( 22 . 8  g ,  68  mmo l ) .  
The mi xture was agi t ated w i th a magne t i c s t i rrer overn i gh t . 
The so lut i on was f i l t ered , an d the f i l t rate  was concen-
t rated under reduced pressure wh i le heat i n g  on a steam 
bath . Co ld  wate r  ( 400 mL ) was added t o  the  f l ask and 3 1  
d i s s o lved l e av i n g  the  un reacted  prop i on i c  ester  a s  a so l i d  
whi ch was c o l l e cted b y  f i l t rat i on . The f i l t rate was ac i d i-
f i e d  w i t h  concentrated hydroch lor i c  a c i d  to pH 1 .  The 
heavy o i l wh i ch resulted  cryst a l l ized in t he cold . The 
wh i t e  pre c i p i t ate was co l lected  by f i l t rat i on and dr i e d  t o  
g i ve 1 3 . 2  g ( 6 3% )  o f  3 1 , m p  1 39 - 1400 ; l it erature ( 6 3 )  mp 
1 3 2 - 1 3 30 . I R  ( Nuj o l ) ;  3300 cm- 1  ( medi um , N-H ) ; 1720 
( st ron g , e s t e r  C=O ) ; 1600 ( st ron g , amide C�O ) ; 1220 ( medium , 
Ar-O-C ) . NMR ( Me2 S0 , d-6 ) : 6 7 . 8  ( s ,  2 ,  N-H , COOH ) ;  7 . 0  
( s ,  4 ,  Ar-H ) ; 4 . 2  ( q ,  2 ,  C-CH2 - O ) ; 3 . 8  ( s ,  3 ,  OCH3 ) ;  3 . 5  
( s ,  2 ,  CH2 ) ;  2 . 0  ( s ,  3 ,  CH 3C=O ) ; 1 . 2  ( t ,  3 ,  C-CH3 ) .  
E t hyl 2-Ac e t am ido- 3-(4-methoxyphenyl ) propanoate 
( � ) . The me t hod o f  Ber l i n guet ( 6 3 ) was used . I n  a 
f lame - dr i e d , 100-mL round-bot tome d f l ask con nected t o  a 
vacuum pump was p laced 31  ( 8 . 0  g ,  26 mmo l ) .  The f lask 
was immersed i n  an  o i l  b ath , and the t emperat ure was rai sed 
to 150° . The compound b e gan to v i gorous l y  decarboxy l ate 
at 120° . The f l ask was left  in  t he oil  bath at 150° for 
f i f t een minut e s . The resu l t an t  ye l low o i l  was crys t a l l ized 
and recryst a l l ized f rom petro leum ether ( bp 60-80° ) t o  g i ve 
6 . 6  g ( 96% ) o f  3 2  as a whi t e  s o l i d , mp 65-65 . 5° ; l i terature 
( 6 3) mp 7 2 - 7 3° . IR  ( CHC13 ) :  3400 cm
- 1 ( medium , N-H ) ; 1220 
( st ron g ,  Ar-O- C ) . NMR ( CDC1 3 ) :  0 7 . 0  ( d  o f  d ,  4 ,  Ar-H ) ; 
6 . 2  ( s ,  1 ,  N-H ) ; 4 . 9  ( t ,  1 ,  CH ) ;  4 . 2  ( q ,  2 ,  C-CH2-O ) ; 3 . 75 
( s ,  3 ,  OCH 3 ) ;  3 . 0  ( d ,  2 ,  CH2- Ar ) ; 2 . 0  ( s ,  3 ,  CH3-C=O) ; 1 . 2  
( t ,  3 ,  C- CH 3 ) .  
2 - Ace t amido- 3- ( 4-me thoxyph e n y l  ) propanol  ( 3 3 ) . The 
met hod of Ber l i n gue t ( 6 3 ) was used . A magne t i c a l l y  s t i rred 
solut ion of 32  ( 6 . 55 g ,  25  mmol ) in  abso lute e ther ( 250-
300 mL ) was coo led  i n  an i ce bath wh i le a suspension  of  
l i t h i um a lumi n um hydr ide ( 1 . 3  g ,  34 mmo l ) in  abso lute 
ether ( 75 mL ) was s lowl y  added dropwi se . The mixture was 
s t i rred for two hours at room t emperature . The excess 
l i th ium a lumi n um hydr ide was de composed with sma l l  lumps 
of ice ( about seven grams ) unt i l  evolut ion of h ydrogen 
gas ceased . The mi xture was heated and f i l tered . The pre­
c i p i t ate was washed twice  w i t h  bo i l in g  e thano l , and the com­
b i ned f i l trates  were evaporated unde r  reduced pressure . 
The resu l tant  oi l was crysta l l i zed  b y  dry i n g  under reduced 
pressure and wash i n g  w i t h  hot ether  to g i ve 4 . 9  g ( 89% ) 
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o f  33  as a whi te so l i d ,  mp 9 8- 104° , l i terat ure (6 3 ) 1 10- 1 1 1° . 
I R  ( Nuj ol ) :  3 30 0  cm- 1 ( weak , N-H ) ; 3200 ( b road , O-H ) ; 1640 
( stron g ,  C=O ) ; 1250 ( stron g , Ar-O-C ) . NMR ( CDC1 3 ) :  Q 7 . 0  
( d  o f  d ,  4 ,  Ar-H ) ; 4 . 1  ( m ,  1 ,  CH ) ;  3 . 75 ( s ,  3 ,  OCH 3 ) ;  3 . 55 
( m ,  2 ,  CH2 ) ;  2 . 8  ( d ,  2 ,  CH2 -Ar ) ;  1 . 95 ( s ,  3 ,  CH 3-C=O ) . 
2 - Amino- 3-(4-met hoxyphenyl ) propanol Hydroch lor ide 
( 34 ) . The procedure o f  Ber l i nguet (63 ) was used . A mix­
ture o f  3 3  ( 4 . 88 g ,  22  mmo l ) and 2 N hydroch lor i c  ac id  
( 100 mL ) was  p laced i n  a 250-mL round-bottomed f l ask and 
heated at r e f l ux for t hree hours . The solut ion was then 
concentrated  unde r reduced pressure . The resul t ant res i -
due was disso l ved i n  wat e r , a n d  pur i f ied w i t h  act ivated 
charcoa l . A f t e r  f i l te r i n g  over Cel i t e , the  c l e a r  solu-
t i on was aga i n  evaporated under reduced pressure , and the  
res i due was  c r ys t a l l ized f rom ethano l / ether to g i ve 2 . 78 
g ( 58% ) o f  34 as a wh i t e  sol i d ,  mp 190- 1940 ; l i t erature 
( 6 3) mp 195 - 19 70 . IR  ( Nuj o l ) :  3390 cm
- 1  ( medium , N-H ,  
O-H ) ; 1260 ( st ron g , Ar-O-C ) .  NMR ( D20 ) : Q 7 . 2  ( d  of  d ,  
4 ,  Ar-H ) ; 3 . 8-4 . 0  ( m ,  6 ,  CH-CH2 and OCH 3 ) ;  3 . 0  ( d ,  2 ,  
CH20 )  . 
( E ) - ( ± ) -N- [ 1-Hydroxy- 3- ( 4-me thoxyphen y l ) -2-propy l ] - 3-
( 2 , 4-di hydroxy-6-me t h y l - 5-pyrimidin y l ) -2-propen amide ( 35 ) . 
The me thod o f  L i n  an d Dub o i s  ( 5 1 ) was modi f ied . A mixture 
of � ( 0 . 74 g ,  3 . 8  mmo l ) and �-e thoxycarbony l - 2-ethoxy- 1 , 2 -
dihydroqu i n o l ine  ( 1 . 1  g ,  4 . 4  mmo l ) in  dry dime t h y l formamide 
( 20 mL ) was magne t i ca l l y  s t i rred at 350 ( o i l  bath , 35
0 ) un ­
t i l  so lut ion was e f fected . A solut ion o f  34 ( 1 . 0  g ,  4 . 6  
mmo l ) i n  water ( min imum amount )  was t re ated with  a f i ve 
1 1 1  
per cent aqueous s o l ut i o n  o f  sod i um h ydroxi de t o  pH 14 . 
The wate r  was removed by azeot ropi c  d i s t i l l at ion with  2-
propano l  under re duced pressure t o  af ford 34 ( free base ) as 
a ye l l ow o i l wh i ch cryst a l l i ze d  i n  c o l d  ether . A solu-
t ion o f  34 ( free b ase ) ( 0 . 68 g ,  3 . 8  mmo l ) i n  dime t h y l ­
formam i de ( 8  mL ) was added to the  react ion  mi xture . A f t e r  
the  add i t ion o f  water ( 3 mL ) ,  the solut i on was st i rred 
for three days at  3 50 . The dime th y l formamide was removed 
under reduced pressure , an d the resu l t an t  ye l low res i due 
was cryst a l l i ze d  w i t h  ab solute ether  to a f ford 0 . 99 g ( 73% ) 
o f  3 5  as a ye l l ow so l i d .  Rec ry s t a l l i zat ion from ethan o l  
a f forded 35 as a wh i t e  so l i d , mp 179 - 1 8 10 . I R  ( Nuj o l ) :  
3 320  cm- 1  ( me d i um , N-H ) ; 3 100 ( broad , O-H ) ; 1 7 10 ( st ron g , 
C=O ) ; 1650 ( st ron g , C=C ) ; 1250 ( me d i um , Ar-O-C ) . NMR 
( Me 2SO , d-6 ) : 0 6 . 7- 8 . 0  ( m ,  10 , Ar-H ,  CH=CH , N-H ,  3 0-H ) ; 
4 . 0  ( m ,  1 ,  CH ) ;  3 . 7  ( s ,  3 ,  OCH3 ) ;  2 . 8- 3 . 5  ( m ,  4 ,  2 CH2 ) :  
2 . 5  ( s , 3 ,  CH3 ) .  
Ana l . Calculated  for C 18H2 1N305 · !H20 :  C ,  58 . 32 ;  H ,  
5 . 98 ;  N ,  1 1 . 34 .  Foun d : C ,  5 8 . 2� ;  H ,  5 . 76 ;  N ,  1 1 . 42 .  
( E ) - ( ± ) -N- ( 2 - Phen y le t h y l ) - 3- ( 2 , 4- d ihydroxy-6 -met h y l -
5-pyrimi d i n y l ) -2-prope n am i de ( � ) . The procedure of  Lin  
and  Dub o i s  ( 51 )  was  mod i f i ed . A mixture o f  � ( 2 . 0  g ,  10  
mmo l ) an d �-e thoxycarbon y l-2-ethoxy- 1 , 2- dihydroqu in o l i n e  
( 2 . 9 7 g ,  12  mmo l ) i n  dry dime t h y l formami de ( 50 mL ) was 
magnet i c a l l y  s t i rred at 350 ( o i l  bath , 350 ) unt i l  solut i on 
was e f fe c te d .  To the  mixt ure described above phen e t h y l a­
m i n e  ( 1 . 2 1 g ,  10 mmo l ) was added . The s o l ut i on was s t i rred 
1 12 
1 1 3  
o at 3 5  for twen t y- four hours . The pre c ip i t at e  was col lected 
by f i l t rat i on and washed with ether  to g ive 1 . 8  g ( 59% ) of  
c rude product . Recry s t a l l izat ion from water  af forded  36  
as  a wh i t e  so l id , mp  2 1 80 ( dec ) . I R  ( Nu j o l ) :  3 100- 1  
( broad , N-H ) ; 1 7 1 0  ( s trong , ami de C=O ) ; 1650 ( st ron g , C=C ) 
NMR ( TFA ) : 6 6 . 6- 7 . 6  ( m ,  7 ,  Ar-H , CH=CH ) ;  5 . 5- 6 . 5  ( s ,  3 ,  2 
O-H , N-H ) ; 3 . 2  ( m ,  2 ,  CH2 -C=O ) ; 2 . 8  ( m ,  2 ,  CH2-Ar ) ;  2 . 2  ( s ,  
3 ,  CH3 ) .  
Anal . Ca lculated  for C 16H 17N303 ' H20 :  C ,  60 . 50 ;  H ,  
6 . 04 ;  N ,  1 3 . 24 .  Found : C ,  60 . 49 ;  H ,  6 . 07 ;  N ,  1 3 . 20 .  
( � ) - ( ± ) -�- [ 2- ( 4-Methy lpheny l ) -et hy l ] - 3- ( 2 , 4-d i hy droxy-
6-meth y l - 5-pyr imidiny l ) - 2-propenamide ( � ) . The method of  
L i n  and Dub o i s  ( 51 )  was modi f ied . A m i xture o f  Q ( 1 . 0  g ,  
5 mmo l )  and �- et hoxy carbon y l -2-ethoxy- 1 , 2 -d ihydroqu i n o l ine 
( 1 . 56 g ,  6 mmo l ) in  dry d i methy l formamide ( 2 5 mL ) was mag­
n e t i c a l l y  s t irred at 350 ( oi l  b at h , 350 ) un t i l  so lut i on 
was e f f e ct e d . To the  mixture descr ibed above , 2- ( 4 - t o ly l ) ­
ethy l am i n e  ( 0 . 6 8 g ,  5 mmol ) was added . The solut ion was 
s t i rred at 3 50 for  twent y - four hours . The pre c i p it at e  
was co l lected  b y  f i l t rat ion and washed w i t h  anhydrous 
ether  to g i v e  1 . 3 g ( 83% ) of 37 as a wh i t e  s o l i d .  Re­
crys t a l l izat i on f rom water a f forded 37 , mp 2 14 . 5 - 2 15 . 50 
- 1  
( dec ) w i t h  evo lut ion o f  gas . I R  ( Nuj o l ) :  3 100 cm ( broad , 
N-H ) ; 1 7 10 ( st rong , C=O ) ; 1650 ( st rong , C=C ) . NMR ( TFA ) : 
6 6 . 8-7 . 7  ( m ,  6 ,  Ar-H ,  CH=CH ) ; 3 . 3 ( q ,  2 ,  CH2C=O ) ; 2 . 8  
( t ,  2 ,  CH2-Ar ) ; 2 . 3  ( s ,  3 ,  CH3-pyrimidine ) ;  2 . 05 ( s ,  3 ,  
CH3
- Ar ) . 
A n a l . Calculated  for C 17H 19N303 ' H20 :  C ,  6 1 . 62 ;  H ,  
6 . 39 ;  N ,  12 . 68 .  Foun d :  C ,  6 1 . 53 ;  H ,  6 . 40 ;  N ,  12 . 6 7 .  
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( E ) - ( ± ) -N- [ 2 - ( 4- Methoxypheny l ) -e t hy l ] - 3- ( 2 , 4-dihydroxy-
6-me t h y l - 5-p y r i m i d i n y l ) -2 -propen am i de ( 38 ) . The procedure o f  
L i n  and Dub o i s  ( 5 1 ) was mod i f i e d . A mixt ure o f  � ( 0 . 9  g ,  
4 . 6  mmo l ) and �-e thoxycarbony l -2- e thoxy- 1 , 2-dihydroqui n o-
l ine  ( 1 . 36 g ,  5 . 5  mmo l ) i n  dry dime t h y l formamide ( 20 mL)  was mag­
net i ca l l y  s t i rred at 350 ( o i l  b ath , 350 ) unt i l solut ion 
was e f fected . To the m i xt ure described above 4 -methoxy-
phenethy l am i n e  ( 0 . 7  g ,  4 . 6 mmo l ) was adde d .  The solut i on 
was s t i rred at 350 for twe n t y- four hour s . The pre c i p it ate 
was co l le c t e d  b y  f i l t rat ion  and washed with anh ydrous 
e t h e r  to g i ve 1 . 1  g ( 75% ) of  38 as a wh i t e  sol i d .  Re ­
crys t a l l i z at i on f rom wate r  a f forded 38 , mp 200 . 5- 2 0 1 . 50 
( de c )  w i t h  evo lut ion  o f  gas . I R  ( Nu j o l ) :  
- 1 
3 100  cm 
( b road , N-H ); 1720 ( st ron g ,  C=O ) ; 1650 ( st ron g , C=C ) ; 1250 
( st ron g ,  Ar-O-C ) .  NMR ( TFA ) : 0 6 . 8- 7 . 7  ( m ,  6 ,  Ar-H ,  CH=CH ) ;  
3 . 7  ( s ,  3 ,  OCH3 ) ;  3 . 2  ( q ,  2 ,  CH2C=O ) ; 2 . 8  ( t .  2 ,  CH2
Ar ) ;  
2 . 25 ( s ,  3 ,  CH3-pyrimidine ) .  
Anal . Calculated  for C17H 19N304 ' H20 :  C ,  58 . 78 ;  H ,  
6 . 09 ;  N ,  12 . 10 .  Foun d : C ,  5 8 . 74 ;  H ,  6 . 1 1 ;  N ,  12 . 0 7 .  
( E ) - ( ± ) -N- [ 2 - ( 4-Bromophen y l  ) -e t h y l  }3-( 2 , 4-dihydroxy-6-
met h y l- 5 - p y r i m i d i n y l ) -2-propenam i de ( � ) . The procedure 
o f  L i n  and Dub o i s  ( 5 1 ) was mod i f i e d . A mi xture of  � ( 0 . 8  
g ,  4 . 1  mmo l )  and �_et hOxycarbonY l -2-ethoxy- 1 , 2- dihydro­
qu i no l i ne ( 1 . 2 3 g ,  5 mmo l ) in dry dime t h y l formami de ( 20 mL ) 
was magne t i cal l y  s t i rred at 350 ( oi l  bath , 350 ) unt i l  so-
lut i on was e f fected . To the mi xture described above 4-
b romophene thy l am i n e  ( 0 . 82 g ,  4 . 1  mmo l )  was added . The 
s o l ut i on was s t i rred at 350 for twe n t y- four hours . The 
prec i p it at e  was co l le c t e d  b y  f i l t ra t i o n  and washed with  
anhydrous ether  to g i ve 1 . 4  g ( 92% ) o f  3 9  a s  a wh i t e  s o l i d .  
Recryst a l l i zat ion  f rom wat e r  a f forded 39 , mp 198- 199 . 50 
( de c ) with  evolut ion  o f  gas . I R  ( Nuj o l ) :  3 100 cm- 1 
( b ro ad N-H ) ; 1 7 1 0  ( st ron g , C=O ) ; 1650 ( st ron g ,  C=C ) . NMR 
( TFA ) : 0 6 . 8- 7 . 2  ( m ,  6 ,  Ar-H ,  CH=CH ) ;  3 . 2  ( q ,  2 ,  CH2C=O ) ; 
2 . 8  ( t ,  2 ,  CH2-Ar ) ; 2 . 25 ( s ,  3 ,  CH3-p y r i m i d i ne ) .  
Anal . Calculated  for C16H 16BrN303 · H20 :  C ,  48 . 50 ;  
H ,  4 . 58 ;  N ,  10 . 60 .  Found : C ,  48 . 50 ;  H ,  4 . 52 ;  N ,  10 . 55 .  
3- ( �- But y loxycarbony l amir.o ) propano i c  A c i d  ( 40 ) .  
The procedure o f  Bent ley , e t  a l . ( 65 ) was fol l owed . Mag­
n e s i um o x i de ( 9 . 0  g ,  0 . 224 mo le ) ,  3- ami nopropan o i c  ac i d  
( 10 g ,  0 . 1 12 mol e ) ,  tert -buty loxyazi do formate ( 34 . 9  mL , 
0 . 246  mole ) , wat e r  ( 145 mL ) , and dioxane ( 3 35 mL)  were 
s t i rred in a 1000-mL , roun d-bot t omed f l ask at 40-450 for 
twenty- four hours . The di oxane an d excess azi de were re­
moved under reduced pressure . Wat e r  ( 450 mL ) was added 
t o  the  f l as k , and t he s o lut i on was f i l t e red . The f i l t rate 
was ac i d i f i e d  with saturated aqueous c i t r i c  a c i d  solut ion  
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t o  pH  3 .  The aqueous port i on was extracted with  e t h y l  
ace t at e  ( 3  X 2 0 0  mL ) . The comb i n e d  e t h y l  acet ate por t i on s  
were washed w i t h  saturated sodium chlor i de s o l ut ion  ( 50 mL) , 
dried  over anhydrous sodi um sul f at e , f i l t ered , an d evapor­
ated under reduced pressure to g ive 40 as a wh i t e  sol i d .  
Recryst a l l i zat ion  from e t h y l  acetate /petroleum ether  ( b p  
60-900 ) gave 16 . 4  g ( 77% ) of  40 , m p  7 1 . 5- 730 ; l i t erature 
1 16 
o - 1 
( 65 )  7 3-74 . I R  ( Nuj o l ) :  3420 ( st rong , N-H ) ; 1700 ( st ron g ,  
C=O ) . NMR ( CDC1 3 ) :  0 1 1 . 1  ( s ,  1 ,  COOH ) ; 5 . 3  ( s ,  1 ,  N-H ) ; 3 . 5  
( q ,  2 ,  N-CH2- C ) ;  2 . 7  ( t , 2 ,  CH2-C=O ) ; 1 . 5  ( s ,  9 ,  3 CH3
) .  
2 , 4 , 5-Tr i ch loropheny l  3- ( tert -But y loxycarbon y l amino ) 
propan oate ( 11 ) . The procedure of  P less and Bo i s sonnas 
( 66 )  was f o l lowed . 3- ( tert -Buty loxycarbony l am i n o ) -pro-
pan o i c  a c i d  ( 40 )  ( 15 g ,  79 mmo l ) , 2 , 4 , 5 - t r i ch lorophenol  
( 17 . 1 g ,  87 mmo l )  , and ethy l ace t at e  ( 260  mL ) were mag-
net i ca l ly s t i rred i n  a 500-mL , round-bottomed f lask unt i l 
solut ion  was e f f ected . D i c y c lohexy l c arbodi im i de ( 16 . 3  g ,  
79 mmo l ) was adde d .  A f t e r  s t i rr ing for three hours , t h e  
react i on m ixt ure was f i l t ered . The f i l t rate was evapor-
ated t o  dryness t o  g ive 4 1  as a dark red sol i d . Recrystal­
l i zat i o n  f rom benzen e / pet roleum e t he r  ( bp 60- 900 ) a f f orded 
19 . 0  g ( 6 5% )  of 41 as a l i gh t p i nk so l i d ,  mp 90-920 ; 
l it erature ( 65 )  9 3-940 . I R  ( Nuj o l ) :  3340 cm- 1  ( st ron g , 
N-H ) ; 1 770 ( st ron g , e s t e r  C=O ) ; 1680 ( st ron g , carb amate 
C=O ) . NMR ( CDC1 3 ) :  0 7 . 5  ( 2 ,  d ,  Ar-H ) ; 5 . 0 ( 1 ,  s ,  N-H ) ; 
3 . 6  ( q ,  2 ,  N-CH2
-C ) ; 2 . 85 ( t ,  2 ,  CH2
-C=O ) ; 1 . 5  ( s ,  9 ,  3 
CH3 ) . 
( + ) -B-Benzy l - 3- ( �-buty loxy carb on y l amino ) propan ami de 
( 12) .  A so lut i on o f  benzy lamine ( 0 . 65 g ,  6 mmol ) i n  methy­
lene c h l o r i de ( 10 ML) was added t o  a 50-mL , round-bo t t omed 
f lask con t a i n i n g  4 1 ( 2 . 0  g ,  5 . 4  mmol ) .  The solut ion was 
s t i rred for f our hours at room temperature . The methy lene 
chlor i de so lut ion was washed w i t h  1 N pot as s i um b is u l f at e  
( 10 mL ) ,  sodium h y drox i de so l ut i on ( 5% ,  10  mL) , and satu-
rated aqueous sodium ch l o r i de solut i on ( 10 mL) . The methy­
lene  ch l o r i de port i on was  dried over  anh ydrous sodium 
s u l f at e , f i ltered , and evaporat ed  under reduced pressure 
to g i ve 42 as a wh i t e  s o l i d . Recry s t a l l i zat ion f rom e t h y l  
ace t at e / pe t ro leum e t her ( b p  60-900 ) af forded 1 . 2  g ( 80% ) 
o f  42 , mp 1 16 - 1 1 80 . I R  ( Nu j o l ) :  - 1  3300 em ( st ron g ,  N-H ) ; 
1690 ( st ron g , carb amate C=O ) ; 1650 ( st ron g , ami de C=O ) . 
NMR ( Me2 SO , d-6 ) : 6 8 . 2  ( s ,  1 ,  carbamate N-H ) ; 7 . 2 5 ( s ,  
5 ,  A r-H ) ; 6 . 7  ( s ,  1 ,  NH-C=O ) ; 4 . 2 5 ( d ,  2 ,  CH2-Ar ) ; 3 . 2  ( m ,  
2 ,  C- CH2-N ) ; 2 . 3  ( t ,  2 ,  CH2-C=O ) ; 1 . 3  ( s ,  9 ,  3 CH 3 ) .  
Anal . Calcua l t e d  for C 15H22N203 : C ,  64 . 7 3 ;  H ,  7 . 9 7 ;  
N ,  10 . 0 7 .  Found : C ,  64 . 86 ;  H ,  7 . 95 ;  N ,  10 . 05 .  
3-Ami n o-Ji-benz y l propan amide Tri f luoroacetate  ( � ) . 
The prote cted  ami n e  42  ( 1 . 0 g ,  3 mmo l ) was d i s so lved i n  
t r i f luoroacet i c  a c i d  ( 4  mL ) i n  a 25-mL , roun d-bottomed 
f l ask . The so lut ion was s t irred for th i rty  minutes at 
room t emperature . The t r i f l uoroacet i c  a c i d  was removed 
unde r reduced pressure t o  g ive 0 . 84 g ( 80% ) of  4 3  as a 
wh i te so l i d , mp 65-6 70 . IR  ( Nuj o l ) :  3 300 cm- 1 ( medium , 
N-H ) ; 1700 ( st ron g , a c i d  C=O ) ; 1650 ( s t ron g , ami de C=O ) ; 
NMR ( D
2
0 ) : 6 7 . 5  ( s ,  5 ,  Ar-H ) ; 4 . 5  ( s ,  2 ,  CH2- Ar ) ; 3 . 3  
( t ,  2 ,  C-CH2 -N ) ;  2 . 8  ( t ,  2 ,  CH2 - C=O ) . 
1 1 7  
Anal . Calculated  for C 12H 15 F3N203 : C ,  49 . 32 ;  H ,  5 . 14 ;  
N ,  9 . 59 .  Found : C ,  49 . 28 ;  H ,  5 . 18 ;  N ,  9 . 57 .  
�) - ( + )-1l-Be nzyl - 3- [ 3- ( 2 , 4- d ihydroxy-6-met hyl-5-pyr i ­
m i d i n y l ) - 2- propenami do ] propanamide ( 44 ) . The method o f  L i n  
and Dub o i s  ( 51 )  was mod i f i ed .  A s o l ut i on o f  43  ( 0 . 76 g ,  
2 . 6  mmo l ) i n  water  ( mi n imum amoun t ) was t reated w i t h  an 
aqueous so lut i on o f  sodium hydrox i de ( 5% )  to pH 14 . The 
aqueous l ayer was ext racte d  w i t h  e t h y l  ace t at e  ( 3  X 1 5  ML ) .  
The comb ined e t h y l  acet at e  ext ract s were washed with  satu-
rated aqueous sodium c h lor i de solu t i on , dried  ove r anhy -
drous sodium s u l f at e , f i l t e re d ,  and concentrated un der re-
duced  pressure t o  g ive 4 3  ( free b ase ) as a c lear o i l .  A 
s o lut ion o f  4 3  ( f ree b as e )  ( 0 . 4  g ,  2 . 2  mmo l ) i n  d imet h y l -
formamide ( 4  mL ) was added t o  a solut ion o f  Q ( 0 . 43 g ,  
2 . 2  mmo l ) and �-e thoxycarbony l-2-ethoxy- 1 , 2- d ih ydroquino-
l ine  ( 0 . 6 5 g ,  2 . 6  mmo l )  i n  dry dime t hy l formami de ( 8  mL ) . 
The so l ut i on was magnet i ca l l y  s t i rred for twen t y-four 
hours at 3 50 . The d imet hy l formami de was removed under 
reduced pressure . The resu l t an t  y e l low res i due was 
crys t a l l i zed  w i t h  anh y drous e t h er to g i ve 0 . 56 g ( 72%)  o f  
1 1 8  
4 4  as a y e l low so l i d .  Recry s t a l l i z at ion from water  a f f orded 
o 
44 as a whi te sol i d ,  mp 2 3 2 . 5-233 . 5 . I R ( Nu j o l ) :  3320 
-1 ( d ·  cm me lum , N-H ) ;  1 7 10 ( st rong , C=O ) ; 1660 ( st ron g , C=C ) . 
NMR ( TFA ) : 0 8 . 1  ( s ,  3 ,  N-H ) ; 7 . 1- 7 . 7 ( m ,  7 ,  Ar-H ,  CH=CH ) ;  
4 . 4  ( s ,  2 ,  CH
2
-Ar ) ;  3 . 6  ( m ,  2 ,  C-CH
2
-N ) ;  2 . 9  ( m ,  2 ,  CH
2
- C=0 ) ; 
2 . 3  ( s ,  3 ,  CH3
) . 









0 :  C ,  59 . 2 3 ; H ,  
5 . 80 ;  N ,  1 5 . 35 .  Foun d : C ,  59 . 61 ;  H ,  5 . 80 ;  N ,  1 5 . 43 .  
( � ) -�- ( 4- Me t h y lbenzy l ) - 3- ( �-but Y loxycarbo n y l am i n o ) 
p ropan am i de ( 45a ) . A so lut ion  o f  4-me thy lbenzy l amine  ( 0 . 73 
g ,  6 mmol ) i n  methy lene ch l o r i de ( 10 mL ) was added to a 
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50  mL , roun d-bot tomed f l ask con t a i n i ng 41  ( 2 . 0  g ,  5 . 4  mmo l ) .  
The solut i on was s t i rred for four hours at  room tempe rature . 
The me t h y lene  ch lor i de solut i on was washed w i t h  1 N potas­
s i um b i sul fate ( 10 mL ) , sodium hydroxi de so lut ion ( 5% ,  10  
mL ) , and  saturated aqueous sodium ch lor i de solut ion ( 10 mL ) . 
The me thy lene ch lor i de port i on was d r i e d  ove r anhydrous 
sodium s u l f ate , f i l t e red , and evaporated under reduced 
pressure to g i ve 45a as a wh i te sol i d . Recryst a l l i zat ion  
f rom ethyl  acetat e / pe t ro leum e ther ( bp 60-900 ) af forded 
1 . 4  g ( 86% ) of  45a , mp 124- 125 . 50 . I R  ( Nu j o l ) :  3 3 10 cm- 1 
( st ron g ,  N-H ) ; 1680 ( st ron g , carb amate C=O ) ; 1640 ( st ron g ,  
ami de C=O ) . NMR ( Me 2SO , d-6 ) : 6 8 . 5  ( s ,  1 carbamate N-H ) ; 
7 . 3  ( s ,  4 ,  Ar-H ) ;  6 . 8  ( s ,  1 ,  NH-C=O ) ; 4 . 3  ( d ,  2 ,  CH2-Ar ) ; 
3 . 2  ( m ,  2 ,  C-CH2-N ) ; 2 . 3  ( m ,  5 ,  CH3-Ar , CH2- C=O ) ; 1 . 4  ( s ,  
9 ,  3 CH3 ) .  
Anal . Calculated for C 16H24N203 : C ,  6 5 . 7 3 ;  H ,  8 . 2 7 ;  
N ,  9 . 5 8 .  Found : C ,  65 . 64 ;  H ,  8 . 2 7 ;  N ,  9 . 53 .  
( E ) - ( + ) -�- ( 4-Methy lbenzy l ) -3- [ 3- ( 2 , 4-d i hydroxy-6-me t h y 1 -
5-pyrimi d i ny l ) -2-propenam i do ]  propanami de ( � ) . The me thod 
of Lin and Duboi s ( 5 1 )  was mod i f ied . The protected  ami ne 
4 5 a  ( 1 . 36 g , 4 . 6  mmol ) w a s  di sso lved i n  t r i f l uoroace t i c 
a c i d  ( 5  mL ) i n  a 25-mL , round-bot tome d f l ask . The s o l ut i on 
was s t i rred for  t h i rt y  m i nutes at room tempe rature. The 
t r i f l uoroace t i c  ac i d  was removed under reduced pressure t o  
g i ve 1 . 29 g .  ( 92% ) o f  45b , mp 83 . 5- 84 . 50 . I R  ( Nu j o l ) :  
- 1  
3 300  c m  ( st ron g , N-H ) ; 1 700 ( st rong , a c i d  C=O ) ; 1650 
s t rong , ami de C=O ) . NMR ( D20 ) : 6 7 . 3  ( s ,  4 ,  Ar-H ) ; 4 . 4  
( s ,  2 ,  CH2-Ar ) ; 3 . 35 ( t ,  2 ,  C-CH2
-N ) ; 2 . 75 ( t ,  2 ,  CH2-C=O ) , 
2 . 35 ( s ,  3 ,  CH3 ) .  A so lut i on o f  45b ( 1 . 29 g ,  4 . 2  mmo l ) 
and water ( mi n imum amount )  was t reated w i t h  an aqueous 
s o lut i on of  sodium hydrox i de ( 5% )  to pH 14 . The aqueous 
l ayer was extracted w i t h  e t h y l  acetate ( 3  X 20 mL ) . The 
comb i n e d  e t h y l  acet ate extracts  were washed w i t h  saturated  
aqueous sodium ch l o r i de solut ion , dr ied over  anhydrous 
sodium sul fate , f i l tered , an d con cent rated under reduced 
pressure t o  g i ve 45b ( free base ) as a wh i t e  s o l i d . A 
so lut i on of  45b ( free base ) ( 0 . 69 g ,  3 . 5  mmo l )  i n  d ime t h y l-
formam i de ( 5  mL ) was added t o  a so lut i on o f  � ( 0 . 68 g ,  
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3 . 5  mmo l ) and �- e thoxycarbony l -2-e thoxy- 1 , 2-dihydroqu i no l i ne 
( 1 . 0  g ,  4 . 2  mmo l ) i n  dry dime t h y l formamide ( 10 mL ) . The 
s o l ut i on was magne t i c a l l y  s t i rred for twe n t y- four hours at 
350 The dime t h y l formamide was removed under reduced pres-
sure . The res u l t an t  yel l ow res i due was crystal l i zed w i t h  
anhydrous e t h e r  t o  g i ve 0 . 8  g ( 60% ) o f  4 6  a s  a pal e  ye l low 
s o l i d . The ye l l ow so l i d  was washed  w i t h  boi l i ng water  t o  
a f ford 46  as a wh i t e  so l i d , mp 262-2650 . I R  ( Nuj o l ) :  3 300 
- 1  cm ( we ak , N-H ) ; 1 7 10 ( st rong , C=O ) ; 16 50 ( st ron g , C=C ) . 
NMR ( TFA ) : 6 6 . 8-8 . 0  ( m ,  10 , Ar-H ,  CH=CH , 4 N-H ) ; 4 . 3  
( m ,  2 ,  CH2-Ar ) ; 3 . 6  ( m ,  2 ,  C-CH2-N ) ; 2 . 8  ( m ,  2 ,  CH2C=O ) ; 
2 . 3  ( s ,  3 ,  pyri m i d i n e-CH3 ) ;  2 . 1  ( s ,  3 ,  Ar-CH3 ) · 
Anal . Calculated  for  C 19H22N404 : C ,  6 1 . 6 1 ; H ,  5 . 99 ; 
N ,  15 . 12 .  Found : C ,  6 1 . 5 7 ;  H ,  5 . 99 ;  N ,  15 . 08 .  
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( � ) -�- ( 4- Me t h oxybenzy l ) -3 - ( tert -buty loxycarbony l ami no ) 
propanam i de ( � ) . A so lut i on of  4-me thoxybenzy l amine ( 0 . 82 
g ,  6 mmo l ) in  meth y lene ch l o r i de ( 10 mL ) was adde d to a 
50-mL , round-b o t t omed f l ask cont a i n i n g  4 1  ( 2 . 0  g ,  5 . 4  mmo l ) .  
The so lut ion was s t i rred for  four hours at room tempera­
t ure . The met h y lene  ch l o r i de s o l ut ion  was washed with  1 
N pot ass i um b i s u l fate ( 10 mL ) , sodium h ydrox ide solut i on 
( 5% , 10  mL ) , and saturated aqueous sodium ch lor ide solut ion 
( 10 mL ) .  The methy lene ch lor ide port ion was dr ied  over 
anhydrous s o d i um s u l fate , f i ltered , and evaporated under 
reduced pressure t o  g i ve 4 7a as a wh i t e  sol i d . Recry s t a l ­
l i zat i on f rom ethy l ace t at e / pet roleum e t h e r  ( bp 60-900 ) 
a f forde d  1 . 1  g ( 6 7% )  o f  47a , mp 104 - 1050 . I R  ( Nu j o l ) :  
3300 cm- 1  ( st ron g , N-H ) ; 1680 ( stron g ,  carb amate C=O ) ; 
1640 ( s tron g , ami de C=O ) . NMR ( Me2SO , d-6 ) : 0 8 . 2  ( s ,  
1 ,  carbamate N-H ) ; 6 . 95 ( d  of  d ,  4 ,  Ar-H ) ; 6 . 5 5  ( s , 1 ,  
NH-C=O ) ; 4 . 25 ( d ,  2 ,  CH2
-Ar ) ; 3 . 65 ( s ,  3 ,  O-CH 3 ) ;  3 . 1  
( q ,  2 ,  C- CH2-N ) ;  2 . 25 ( t ,  2 ,  CH2-C=O ) ; 1 . 25 ( s ,  9 ,  3 CH 3 ) .  
An a l . Calculated  for C 16H24N204 : C ,  62 . 31 ; H ,  7 . 84 ; 
N ,  9 . 0 8 . Foun d : C ,  62 . 4 1 ; H ,  7 . 88 ;  N ,  9 . 00 .  
( E ) - ( + ) -N- ( 4-Methoxybenzyl ) - 3- [ 3-(2 , 4- dihydroxy-6 -
met h y l - 5 -pyrimi d i n y l ) -2-prope n am i do ] propan ami de ( � ) . 
The me thod of  Lin  and Dub o i s  ( 51 ) was mod i f ied . The pro­
tected  ami n e  47a ( 1 . 0  g ,  3 . 2  mmo l ) was di ssolved in  t r i ­
f luoroace t i c  a c i d  ( 4  mL ) i n  a 2 5-mL , round-bot t omed f l ask . 
The so lut ion  was s t i rred for th i rt y  m i nutes at room tem-
perature . The t r i f luoroacet i c  ac i d  was removed under re-
duce d pressure to give 1 . 0  g ( 97% ) of  4 7b , mp 89 . 5-9 10 . 
I R  ( Nu j o l ) ;  3260 cm- 1  ( st ron g , N-H ) ; 1680 ( st ron g , ac i d  
C=O ) ; 1640 ( s t rong , ami de C=O ) . NMR ( D
20 )
', o 7 . 2  ( d  of  
d ,  4 ,  Ar-H ) ; 4 . 4 ( s ,  2 ,  CH
2
-Ar ) ; 3 . 9  ( s ,  3 ,  O-CH 3 ) ;  3 . 3  
( m ,  2 ,  C-CH2 -� ) ; 2 . 7  ( m ,  2 ,  CH2 -C=O ) . A solut ion of  4 7b 
( 0 . 9  g ,  2 . 8  mmo l ) and water ( mi n imum amount ) was treated 
with an aqueous solut i on o f  sodium hydrox i de ( 5% )  to pH 
14 . The aqueous layer was extracted w i t h  e t h y l  acetate 
( 3  X 2 0  m L ) . The comb ined e t h y l  acetate  ext racts  were 
washed w i t h  s at urated aqueous sodium ch l o r i de solut ion , 
d r i e d  over anhydrous sodium sul fat e , f i l t ere d ,  and con-
centrated  under reduced pressure t o  give 47b ( free base ) 
as a wh i t e  s o l i d . A so lut ion  o f  47b ( free base ) ( 0 . 3  g ,  
1 . 4  mmo l )  i n  d imethy l f ormam i de ( 5  mL ) was added to a 
solut i on o f  � ( 0 . 28 g ,  1 . 4  mmo l ) and B-et hoxycarbo n y l -2-
e thoxy- 1 , 2 - d ih ydroqu i n o l i ne ( 0 . 4 3 g ,  1 . 7  mmo l ) i n  dry 
dime t hy l formamide ( 5  mL ) . The s o l ut i o n  was magne t i ca l ly 
s t i rred for twe n t y- four hours at 350 . The dime t h y l  forma-
mide  was removed un der reduced pressure . The resu l tant 
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res i due was crys t a l l i zed  w i t h  anhydrous ether to give 0 . 3  g 
( 7 1%) o f  4 8  as a pale  y e l low sol i d . Recry s t al l i zat ion from 
o 
water a f forded 4 8  as a wh i t e  so l i d , mp 187- 188 . I R  ( Nuj o l ) : 
3280 cm- 1 ( weak , N-H ) ; 1700 ( st ron g , C=O ) ; 1650  ( st ron g , 
C=C ) . NMR ( TFA ) : 0 6 . 8- 7 . 8  ( m ,  10 , Ar-H , CH=CH , 4 ,  N-H ) ; 
4 . 4  ( s ,  2 ,  CH2
-Ar ) :  3 . 9  ( s ,  3 ,  O-CH3 ) ;  3 . 55 ( m ,  2 ,  C-CH2 -
N ) ; 2 . 9  ( t ,  2 ,  CH2
-C=O ) ; 2 . 45 ( s ,  3 ,  CH3 ) .  
Anal . Calculated  for C 19H2 2N405 ' H20 :  C ,  56 . 45 ;  H ,  
5 . 94 ;  N ,  1 3 . 86 .  Found : C ,  56 . 4 3 ;  H ,  6 . 00 ; N ,  1 3 . 85 .  
( � ) -�- ( 4-Bromobenzy l ) - 3- ( tert -but y loxycarbon y l ami n o ) 
propanami de ( 49a ) . A so lut i on o f  4-b romobenzy l amine  h y ­
droch lor i de ( 2 . 0  g ,  9 mmo l ) a n d  water ( 100 mL ) was t reated 
w i t h  an aqueous sodium hydrox i de solut i on ( 10% ) t o  pH 12-
14 . The aqueous s o lut i on was extracted w i t h  meth ylene  
c h l o r i de ( 3  X 50 rnL ) . The comb ined methy lene ch lor i de ex­
t racts  were washed w i t h  saturated sodium ch lor i de so lut i on , 
dri e d  over anhydrous sodium s u l fate , f i l tered , and concen­
t rated under reduced pressure t o  g i ve 4-bromobenzy l amine  
as an  opaque l iqu i d . A so lut i on o f  4-b r omobenzy l amine  
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( 1 . 6  g ,  8 mmo l ) i n  methy lene ch lor i de ( 10 mL ) was added t o  
a 50-mL , round-bot t omed f lask cont a i n i n g  4 1  ( 2 . 0  g ,  5 . 4  
mmo l ) .  The so lut i on was s t i rred for f our hours at room 
t emperature . The met h y lene ch l or i de s o lut i on was washed 
w i t h  1 N pot a s s i um b is u l fate ( 10 mL ) , sodium hydrox i de 
solut i on ( 5% ,  10  mL ) , and saturated aqueous sodium ch lor i de 
solut ion  ( 10 m L ) . The met h y l ene  ch l or i de port ion was 
d r i e d  over anh ydrous sodium s u l fate , f i l t ered , and evapo­
rated un der reduced pressure to g i ve 49a as a wh i t e  s o l i d . 
Rec ry s t a l l i zat ion  f rom e t h y l  acetate / pe t ro l eum e t her ( b p  
60-900 ) a f forded 1 . 1  g ( 57%) o f  49 a ,  m p  1 2 2 . 5- 124 . 50 . I R  
( Nu j o l ) :  3 300 cm
- 1 ( st ron g , N-H ) ; 1 6 8 0  ( st ron g , carbamate 
C=O ) ; 1640 ( st ro n g , ami de C=O ) . NMR ( Me2 S0 , d -6 ) : 6 8 . 4  
( s ,  1 ,  carbamate N-H ) ; 7 . 4  ( d  of  d ,  4 ,  Ar-H ) ; 6 . 7  ( s ,  1 ,  
NH-C=O ) ; 4 . 3  ( d ,  2 ,  CH2-Ar ) ; 3 . 1  ( m ,  2 ,  C-CH2 -N ) ; 2 . 3  ( t , 
2 ,  CH2 -C=O ) ; 1 . 35 ( s ,  9 ,  3 CH3 ) .  
Anal . Calculated for C 15H2 1BrN203 : C ,  50 . 4 3 ;  H ,  
5 . 9 3 ;  N ,  7 . 84 .  Found : C ,  50 . 34 ;  H ,  5 . 9 7 ; N ,  7 . 8 1 .  
(�) - ( ± )-N- ( 4-Bromobenzyl )- 3- [ 3- ( 2 , 4-dihydroxy 6 me thyl 
5-pyrimi d i n y l - 2-propenamido ] propanami de ( 50 ) . The me thod 
of Lin and Dubo i s  ( 51 )  was mod i f ied . The prot ected ami n e  
49a ( 1 . 0 g ,  2 . 8  mmo l )  was  di ssolved i n  t r i f l uoroace t i c  
a c i d  ( 5  mL ) i n  a 25-mL , round-bot tomed f l ask . The solut ion 
was s t i rred for th i rt y  minutes at room t emperature . The 
t r i f luoroacet i c  ac i d  was removed under reduced pressure to 
g i ve 1 . 0  g ( 96% ) o f  49b , mp 106 . 5- 1080 . I R  ( Nuj o l ) :  3300 
cm- 1  ( me d i um , N-H ) ; 1690 ( s t ron g , acid C=O ) ; 1650 ( st ron g ,  
amide C=O ) . NMR ( D20 ) ; 6 7 . 5  ( d  o f  d ,  4 ,  Ar-H ) ; 4 . 5  ( s ,  
2 ,  CH2 -Ar ) ; 3 . 4 ( t ,  2 ,  C-CH2-N ) ;  2 . 8  ( t ,  
2 ,  CH 2-C=O ) . A 
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so lut i on of 49b ( 0 . 95 g ,  2 . 6  mmo l ) and water ( mi n imum amount ) 
was t reated w i t h  an aqueous so lut i on o f  sod i um hydrox i de 
( 5% )  t o  pH 14 . The aqueous l ayer was ext racted w i t h  ethy l 
ace t at e  ( 3  X 20  mL ) . The comb i ned e t h y l  acetate extract s 
were washed w i t h  saturated aqueous sodium ch lor i de so lut i on , 
dried  over anh ydrous sodium sul f ate , f i l te re� and concen-
t rated unde r reduced pressure to gi ve 49b ( f ree base ) as 
a wh i t e  so l i d . A so lut i on of 49b ( f ree base ) ( 0 . 6 1 g ,  2 . 4  
mmo l ) i n  dime t hy l formam i de ( 5  mL ) was added t o  a solut i o n  
o f  � ( 0 . 46 g ,  2 . 4  mmo l ) a n d  N-ethoxycarbo n y l -2-ethoxy- 1 , 2-
d ihydroqu i n o l i n e  ( 0 . 7 1 g ,  2 . 9  mmo l )  i n  dime t h y l formam i de 
( 8  m L ) . The so lut i on was magnet i ca l l y  st irred for twe n t y-
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four hours at 350 . The dimethy l f ormamide was removed under 
reduced pressure . The res u l t an t  yel low res i due was crys t a l ­
l i zed w i t h  an hydrous e t h e r  t o  g i ve 0 . 59 g ( 56% ) o f  50 a s  a 
p a l e  y e l l ow so l i d . Recrys t a l l i z a t i o n  from wat er 
50  as a wh i t e  sol i d , mp  19 1-1920 . I R  ( Nu j o l ) :  
a f forded 
- 1  
3320 cm 
( me d i um ,  N-H ) ; 1 7 1 0  ( s t ron g , C=O ) ; 1640 ( st rong , C=C ) . 
NMR ( TFA ) : 0 6 . 7-7 . 7  ( m ,  10 , Ar-H , CH=CH , 4 N-H ) ; 4 . 4  
( d ,  2 ,  CH
2
-A r ) ; 3 . 6  ( q ,  2 ,  C-CH 2-N ) ; 3 . 0 ( t , 2 ,  CH2-C=O ) ; 
2 . 5  ( s ,  3 ,  CH
3 ) .  
A n a l . Calculated for C18H 19BrN404 ' H20 :  C ,  47 . 70 ;  H ,  
4 . 67 ;  N ,  12 . 36 .  Found : C ,  4 7 . 69 ;  H ,  4 . 67 ;  N ,  12 . 38 .  
( � ) -N- ( 3 , 4-Di c h l orobenzyl ) - 3- ( �-buty loxycarbon y l ­
ami no ) propanami de ( � ) . A solut i o n  o f  3 , 4- dich lorobenzy l-
ami n e  ( 1 . 06 g ,  6 mmo l ) i n  methylene  ch lor i de ( 10 mL)  was 
added to a 50-mL , round-bo t t omed f l ask cont a i n ing  4 1  ( 2 . 0  
g ,  5 . 4  mmo l ) .  The solut ion  was st i rred f or four hours at 
room temperature . The methy lene ch lor i de so lut ion was 
washed w i th 1 N pot a s s i um b i sul fate ( 10 m L ) , sod i um hy-
drox i de so lut i on ( 5% ,  10  mL ) ,  and saturated aque ous sodium 
ch lor i de so lut i o n  ( 10 mL ) . The me thylene  ch lor i de port ion  
was  dri e d  over anhydrous sod i um sul fat e , f i l t ered , and 
evaporated under reduced pressure t o  g i ve 51a  as a wh i te 
sol i d . Recryst a l l i za t i on from e t h y l  acetate / petroleum 
e t he r  ( bp 60-900) a f forded 1 . 3  g ( 69% ) o f  5 1a , mp 124-1280 . 
- 1  
I R  ( Nu j o l ) :  3320  cm ( st ron g , N-H ) ; 1680 ( s t ron g ,  car-
b amate C=O ) ; 1640 ( st ron g , ami de C=O ) . NMR ( Me2S0 , d-6 ) : 
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o 8 . 6  ( s , 1 ,  carb amate N-H ) ; 7 . 5  ( m ,  3 ,  Ar-H ) ; 6 . 8  ( s ,  1 ,  
NH-C=O ) ; 4 . 4  ( d ,  2 ,  CH
2
-Ar ) ;  3 . 2  ( q ,  2 ,  C-CH2-N ) ;  2 . 4  ( t ,  
2 ,  CH2
-C=O ) ; 1 . 4  ( s ,  9 ,  3 CH3
) .  
Ana l . C a l c u l ated for  C1 5H20C12N203 : C ,  5 1 . 88 ;  H ,  
5 . 81 ;  N ,  8 . 0 7 .  Foun d : C ,  5 1 . 84 ;  H ,  5 . 84 ;  N ,  8 . 04 .  
CE ) - ( ± ) -�- ( 3 , 4-Dichloroben zyl ) - 3- [ 3- ( 2 , 4-d ihydroxy-6-
met hyl - 5-pyr i m i d i nyl ) -2-propenami do]  propanamide ( � ) . The 
me thod of L i n  and Dub o i s  ( 51 )  was mod i f ied . The protected  
ami n e  5 1 a  ( 1 . 18 g ,  3 . 4  mmo l ) was di sso lved i n  t r i f l uoro-
ace t i c  a c i d  ( 5  m L )  i n  a 25-mL , round-bottomed f l ask . The 
s o lut ion  was s t i rred for t h i rt y  m i nutes at room tempera-
ture . The t r i f l uoroace t i c  a c i d  was removed under reduced 
pressure to gi ve 1 . 0 3 g ( 84% ) of  5 1b , mp 71 -730 . I R  ( Nu j o l ) :  
3 300  cm- 1 ( medium , N-H ) ; 1680 ( st rong , a c i d  C=O ) ; 1650 
( st ron g , ami de C=O ) . NMR ( D20 ) : 0 7 . 5  ( m ,  3 ,  Ar-H ) ; 4 . 5  
( s , 2 ,  CH2 -Ar ) ; 3 . 5  ( t ,  2 ,  C-CH2-N ) ;  2 . 9  ( t ,  2 ,  CH2 -C=O ) . 
A so lut i on o f  5 1 b  ( 0 . 98 g ,  2 . 7 mmo l ) an d water  ( mi n imum 
amount )  was t reated w i t h  an aqueous so lut i on of sodi um 
hydroxide ( 5% )  t o  pH 14 . The aqueous l ayer was ext racted 
w i t h  e t h y l  acetate ( 3  X 20 mL ) . The comb ined  e t h y l  acet a t e  
extrac t s  w e r e  washed w i t h  saturated aqueous sodium ch lor i de 
s o l ut ion , dr i e d  over anhydrous sodium sul f at e , f i l t ered , 
and concen t rated  under reduced pressure t o  g ive 5 1b ( free 
b ase ) as  a wh i te so l i d . A so lut i on o f  51b  ( free base ) ( 0 . 62 
g ,  2 . 5  mmo l ) i n  dimethy l f ormami de ( 4  m L )  was added to a 
solut i on o f  � ( 0 . 49 g ,  2 . 5  mmo l ) and �-ethoxycarbon y l-2-
e thoxy - 1 , 2-dihydroquino l ine  ( 0 . 74 g ,  3 . 0  mmo l ) i n  dry d i -
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met h y l formamide ( 8  mL ) .  The s o l ut ion was magne t i c a l l y  
s t i rred f o r  twe n t y - four hours at 350 . The dime t h y l forma-
m i de was removed unde r reduced pressure . The resul tant  
y e l l ow res i due was  cryst a l l ized w i t h  anhydrous e t he r  to 
give  0 . 65 g ( 6 1% )  of  52  as a pale  yel low sol id . The ye l-
l ow so l i d  was washed with  boi l in g  water t o  a f ford 52  as a 
wh i te so l i d , mp 262- 2640 ( dec ) . I R  ( Nuj o l ) :  3300 cm- 1 
( weak , N-H ) ; 1710  ( medium , C=O ) ; 1650 ( me d i um ,  C=C ) . NMR 
( TFA ) : 8 6 . 9-8 . 0  ( m ,  9 ,  Ar-H ,  CH=CH , 4 N-H ) ;  4 . 3  ( m ,  
2 ,  CH2
-Ar ) ; 3 . 7  ( m ,  2 ,  C-CH2-N ) ;  2 . 8  ( m ,  2 ,  CH2-C=O ) ; 
2 . 3  ( s , 3 ,  CH3 ) .  
Anal . Calculated  for C18H 18C 1 2N404 : C ,  50 . 84 ;  H ,  
4 . 2 7 ;  N ,  1 3 . 1 7 .  Foun d : C ,  50 . 80 ;  H ,  4 . 30 ;  N ,  1 3 . 14 .  
2 � -Ph t h a l y l-�-aspar t i c  Anhydr ide (�) .  The method of  
Murphy and Stubb i n s  ( 7 1 )  was used . DL-Aspar t i c  a c i d  ( 26 . 6  
g ,  0 . 2  mo le ) and phth a l i c  anhydr i de ( 29 . 6  g ,  0 . 2  mo le ) i n  
p y r i dine  ( 400 mL ) were heated under ref lux f o r  two hours i n  
a 1000-mL , round-bo t t ome d f l ask . The mixture was coo led to 
room t emperature , and the  undisso lved sol ids were removed 
b y  f i l t ra t i on . The f i l t rate was con centrated under reduced 
pressure to a y e l low o i l . Acet i c  anhydr i de ( 100 mL ) was 
added to t h e  o i l  wh i le v i gorou s l y  a g i t at in g . A f t er ch i l-
l in g  the  mixture at 00 overn i ght , the  prec i p it ate was col-
l e c t ed by f i l t rat ion , washed with  anhydrous ether , and 
recry s t al l i ze d  f rom 1 , 4-di oxane to g ive 3 1 . 8  g ( 6 5% ) of  
5 3 , mp 220-2220 ; l it e rature ( 71 )  mp 224-226
0 . I R  ( KBr ) : 
18 75 cm
-1  
( st ron g , O=COC=O ) ;  1795 ( s t rong , C=O ) ; 1785  
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( st ron g , imi de C=O ) ; 1705 ( st ron g , i m i de C=O ) . NMR ( Me2
SO , 
d-6 ) : C 7 . 95 ( s ,  4 ,  Ar-H ) ; �. 7 ( t ,  1 ,  CH ) ;  3 . 5  ( d ,  2 ,  CH2 ) · 
4 2 � -Benzy l -� -phth a l y l -DL- asparag ine  ( 54 ) . The pro­
cedure of  Murphy and St ubb i n s  ( 71 )  was mod i f i e d . N
2
-Pht h a l y l-
DL- aspart i c  anhydr i de ( 53 )  ( 5 . 0  g ,  20 mmo l ) was suspended  
i n  1 2 5  mL o f  anhydrous e t her i n  a 250-mL , three-n ecked , 
round-bo t t omed f lask equ i pped w i t h  n it rogen i n l e t  and out-
let  adapters  and a rubber septum . Benzy l amine  ( 4 . 3  g ,  40 
mmo l ) was added to the  react ion f l ask via a s y r in ge and the 
m ixture was magn e t i c a l l y  st i rred at room temperat ure for 
twe n t y- four hour s . At  the  end of  the a l loted t ime , the 
so l i d  mat e r i a l  present was co l lected by  f i l t rat ion an d 
washed w i t h  anhydrous e t he r  ( 2  X 2 5  mL ) . The sol i d  was 
t hen suspen ded in wat er ( about 150 mL ) an d t he suspen s ion 
was a c i d i f i e d  w i t h  6 N h ydroch l o r i c  a c i d  to pH 1 .  The 
wh i t e  so l id was co l lected  by  f i l t rat ion , washed  w i t h  b o i l ­
ing  aceton i t r i le , and dr ied ( t o luene , 1 1 10 ) to  give 4 . 5  g 
o . 0 ( 6 3% )  of  54 , mp 2 1 3-2 1 5  ; l lt erature ( 71 )  mp 220-222 . I R  
( Nu j o l ) :  3365  cm
- 1  
( med ium , NH ) ;  1780 ( weak , imide C=O ) ; 
1710  ( st ron g , i m i de C=O ) ; 1620 ( st ron g , ami de C=O ) . NMR 
( TFA ) : c 7 . 8 ( s ,  4 ,  phth a l y l-H ) ; 7 . 1  ( s ,  5 ,  Ar-H ) ; 5 . 7  ( t ,  
1 ,  CH ) ;  4 . 4  ( s ,  2 ,  CH2-Ar ) ; 3 . 3  ( m ,  2 ,  CH2 -C=0 ) . 
N-Benzy loxycarbon y l-DL-aspar t i c  A c i d  ( � ) . The pro­
cedure of  Bergmann and Zervas ( 72 )  was modi f ied . DL-Aspar-
t ic ac i d  ( 8 . 0  g ,  60 mmo l )  , magne s i um ox i de ( 7 . 4  g ,  0 . 18 
mo l e ) ,  water ( 100 mL ) , and d i e t h y l  ether  ( 30 mL ) were 
s t irred in a 2 50-mL , round-bot t omed f lask wh i l e  coo l i n g  i n  
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an i ce bath . The suspens ion was con t in uous ly s t i rred wh i l e  
benzyl ch l oroformate ( 20 . 4  g ,  0 . 12 mo le ) was added dropwise  
ove r a t h i r t y  minute  per iod . The mixture was st i rred at 
room temperature overn i ght . Fo l lowi n g  the a l lotted react ion 
t ime , the  e t h er port ion  was separat ed  and d i scarded . The 
aqueous port ion  was a c i d i f i e d  w i t h  concent rated h ydroch l o r i c  
a c i d  t o  p H  1 .  The aqueous so lut i on was then extracted w i t h  
e t h y l  acet at e  ( 3  X 5 0  mL ) . The comb ined ethy l acet ate ex-
t racts  were washed w i t h  hydroch lor i c  a c i d  ( 5% ,  25  mL ) ,  
saturated sodium chlor i de so l ut ion ( 25 mL) , and dried over 
anh y drous sodium s u l fate . The e t h y l  ace t at e  was evaporat ed 
under reduced pressure t o  l e ave a wh i t e  so l i d  wh i ch was 
recryst a l l i zed f rom ethy l ace t at e / pet ro leum e t her to g ive 
10 . 2  g ( 64% ) of 60 , mp 100- 10 30 ; l it erature ( 96 )  mp 114- 1 1 50 . 
- 1 
I R  ( Nu j o l ) :  3310  cm ( broad , N H ) ; 3100 ( broad , OH ) ;  1730 
( st ron g ; acid C=O ) ; 1 700 ( st ron g , carbamate C=O ) . NMR 
o 7 . 7  ( m ,  1 ,  N H ) ; 7 . 4  ( s ,  5 ,  Ar-H ) ;  5 . 1  ( s ,  
2 ,  CH
2
-Ar ) ; 4 . 5 ( m , 1 ,  CH- C=O ) ;  2 . 7  ( m , 2 ,  CH2
-C=0 ) . 
N-Benzyloxycarbon y l -DL-aspart ic  Anhydr i de ( � ) . The 
method of Bergmann and Zervas ( 72 )  was used . Acet ic  anhy-
dr i de ( 16 mL ) was added to carbobenzoxy-DL- aspart ic  a c i d  
( 60 )  ( 5 . 4  g ,  0 . 02 mo l e )  a n d  heated to bo i l i n g . The solu­
t ion was imme d i a t e l y  coo led  and t reated w i t h  anhydrous e t he r  
a n d  petroleum et her ( bp 30-60
0 ) ( 30 : 70 ;  v / v )  to  i n duce 
cryst a l l i zat ion . The wh i t e  sol i d  was col lected by f i l tra­
t ion , washed w i t h  anhydrous et her , and dr i e d  t o  g ive 4 . 6  g 
( 9 1% ) of 6 1 . Recry s t a l l izat ion from ethyl  ace t at e / pe t ro leum 
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e t h e r  gave 6 1  as a wh i t e  sol i d , mp 126- 1280 ; l it erature ( 96 )  
mp 1 300 . I R  ( Nuj o l ) : 3380 cm- 1  ( medium , NH ) ;  1780 ( st ron g ,  
anhydr ide C=O ) ; 1690 ( st rong , carbamate C=O ) . NMR ( Me2SO , 
d-6 ) : 8 8 . 2  ( m ,  1 ,  NH ) ;  7 . 4  ( s ,  5 ,  Ar-H ) ; 5 . 1 ( s ,  2 ,  CH Ar ) ;  
2 
4 . 8  ( m ,  1 ,  CH-C=O ) ; 3 . 2  ( m ,  2 ,  CH2-C= 0 ) . 
a -Benzyl �-Ben z y l oxycarbon y l-DL-aspartate  ( 62 ) . The 
p rocedure of  Bergmann , et  a l . ( 73 )  was f o l lowed . A mixture 
o f  fresh l y  d i s t i l led  benzy l a lcoho l ( 1 . 3  g ,  12  mmo l )  and 
c arboben zoxy-DL- aspart ic  anhydride ( 6 1 )  ( 2 . 0  g ,  8 mmo l ) 
were heated for 3 . 5  hours at 1000 ( o i l  bath , 1000 ) .  The 
c lear , pa le  y e l low syrup wh ich resul t ed was d i s so lved in 
ether , and ext racted w i t h  sodium b icarbonate ( 5% ,  2 X 50 mL) . 
The comb ined  b icarbon ate por t i on s  were washed once w i t h  ether 
( 2 5 mL ) , and a c i d i f i e d  with 2 N hydroch lor i c  acid t o  pH 1 .  
The product cryst a l l i zed a f t e r  standing  overn i ght  at room 
t emperature . The so l i d  was co l lected b y  f i l t rat ion , and 
recryst a l l i zed  f rom e t h y l  ace t a t e/ petro leum ether , benzene , 
or  t o luene , to g ive 2 . 5  g ( 86% ) of  62 as a wh i t e  so l i d ,  
mp 9 3- 960 ; l i t erature ( 96 )  mp 104 . 50 . A pot ent iome t r i c  
t it rat ion  o f  40 m g  of  6 2  i n  2 5  m L  of  wat e r / di oxane ( 1 : 2 ) 
was carr i e d  out at 2 50 us ing  0 . 1 M NaOH t o  g i ve a pKa of  
- 1 
6 . 7 ;  l i terature ( 78 )  pKa 6 . 6 .  I R  ( Nu j o l ) :  3 3 1 0  cm ( medi-
um , NH ) ;  1 760 ( st rong , ester  C=O ) ; 1 720 ( strong , ac id C=O ) ; 
1695 ( st rong , carbamat e  C=O ) . NMR ( CDC1 ) :  8 9 . 2  ( s ,  1 ,  
3 
OH ) ;  7 . 3  ( s ,  10 , Ar-H ) ; 5 . 8 ( m ,  1 ,  NH ) ;  5 . 1 5 ( d ,  4 ,  CH
2
- Ar ) ; 
4 . 7  ( m ,  1 ,  CHC=O ) ;  3 . 0  ( m ,  2 ,  CH
2
C=0 ) . 
1 3 1  
S -Benzy l �-Benzy loxycarbony l-DL-aspart at e  ( 62a ) . T h e  pro­
cedure of  Berger and Kat c h a l s k i  ( 78 )  was used . �-Benzy loxy­
carbon y l -DL- aspart i c  ac i d  ( 60 )  ( 5 . 0  g ,  19 mmo l ) and benzyl 
a l cohol ( 2 5 mL , 0 . 36 mo le ) were added to a bo i l in g  solut ion 
o f  E-t o luenesu l f on i c  ac i d  ( 0 . 3  g ,  1 . 6  mmo l )  in toluene ( 30 
mL ) . The s o lut ion was heated at ref lux for 2 . 5 hours , dur­
i n g  wh i ch t ime , wat er was removed azeot rop i c a l l y . The so lu­
t ion  was cooled t o  room t emperature , shaken for ten m i nutes 
with  magnes ium o x i de ( 0 . 6  g ,  15  mmo l )  and f i l t ered . The 
t o l uene and excess benzy l alcohol were removed f rom t h e  
f i l t rate under reduced pressure to leave the  i n terme d i at e , 
d ibenzy l �-benzy loxycarbo n y l -DL-aspartate  as a v i s cous 
y e l l ow o i l .  A mixt ure of 2 N sodium h y droxi de ( 2 . 5  mL ) 
wat e r  ( 12 mL) , and d i oxane ( 30 mL)  was added t o  a solut i on 
o f  t h e  crude d ib enzy l �-benzy loxycarbonY l-DL-aspartate  ( 2 . 3 
g ,  6 mmo l )  i n  d i oxane ( 2 5 mL)  and water ( 10 mL ) . The solu­
t io n  was s t i rred at room t emperature for twent y-four hours . 
The pH o f  t h e  s o lut ion was adj usted to 5 . 5  with  6 N hydro­
chlor i c  a c i d  and the  so lvent s were evaporated  under reduced 
pressure . The res i due was t reated w i t h  1 N pot a s s i um b i ­
carbonate ( 5  mL ) . The m ixture was extracted w i th et her 
( 1  X 1 0  mL ) t o  remove any unreacted dibenzy l ester . Upon 
a c i d i f i cat ion  of  the  aqueous por t ion w i t h  6 N hydroch lor i c  
a c i d , t h e  product 62a separated as a y e l low o i l whi ch was 
ext racted w i t h  e t h er ( 3  X 10 mL ) . The comb i ned e t h er ex­
t ract s were washed w i t h  saturated sodium ch l o r i de ( 5  mL ) , 
and dr ied over anhydrous sod i um sul f at e . The solvent was 
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removed under  reduced pressure t o  leave 0 . 42 g ( 2 3% ) of  62a 
as a wh i t e  sem i - so l i d , mp 82-920 . A pote n t i ome t r i c  t i t rat ion 
of  40 mg of  62a i n  25  mL of  wat e r / d i oxane ( 1 : 2 ) was carr i ed 
out at 2 50 us i ng 0 . 1  M NaOH t o  give a pKa of 6 . 2 ,  l it e rature 
( 78 )  pKa 6 . 1 .  I R  ( Nuj o l ) :  3 3 30 cm- 1 ( weak NH ) ;  1730  ( medium , 
ester  C=O ) ; 1700 ( me d i um , acid  C=O ) ; 1650 ( medium , carbamate 
C=O ) . NMR ( CDC1 3 ) :  0 8 . 1 ( s ,  2 ,  NH , OH ) ;  7 . 3  ( s ,  10 , Ar-H ) ; 
5 . 1 ( s ,  4 ,  CH
2
- A R ) ; 4 . 6  ( m ,  1 ,  CHC=O ) ;  2 . 9  ( m ,  2 ,  CH
2
C=0 ) .  
�- ( 4-Bromob enzy l ) - 3-benzy loxycarbon y lamino-2 , 5-pyr-
ro l idinedione  ( 62b ) .  The method of  Lin and Dub o i s  ( 51 )  was 
mod i f i ed .  A mixt ure of  62 ( 3 . 0  g ,  8 . 4  mmo l )  and �-ethoxy-
carbony l - 2 - et hoxy - 1 , 2 - d i hy droqui no l ine  ( 2 . 3  g ,  9 mmo l ) i n  
tet rahydrofuran ( 15 mL ) was magnet i c a l l y  s t i rred a t  350 
( o i l  b at h , 350 ) un t i l  solut ion was e f fected . Sub sequent ly , 
4-bromob enzy l amine  ( 1 . 6  g ,  8 . 4  mmo l ) was added . The solu­
t ion was st i rred for  forty -e i ght hours at  350 . The t e t ra-
h ydro furan was removed un der reduced pressure . The clear  
res idue was di ssolved  i n  ether ( 2 5 mL ) , washed w i t h  hydro-
chlori c  a c i d  ( 5% ,  10  mL ) , sodium hydroxi de so lut ion ( 5% ,  
1 0  mL ) , s at ur at e d  aqueous sodium c h l o r i de solut ion ( 10 mL) , 
an d dri ed ove r anhy drous sodium su l f at e . The et her was 
evaporated un der reduced pressure to give 1 . 35 g ( 3 1% ) of  
6 2b as a w h i t e  so l i d ,  mp  164 - 16 80 . 
- 1  
I R  ( Nu j o l ) :  3280 cm 
( medium , NH ) ;  1700 ( stron g , carbamate C=O ) ; 1680 ( st ron g , 
imide C=O ) . NMR ( CDC1 3 ) :  0 7 . 3-8 . 0  ( m ,  10 , 9Ar-H , NH ) ;  5 . 2  
( s ,  2 ,  OCH2 Ar ) ;  4 . 7 ( s ,  2 ,  CH2
ArBr ) ; 4 . 4  ( t ,  1 ,  CHC=O ) ;  
3 . 0  ( t , 2 ,  CH2C= 0 ) .  
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Anal . Calculated for C 19H 17BrN204 : C ,  54 . 69 ;  H ,  4 . 1 1 ;  
N ,  6 . 71 .  Found : C ,  54 . 69 ;  H ,  4 . 14 ;  N ,  6 . 68 .  
2 4 Benzy l � -Benzyl oxycarbony l-N - ( 4 -bromobenz y l ) -DL-aspar-
aginate  ( � ) . The method o f  L i n  and Dubo i s  ( 51 )  was mod i f ied . 
A m i xt ure o f  62 ( 1 . 0  g . , 2 . 8  mmol ) and �- ethoxycarbony l -
2-ethoxy- 1 , 2 - dihydroqu i no l i n e  ( 0 . 76 g ,  3 mmo l )  in  d imet h y l ­
formam ide ( 15 mL ) was magnet i c a l l y  st i rred at  350 ( o i l  bat h , 
3 50) un t i l  solut i on was ef fected . Subsequent l y ,  4-b romobenzy l­
ami n e  ( 0 . 52 g ,  2 . 8  mmol ) was added . The so lut ion was s t i rred 
for  f o rt y - e i gh t  hours at 3 50 . The dime t h y l formami de was 
removed under reduced pressure . The resu l tant  res i due was 
crys t a l l ize d  w i t h  anhydrous et her to g ive 0 . 65 g ( 44% ) of 6 3  
as a wh i t e  so l id .  Recrys t a l l izat ion  from ch loroform / e t he r  
- 1  
a f forded 63 , m p  124- 1260 . I R  ( Nuj o l ) :  3280 cm ( medium , NH ) ; 
1 740  ( s t ron g ,  ester  C=O ) ; 1690 ( st ron g , carb amate C=O ) ; 
1650 ( st ron g , ami de C=O ) . NMR ( CDC1
3
: 8 6 . 85-7 . 5  ( m ,  14 , 
Ar-H ) ; 6 . 0  ( m ,  2 ,  NH ) ; 5 . 2  ( d ,  4 ,  O-CH2-Ar ) ;  4 . 8  ( m ,  1 ,  CH ) ; 
4 . 3  ( d ,  2 ,  N-CH2-A r ) ; 2 . 8  ( m ,  2 ,  CH2 -C=0 ) . 
Anal . Ca lculated  for  C26H2 5BrN205 : C ,  59 . 44 ;  H ,  4 . 80 ;  
N ,  5 . 3 3 .  Foun d : C ,  59 . 18 ;  H ,  4 . 88 ;  N ,  5 . 26 .  
At t empt e d  synthes i s  o f  N- ( 4-6 romobenzy l ) - 3-benzy loxy­
carbony l am ino-4-h ydroxybut anam i de ( � ) . The procedure of 
L i n  and Dubo i s  ( 5 1 )  was used . To a solut ion o f  l i t h ium 
borohydr i de ( 0 . 0 78 g ,  3 . 6  mmo l ) in tet rahydrof uran ( 10 mL ) 
un der n i t rogen was added 6 3  ( 0 . 9  g ,  1 . 7 mmo l ) d i sso lved i n  
t e t rahydro f uran ( 5  mL ) wh i le coo l i n g  i n  i ce . The mixture 
was s t i rred at room t emperature for twen t y hours . The re-
act ion vesse l was coo led  i n  an ice  bat h , wh i le 1 . 5  mL of  
6 N hydroc h lo r i c  a c i d  was added . The sol u t i on was st i rred 
for  one hour at room temperature . The tet rahydrofuran was 
removed under reduced pressure . The aqueous l ayer was ex­
t racted  w i t h  ch loroform ( 3  X 20 mL ) , washed with saturated 
sodium chlor i de solut ion  ( 10 mL ) and dr ied over anhydrous 
sodium s u l f ate . The comb ined  ch loroform ext racts  were 
evaporated un der reduced pressure to l e ave 0 . 5 3 g ( 75% ) 
o f  a wh i t e  so l i d , mp 166 . 5- 1680 . The me l t i n g  point , NMR , 
and I R  were i den t i ca l  to those of  62b . 
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C .  Pharmaco logical  Mat e r i a l s  an d Met hods 
1 .  E xper iment a l  A n i ma l s  
M a l e  CD- 1  an d DBA / 2  m i c e  were obt a ined f rom Char l es 
R i ver Breeding Laboratories , Wi lmington , MA . The mice 
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were ma int ained  on Pur in a  Laboratory Chow ( Ral ston Pur in a , 
I n c . , R i chmon d ,  IN ) and tap wate r  ad l ib i tum i n  t emperature 
con t ro l led quarters  w i t h  a twe lve hour l i ght / dark cycle . 
2 .  Preparat ion of  Media  
With  t h e  except ion of  water , sodium b i carbonat e ,  an d 
sodium hydrox i de , a l l  reagent s  were obt ained  from e i ther 
G ibco ( Grand I s l an d ,  NY ) or F low Laborator i e s  ( Rockv i l le , 
MD ) .  A l l  o f  t h e  so lut ions were prepared under s t er i le con ­
d i t ions . Bacte r i a l  con t aminat ion was mon it ored b y  in cubat ­
i n g  one mL o f  media  w i t h  one mL o f  50% Bra i n-Heart In fus ion 
Broth ( Di fco , Detro it , M I ) for seven ty- two hours at 370 
an d 5% c arbon diox i de . I f  bact e r i a l  cont aminat ion occurred , 
as  v i sual ized b y  an i n c rease in  t h e  turb i di t y  of  the solu­
t ion , the med i a  was d i scarded . The d irect ions for the  
preparat ion o f  the  s t e r i le media  emp loyed in t h e  test ing  
procedures of  t h i s  proj ect  f o l low .  
a .  A lpha Mod i f i cat i on o f  Eagle ' s  M i n imum Essen t i a l  
Medium ( aMEM ) 
A package cont ain i n g  10 . 1  g of  the  comme r c i a l l y  ava i l ­
abl e  a MEM powdered media , i n c luding L-g l u t am i n e  and exc l ud­
i n g  r ibos i des , deoxy r ib o s i des , and sodium b icarbon at e , was 
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mixed w i t h  2 . 2  g of  sodium b i carbonate and enough deion ized 
water  to make one l it er of med i a . The solut ion was s t e r i-
l ized by f i l t rat ion . 
b .  Comp l e t e  Dulbecco ' s  Mod i f ied Eagle ' s  Min imum 
Essen t i a l  Medium ( CDMEM ) 
The f o l low i n g  s t er i le reagean t s  were mixed w i t h  enough 
deion i zed water to make f ive l iters of  CDMEM : 
66 . 9  g Dulbecco ' s  Mod i f i ed Eag l e ' s  M i n imum Essen t i a l  
Medium ( #430- 2 100 , w i t h  glucose and glutamine ,  a n d  
w i t hout sod ium b icarbonate and sodium pyruvate )  
1 0  mL glutam i n e  ( 200 mM )  
c .  Sp inner ' s  Medium 
The f o l lowing reage n t s  were mixed t o  ob t a in 500 mL 
of  Spinner ' s  med i a  wit hout amino acids : 
5 . 2  g Spinner ' s  Powdered Medium 
2 0 . 0  mL Pen ic i l l in ( 5000 U / mL ) / St reptomy c i n  ( 5000 � g/mL ) 
2 0 . 0  mL 1 M Hepes b u f f er ( 4- ( 2-Hydroxyethy l ) - 1 -
p iperaz ineethanesu l f o n i c  A c i d )  
1 . 5  mL 7 . 4% sodium b i carbonate 
5 . 0  mL MEM v i t am i n s  ( 100X ) 
The volume was adj usted  t o  500 mL u s i n g  de ion i zed wa-
t e r  and t h e  pH was adj usted  to 7 . 4  u s i n g  10 N sodium hydrox­
i de . The so lut ion was s t er i l ized by f i l t rat ion us i n g  a 
Nalgene  f i lt e r  un it  ( s ize  0 . 4 5 mi cron , Na l ge Co . ,  Rochester , 
NY ) . 
When t h e  me d i a  was t o  be  used for  in cubat i n g  P815  or 
P388  c e l l s , 1 0% heat- i nact ivated  f e t al calf  serum ( heat -
1 3 7  
i n act ivated for one hour at 560 ; for Spinner ' s  med i a : Lot 
#00946 3 ,  North Ame r i can B i o logical  I n s t i tute , Ch i cago , I L ; 
for  CDMEM : S t e r i le  Systems , Logan , Utah ) was added to the  
s tock med i a . A l l  i n cubat ions  were carr i e d  out i n  a mode l 
3028 i n cubator ( Forma S c i e n t i f iC , Mar iet ta , OH ) at 370 , 5% 
carbon d iox i de , 9 5% a i r , and 95% hum i d i t y . 
3 .  E n umerat ion  of  Ce l l s 
The concen t rat ions  of  bone marrow ce l l s  and tumor ce l l s  
were determ i n e d  w i t h  a Cou l t e r  Counter ( model ZB I ,  Cou l t er 
E lectron i cs , H ia l eah , FL ) or w i t h  a B r i gh t- Line hemacyto-
met e r  ( Amer i can Opt i c a l , Buf f alo , NY ) .  To el iminate  e ry -
throcy t e s , three drops of  Zapoglobin  I I  l y s i n g  agent ( Coul-
t e r  D i agnos t i c s , H ia leah , FL ) were added to a l l  ce l l  sus-
pen s ions  i n  I soton- I I  coun t i n g  solut ion  ( Cou l t e r  D i agnos t i c s , 
H i a leah , F L ) . For hemacytometer  coun t i n g , 0 . 3  mL of  
5 approx imate l y  5- 10 X 10 cel l s  / mL was added to t he hemacyto-
meter , an d the  ce l l s were enumerated u s i n g  a b i nocu l ar l i gh t  
m i c roscope ( Ze i s s , West Germany ) .  Ce l l  v i ab i l i ty  was checked 
b y  the  t r ypan b lue exc lus ion  test ( 97 , 9 8 )  u s i n g  0 . 4% t rypan 
b lue so lut ion ( 0 . 4  g t rypan b lue/ 100 mL 1 . 5  M s a l i n e , Gibco , 
Gran d  I s l an d , NY ) .  
4 .  Tumor Line  Mai n tenance 
a .  I n  v ivo 
The P388 tumor c e l l s  in 1 5% dimet h y l su l fox i de were fro-
zen in l i qu i d  n i t rogen an d were qu i ck-thawed w i t h i n  5 t o  10 
seconds at 370 when readied for use . The c e l l s  were cen-
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t r i fuged for t e n  m i nutes at 300 X g ( I n ternat ional  CRU- 5000 
cent r i f uge , Damon , IEC D iv i s ion , Needham , MA ) and resus-
pended  i n  S p i n n e r ' s  me di a .  The P388  tumor l in e  was ma i n t a ined 
i n  DBA / 2  male  m i c e  by s e r i a l  i n t rape r i toneal  ( i . p . ) passage 
5 o f  10  ce l ls every seven t o  ten  days . 
To harvest the  t umor cel ls , the DBA/ 2  m i c e  were sacri-
f i ced b y  cerv i ca l  d i s locat i on . The per i toneal  ce l ls were 
co l lected  asept i c a l l y  by i n j e c t i n g  and withdrawing 4-8 mL 
o f  Spinner ' s  med i a  f rom t he per i t on e a l  cav i t y . The cel l s  
were spun a t  300 X g f o r  t e n  minutes . The supernatant was 
decant e d  and the ce l l s were resuspended in 1- 5 mL of Sp i n-
n er ' s  me d i a  con t a i n i n g  10% heat - in act ivated f e t a l  c a l f  
serum . The ce l ls were enumerated on a Coul t er counter  and 
6 
t h e  concen t rat ion  of  ce l l s  was adj us t e d  t o  3 X 10  ce l ls / mL 
b y  d i lut i on w i t h  Sp i nner ' s  med i a . 
b .  I n  v it ro 
P 8 1 5  cel l s , court esy  of  Dr . Do lph Adams , Department  of  
Pat h o logy , Duke Un ivers i t y  Hosp it a l , Durham , North  Caro l i n a , 
were ma i n t a ined i n  culture f l asks ( 2 5  cm2 T f l asks , Corn ing , 
Corn i n g , New York ) i n  CDMEM . The ce l ls were passaged twi ce 
5 wee k l y  by add i n g  an a l i quot of  1 X 1 0  c e l l s  to 7 mL of  
CDMEM . When  n e eded for the prot e i n  syn t he s i s  studi e s , t he 
6 
con cen t rat ion  of ce l l s  was adj usted to 3 X 10  ce l l s / mL b y  
d i lu t ion  w i t h  CDMEM . 
5 .  Preparat ion  o f  Sub s t rat e , Drug , and I nh i b i tor Solut ions . 
a .  Cont ro l Drugs 
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Puromyc i n  d ihydroch l o r i de ( NSC- 3055 ) was obt a i ned from 
S i gma Chem i cal Company ,  St . Lou i s , MO . Sparsomy c i n  ( NSC-5972 
9NB ) and Ara- C ( NSC-63878 , 4 amino  - 1 B -Q- arab i no furanosy l - 2-
( lH ) - py r im i d i none ) were generou s l y  obta i ned from the  Nat i o-
al Cancer I n s t i t ut e , Bethesda , MD . So lut i on s  of  these drugs 
at the concen trat i ons spec i f i ed in the d i scus s i on of the  
pharmaco l o g i c a l  resu l t s  were prepared us ing the  appropri at e  
med i a  f o r  t h e  assay . 
b .  Rad i o i s ot opes 
5 125 1 . 2 (
125  - - lodo- - deoxyur i d i ne IUdR ) was obt a i ned f rom 
New E n g l an d  Nuc l ear , Bos ton , MA , and prepared as a solut ion 
o f  0 . 1  � C i  
1 2 5
IUdR in  20 �L of  2 X 1 0
- 5 
M f luorodeoxyur i dine  
( FUdR , S i gma Chem i c a l  Company , St . Lou i s , MO ) . L_ [
75
Se 1 _  
sel enome t h ion ine  was ob t a i ned f rom Amer sham Corporat ion , 
A r l i ngton He i ght s , I L , and was prepared as a solut ion of  
0 . 2  �Ci  [
75
Se l -s e l enome t h ion i ne per  20  � L  of  the  indicated 
med i a  for  t h e  assay being  per formed . 
c .  Analogues of  Sparsomy c i n  
Compounds 1 9 , 22 , 24 , 28 , 36 , 37 , 38 , 39 , 48 , a n d  50 
were prepared as 10
- 2 M aqueous stock solut ions us i n g  d i s-
t i l led  wat e r . D i lut i ons were made us i n g  med i a  to obt a i n  
t h e  concent rat ions requ i red for  experimen t at ion . Compound 
- 2  3 5  w a s  i nso lub le  i n  wat er an d was prepared as a 10 M 
a l coho l i c  solut ion  u s i n g  abso lute ethan o l . D i lut ions were 
made w i t h  med i a  to decrease the percent age of a l coho l pre-
s ent i n  t h e  ce l l  cult ure . Compounds 44 , 46 , and 52  were 
not so lub le  in wat e r  or ethanol  at the requ i red  con centra-
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t ion t hereby precluding t h e  test i ng of  t hese three compounds . 
6 .  Exper imen t a l  Procedures for the  B i o logical  Assays 
a .  DNA Synthes i s  I n h ib it ion Assay 
( 1 )  T ime Course Determinat ion 
CD- 1  m i ce were sacr i f iced by cerv i c a l  d i s locat ion . 
The lower h a l f  o f  t h e i r  bodies was washed w i t h  95% et hano l ,  
t h e  femurs were d i ssected , and a l l  the  t i ssue surrounding  
t he bone  was  removed .  Both  ends ( i f necessary ) of  the fe-
mur were cut o f f  and the marrow was f lushed out i n t o  a 
p last i c  cen t r i fuge tube  u s i n g  a 2 5-gauge needle f i l l ed 
w i t h  a MEM . Th e bone marrow suspens ion  was cen t r i fuged at 
300 X g for  ten m i nutes . The supernatent  was decanted and 
t h e  ce l l s  were resuspended i n  one mL of  aMEM . The ce l l s 
were count e d  on a Cou l t er counter and the  conce n t rat i on of  
ce l l s  adj usted  t o  3 X 10 6 ce l l s /mL by d i lut i on w i t h  aMEM . 
A f t e r  prepa r i n g  the  c e l l s , 200 � L  of t he ce l l  suspen s i on 
was added t o  each wel l of  a m icrot i t e r  plate  ( M i crotest 
I I , Fa l con  Plast i c s , Oxnard , CA ) .  I n  add i t ion t o  the  cel l s , 
20  � L  
� L  o f  
o f  125 IUdR at a concent rat i on of  0 . 1 � C i  125 I UdR/ 20 
- 5 
2 . 0  X 10 M FUdR was added to each we l l . The i n cu-
bat ion t imes were var i e d  so that s i x  we l l s  of  ce l l s  were 
harvested at  e ach t ime po i nt : 1 5 , 30 , 45 , 60 , and 120 min -
utes . Fo l low i n g  i n cub at i on , the cel l s  were harvested on a 
T it e rt ek c e l l  harvester wh i le f lush i n g  the  we l ls w i t h  nor-
mal s a l i n e  ( 1 . 5  M sod ium c h l o r i de) for comp l e t e  removal of  
t he ce l l s . The  f i l t er paper disks con t a i n g  the 125 IUdR 
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i n co rporated  into DNA were pl aced in  tubes and radioassayed 
on a gamma count e r  ( model 7000 or model 300 , Beckman I nstru-
ment s ,  Fu l l er t on , CA ) . 
( 2 )  Bone Marrow C e l l s  
Bone marrow ce l l s at  a concent rat ion of 3 X 106 ce l l s /  
mLaMEM were ob t a i ned  a s  out l ined in  sect ion V I . C . 6 . a . ( 1 ) . 
A f t er prepar i n g  the  c e l l s , 200 � L  of  the c e l l  suspens ion 
was added t o  each we l l  o f  a m icrot i t er p l at e  ( Mi crotest I I , 
Fal con Plast i c s , Oxnard ,  CA ) . I n  add i t ion to t he cel l s , 
20  � L  o f  1 2 5 I UdR at a concent rat ion of 0 . 1  � C i  1 2 5 I UdR/ 20 
�L of 2 . 0  X 10- 5  M FUdR was added to each wel l .  The com-
pounds to be t e s t e d  were added to the  m icrot i t e r  plate  i n  
20  � L  a l i quots of  10- 2  M solut ions . As  a negat ive control  
for  DNA s y n t hes i s , 20 �L  of  10 - 2  M AraC  was added to s i x  
wel l s  o f  ce l l s . The f in a l  micro t i t e r  p l at e  conta ined : 
1 2 5  6 we l ls o f  bone marrow c e l l s  ( BMC ) a n d  I BdR 
1 2 5  6 we l l s  of  each t e s t  compound + BMC + I UdR 
6 we l ls of AraC + BMC + 1 2 5 I UdR 
6 we l ls of 1 2 5 I UdR o n l y  
T h e  ce l l s  were i ncubated w i t h  t he drugs on a rocker 
p lat form for two hours . A f t er i ncubat i on , the  ce l l s  were 
harves t e d  on a T itertek cel l harvest er an d radioassayed as 
desc r ibed in sect ion I V . C . 6 . a . ( 1 ) . 
( 3 ) P388 Ce l l s  
The assay des c r i bed i n  sect ion  V I . C . 6 . a . ( 2 )  was re­
peated  u s ing  P388 ce l l s harvested f rom DBA / 2  mice w i t h  
matured P388 t umor s  according to sect ion V I . C . 4 . a .  aMEM 
was subst i tuted for Spinne r ' s  med i a .  
b .  Prot e in Synthes is I n h ib i t ion Assay 
( 1 ) T ime Course Det e rmi nat ion 
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P388 ce l ls were h arves ted f rom DBA / 2  mice with  matured 
P388 t umo rs according  t o  section  V I . C . 4 . a . The prepared 
cel l s  were added t o  a mi crot i te r  p l at e  ( M icrot est  I I , Fal­
con  P l as t i cs , Oxnard , CA ) in  a l i quots of  200 � L  per we l l .  
To each we l l  was added 0 . 2  � C i  L- [ 75Se ] -sel enomethionine  in  
20  � L  o f  Spinne r ' s  med ia . I n cubation  t imes were var ied so 
t h at s ix we l l s  of ce l l s  we re harvested at each t ime point : 
1 ,  3 ,  6 ,  1 0 , 18 , 2 1 , and 24  hour s . Fo l lowing the  a l loted 
i n cubat ion per iod , t h e  ce l l s were harvested on a T i t ertek 
ce l l  harvester  and radioassayed as descr ibed in  sect ion 
I V . C . 6 . a . ( 1 ) . 
The procedure was repeated u s i n g  bone marrow ce l l s  ob­
t ained as described in section  V I . C . 6 . a . ( 1 ) . I n cubation  
t imes were var ied so t hat t hree we l l s  of  ce l ls were har-
vested  at each t ime point : 1 ,  3 ,  14 , 18 , and 24 hours . 
( 2 )  Bone Marrow Ce l l s  
The bone marrow c e l l s  were obtained  a s  described in 
Sect ion V I . C . 6 . a . ( 1 ) , us ing  Spinner ' s  media  instead of  aMEM . 
A f t e r  adding 200 � L  of  t he prepared bone marrow ce l l s  t o  each 
we l l  of a microt iter  p l at e  ( M icrotest I I ,  Fal con P last ics , 
Oxnard , CA ) ,  each of  the  test  compounds was added t o  four 
d i f f erent we l l s in  20 �L a l iquot s .  I n  addit ion , four we l ls 
o f  con t r o l  ce l l s  were prepared by adding 20  � L  of Sp inner ' s  
media  to each o f  four we l l s  con t a i n i n g  bone marrow ce l l s . 
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As  a negat ive cont rol  for prote i n  synthes i s , 20 �L o f  10-2  
M puromy c i n  was added to f our we l l s  o f  bone marrow c e l l s . 
The ce l ls were i ncubated on a rocker p l at form for  1 . 5  hours . 
A f t er t h e  a l l o t t e d  i ncubat ion per i od , 20  � L  o f  0 . 2  � C i  
L- [ 7 5Se ] - se lenometh ion i n e / 2 0  � L  o f  Spinner ' s  media was 
added to each of the we l ls . The f inal  m icrot i t e r  plate  
con t a ined : 
4 we l l s  BMC + [ 75Se ] - selenomet h ion i n e  
75 4 we l l s  o f  each test  compound + BMC + [ Se ] - se l enome t h-
i on i ne 
4 we l l s  o f  puromy c i n  + BMC + [ 75S e ] - s e l enometh ionine  
4 we l l s  o f  [ 75Se ] _ sel enome t h i on i n e  o n l y  
T h e  m icrot i t e r  p l a t e  was i ncubated on a rocker plat form 
for twen t y - four hour s . The c e l l s  were harvested on a T i t er-
tek ce l l  harvester and radioassayed as desc r ibed in  sect ion  
V I . C . 6 . a . ( 1 ) . 
( 3 ) P388 c e l l s  
The assay described i n  sect i o n  V I . C . 6 . b . ( 2 )  was re-
peated us i n g  P388 c e l l s  harves t ed f rom DBA / 2  mice w i t h  
matured P388  tumors according  t o  sect ion V I . C . 4 . a .  
( 4 )  P 8 1 5  ce l l s  
The assay described i n  sect i on V I . C . 6 . b . ( 2 )  was re­
peated u s i n g  P 8 1 5  ce l l s  obt a i ned  f rom the cul tures descr ib­
ed  i n  sect ion I V . C . 4 . b .  CDMEM was used i ns t ead o f  Spinner ' s  
med i a . 
c .  Ce l l  Growth Studies 
( 1 ) Time Course Determ i nat ion  
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P815 ce l ls ma i n t ained  i n  cul ture V I . C . 4 . b . ) were added 
to four d i f f erent  m i c ro t i ter p l at es , ( Costar , Be l l co , Vine­
l and , New Jersey ) i n  a l iquots con t a i n in g  1 X 105 P815  ce l l s  
pe r we l l . Each of  the  test  compounds , i n  a l iquots o f  20 � L ,  
was added t o  four d i f f erent we l l s  on each p l at e , leav i n g  
four we l ls o f  ce l l s  as con t r o l s  ( 20 � L  of  CDMEM was added 
to these  four we l ls ) .  The i ncubat ion t imes for each plate  
were var i e d  to i n c l ude 9 ,  24 , 33 , and 48 hours o f  i n cubat ion . 
Fol low i n g  i n cubat i on , the c e l l s  were enumerated us i n g  a 
h emacytometer  v i ewed under a b i nocu l ar l i ght m i croscope . 
( 2 )  ED
50 
Calcu l a t i on 
P 8 1 5  ce l l s ma i n t a i ned i n  c u l t ure ( V I . C . 4 . b . ) were added 
to each we l l  of  a m icrot i t e r  p late  ( Costar , Be l lco , V i n e l and , 
New Jersey ) i n  180  � L  a l iquo t s  con t a i n i n g  approxima t e l y  
5 
2 . 5  X 10 ce l ls / mL .  Each o f  the  test compounds , i n  20  � L  
a l i quot s , was added t o  four d i f f erent we l l s  of  cel l s , leav-
i n g  four we l ls o f  c e l l s  as contro ls  ( 20 � L  of  CDMEM was 
added to these four we l l s ) . A f t er i ncubat i n g  the  mi crot i t er 
p l a t e  for twenty- four hours , the c e l l s  were enumerated u s i n g  
a hemacyt ome ter v iewed under a b i nocular l i ght mi croscope . 
Var i a t i o n s  were made i n  the  conce n t rat ion of  the  test  
drugs to dete rm i n e  the  ED
50 . 
7 .  Stat i s t i c a l  Anal y s i s  
The leve l  o f  con f i dence f o r  a l l  expe r imen t s  was set 
at n inety- f ive percen t . A one-way analys i s  of  var i ance 
146 
( ANOVA ) w i t h  a Dun n et t ' s  t - test  was used to compare a control 
to more t han one experime n t a l  group ( 99 ) . Linear regress ion 
analys i s  was used to det ermi n e  the s lopes of ce l l  growth 
curves . 
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